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Summary.
The protein DC-SIGNR (Dendritic-cell specific ICAM3 grabbing non-integrin
related) is a C-type (calcium-dependent) lectin, which binds highly-branched
mannose oligosaccharides. DC-SIGNR interacts with a range of deadly diseases via
surface glycans on pathogenic glycoproteins, and the ability of DC-SIGNR to
increase the rate of infection of viruses including human immunodeficiency virus
(HIV) and hepatitis C virus (HCV) makes the study of DC-SIGNR/oligosaccharide
interactions very attractive. The research described in this thesis sought to gain
insight into the calcium and ligand binding properties of the DC-SIGNR
carbohydrate recognition domain (CRD) in solution by utilising solution state
nuclear magnetic resonance spectroscopy (NMR).
A protocol for the production of uniformly 15N /13C labelled DC-SIGNR CRD
was developed, allowing the acquisition of heteronuclear NMR experiments and
the first assignment of the calcium-bound (holo) DC-SIGNR CRD to be reported.
The assignment has allowed investigation of calcium and glycan binding, as well
as the pH dependence of the DC-SIGNR CRD.
The data presented in this thesis reveal that the DC-SIGNR CRD is highly
dynamic in the calcium-free state, with the addition of calcium resulting in global
conformational and dynamic changes throughout the CRD. While calcium binding
hinders the protein dynamics (particularly in the calcium binding regions), a large
degree of mobility remains. The evidence that ligands are released at low pH
suggests that DC-SIGNR may act as an endocytic receptor.
In addition to calcium binding, interactions of the DC-SIGNR CRD with a
range of ligands were investigated. In particular, interactions with the
oligosaccharide Man9GlcNAc (present on the HIV viral envelope) are described,
representing the first direct study of the CRD interacting with a disease-
associated ligand. The glycans employed in this study all bind to the primary
calcium binding site, supporting previous crystal data. However, each glycan
displays distinct patterns of chemical shift perturbations implying that they each
have different, extended binding modes. Particularly striking is the difference
between the disease-associated Man9GlcNAc ligand and the ligand present in a
previously published crystal structure, (GlcNAc)2Man3.
An investigation of the dynamics of the CRD in the holo form and bound
to the ligand Man5 shows that the CRD is highly dynamic and that glycan binding
further hinders, but does not abolish, the molecular motions. The dynamics data
also suggests that a ligand-induced conformational change may occur and
indicates potential new binding sites which are not present in any published
crystal structures. The dynamic nature of the DC-SIGNR CRD may explain the wide
range of ligand specificities and affinities of the C-type lectin scaffold and
suggests that the study of the ligand binding properties and dynamics of proteins
such as DC-SIGNR in solution is essential to further understanding of this class of
proteins.
Chapter 1: Introduction
1
Introduction.
1.1 Carbohydrate Binding Proteins.
Complex carbohydrates have the potential to encode a huge amount of
biological information which can be several orders of magnitude greater than
that encoded in oligonucleotides and peptides. The ability to form different bond
configurations (α or β) at many different positions along with variations in ring 
sizes produces a vast assortment of structures (Gabius et al, 2004). Glycosylated
proteins in mammals are abundant in serum, the extracellular matrix and on cell
surfaces and have roles in cell adhesion and molecular recognition (Drickamer,
1999; Shenoy et al, 2002). In addition, the distribution of oligosaccharides differs
between mammalian and bacterial cell surfaces as well as viral envelopes and so
recognition of specific glycosylation patterns aids in pathogen recognition and the
discrimination between self and non-self (Larkin & Imperiali, 2011; Weis &
Drickamer, 1996).
Carbohydrate binding proteins, known as lectins, have evolved to de-code
the information contained within complex carbohydrate structures. In contrast to
carbohydrate binding enzymes and antibodies, lectins possess no catalytic activity
and are not the result of an adaptive immune response (Lis & Sharon, 1998).
Lectins can vary greatly in size, structure and ligand binding profiles. However,
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several sub-families exist which share similar characteristics. This project
investigates a member of the sub-family of calcium-dependent (C-type) lectins.
1.1.1 C-type Lectins.
Members of the C-type lectin family contain a C-terminal carbohydrate
recognition domain (CRD) which folds independently from the rest of the protein
structure and is entirely responsible for the carbohydrate binding activity of the
protein (Lis & Sharon, 1998). The remaining domains vary but often consist of an
N-terminal transmembrane domain and ‘neck’ regions which project the CRD
away from the cell surface. Interactions between residues in the neck domains
can promote oligomerisation and the formation of higher-order clusters on cell
surfaces. This clustering encourages multi-valent interactions with glycans,
increasing the overall binding affinity, since monomeric CRDs tend to bind
oligosaccharides with low affinity (dissociation constants are typically on the
order of 2 mM for simple glycans) (Weis & Drickamer, 1996). All animal C-type
lectins can be identified by a number of conserved residues in the CRD
(Drickamer, 1993). In addition, the ligand binding specificity can be predicted
from the CRD sequence (for example the EPN tri-peptide motif is characteristic of
mannose binding, the QPD motif of galactose binding) (Drickamer, 1999).
Although the number of calcium binding sites varies between C-type lectins, the
primary calcium binding site is conserved (see Figure 1.2-4) (Drickamer, 1999).
This calcium ion exploits the non-covalent binding ability of the monosaccharide
3- and 4-OH groups. Each OH group forms a calcium co-ordination bond in
addition to hydrogen bonds with the protein side-chain (Feinberg et al, 2001; Ng
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et al, 1996; Weis et al, 1992). This forms an intimate ternary complex between
protein, glycan and calcium which is the hallmark of C-type lectin binding. Despite
this conserved binding site and the structural similarity of C-type lectin CRDs
there is huge ligand binding diversity and C-type lectins are responsible for a vast
range of cellular functions (including pathogen recognition and neutralisation and
receptor-mediated endocytosis) (Varki et al, 2009). The mechanisms by which the
same protein scaffold can accommodate such a wide variety of interactions are
not fully understood and investigations of the extended binding sites which
confer specificity for particular oligosaccharides are still on-going in many cases.
1.2 Dendritic-cell Specific ICAM3 Grabbing Non-Integrin
Related Protein (DC-SIGNR)
DC-SIGNR (Dendritic-cell specific ICAM3 grabbing non-integrin related) is a
type II transmembrane C-type lectin that binds high mannose N-linked
oligosaccharides (Feinberg et al, 2001) present on viral envelopes and host
glycoproteins. In particular, DC-SIGNR interacts with the human
immunodeficiency virus (HIV) glycoprotein gp120 via association with branched
Man9GlcNAc2 oligosaccharides resulting in enhanced HIV infection (Bashirova et
al, 2001), as well as intercellular adhesion molecule 3 (ICAM-3) (Bashirova et al,
2001) a protein involved in initiation of primary immune response, cell adhesion
and cell signalling (Campanero et al, 1993; Defougerolles & Springer, 1992;
Montoya et al, 2002). The interaction of DC-SIGNR with ICAM-3 along with the
fact that DC-SIGNR shares 77% sequence identity with the protein DC-SIGN
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(Dendritic-Cell specific ICAM3 grapping Non-integrin) (Soilleux et al, 2000), which
acts as an adhesion receptor, with roles in antigen presenting, cell signalling and
cell trafficking (Svajger et al, 2010), has led to speculation that DC-SIGNR may
have a similar function. However, unlike DC-SIGN, which is expressed
predominantly on dendritic cells (Geijtenbeek et al, 2000), DC-SIGNR is expressed
on specialised endothelial cells found in the liver, lymph node, placenta and
epithelial cells of the upper respiratory tract (Chen et al, 2007; Soilleux et al,
2000). As a result of the difficulties in studying these native cell types, the true
physiological function of DC-SIGNR is not known with confidence but recent
studies have confirmed that DC-SIGNR can act as an adhesion receptor (Yabe et
al, 2010) and is involved in cell signalling which can modulate immune response
(Johnson et al, 2012). There is also evidence that DC-SIGNR may act as an
endocytic receptor by internalising ligands and then releasing them at low pH in
the cytosol (Gramberg et al, 2008; Snyder et al, 2005b). However, DC-SIGNR
contains only a single internalisation motif (while DC-SIGN contains an additional
internalisation motif consisting of a tyrosine which is separated from a leucine by
two amino acids; Y L) and another report shows that DC-SIGNR/oligosaccharide
binding is not pH dependent and does not internalise ligands (Guo et al, 2004).
1.2.1 Structure.
DC-SIGNR consists of four distinct domains as shown schematically in
Figure 1.2-1. A short N-terminal cytoplasmic domain containing a di-leucine
internalisation motif is followed by a single transmembrane domain which
anchors the protein in to the cell surface. An α-helical ‘neck’ consisting of 7.5 
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highly conserved, 23 amino acid repeats projects the carbohydrate recognition
domain (CRD) away from the cell surface. The neck is responsible for tetramer
formation (Yu et al, 2009) while the calcium binding and carbohydrate
recognition properties of DC-SIGNR are contained solely within the CRD (which
exists as a monomer in solution (Mitchell et al, 2001)). As such, this project
concentrates on the structure and binding properties of the CRD in isolation (the
amino acid sequence of the CRD used throughout this project is shown in Figure
1.2-2).
Figure 1.2-1: Schematic representation of full length DC-SIGNR. The full length protein consists of
four distinct domains. A carbohydrate recognition domain is projected away from the cell surface
by an α-helical neck. The neck is anchored in to the cell membrane by a single transmembrane 
domain followed by a short cytoplasmic domain.
Figure 1.2-2: DC-SIGNR CRD sequence. The CRD sequence is numbered with the amino acid
position in the full length protein. This is the fragment of the protein used throughout this project.
α-helical 
‘neck’
Cytoplasmic
domain
Carbohydrate
recognition
domain
Transmembrane
domain
AERLCRHCPK DWTFFQGNCY FMSNSQRNWH DSVTACQEVR AQLVVIKTAE EQNFLQLQTS
RSNRFSWMGL SDLNQEGTWQ WVDGSPLSPS FQRYWNSGEP NNSGNEDCAE FSGSGWNDNR
CDVDNYWICK KPAACFRDE
270 280 290 300 310 320
330 340 350 360 370 380
390 399
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1.2.2 The Carbohydrate Recognition Domain (CRD).
The DC-SIGNR CRD adopts a typical ‘lectin fold’ consisting of α-helices and
anti-parallel β-sheets connected by irregular loops which are stabilised by 
disulphide bonds and calcium ions (Drickamer, 1997). Thus far, X-ray
crystallography has been the primary method employed for atomic-level study of
the DC-SIGNR CRD structure. A number of crystal structures have been
determined for the DC-SIGNR CRD: 1) in complex with the branched
pentasaccharide (GlcNAc)2Man3 (PDB: 1K9J) (Feinberg et al, 2001), 2) in the
absence of ligand (but in complex with one Ca2+) and containing a portion of the
N-terminal α-helical neck region  (PDB: 1XPH) (Snyder et al, 2005a), 3) with two 
repeats of the α-helical neck region and one sodium ion bound (but no bound 
Ca2+, PDB: 1XAR) (Feinberg et al, 2005); and 4) in complex with Lewis-x
trisaccharide and containing a portion of the neck (PDB:1SL6) (Guo et al, 2004).
There is very little variation in CRD conformation across all crystal structures
(Figure 1.2-3).
Figure 1.2-3
crystal structure bound to (GlcNAc)
(black) are shown
that the DC
glycan.
Figure
primary loop (this calcium is present
two in a secondary binding loop. To date
binding of Ca
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The primary calcium ion binds to the internal α1-3-linked mannose in 
(GlcNAc)2Man3 forming coordination bonds with the equatorial 3- and 4-OH
groups. Amino acids that directly bind to the primary calcium also form hydrogen
bonds with the ligand (Feinberg et al, 2001). This binding paradigm at the primary
site is well characterised (and is the hallmark of C-type lectin binding). It has been
previously indicated that the EPN sequence is responsible for mannose specificity,
as mutation to QPD in the mannose-binding protein switches the specificity to
galactose (Drickamer, 1992), while the location of speculated extended secondary
glycan binding sites (shown in Figure 1.2-4 (B)) vary between lectins and confers
specificity for larger oligosaccharide substructures (Guo et al, 2004). The
extended glycan binding site of DC-SIGNR is less well characterised due to the
lack of crystal structures in complex with disease associated ligands and lack of
extensive mutagenesis studies. As a result, all oligosaccharides are assumed to
interact with DC-SIGNR in the same way as (GlcNAc)2Man3.
Figure 1.2-
(GlcNAc)2Man
CRD (PDB: 1K9J). Regions of interest are marked on to the
calcium ions are represented by green spheres. The mannose residues in the (GlcNAc)
glycan are light grey while the GlcNAc residues are dark grey. Disulphide bonds are highlighted in
blue. (B) Highlights the extended b
formed by α
The 1K9J crystal (
site for the DC
and a solvent exposed F
the loop joining β
formed by α
moiety ‘arm’ of (GlcNAc)
hydrogen bonds with S
involved in binding). In addition, it is speculated that the F
responsible fo
mannose moiety (grey box in
4: (A) Crystal structure of DC
3 extended binding site
-helix 2 and the solvent exposed residue F
-SIGNR
-sheets 6 and 7 forming a continuous binding surface. The ‘shelf’
-helix 2 and F
r the selective binding of DC
.
inding site for the (GlcNAc)
Figure 1.2
-(GlcNAc)2
325 residue. The C
325 creates a complementary shape to the Manα1
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372 (see
Figure
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(A) The first published crystal structure of the DC
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325.
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Man9GlcNAc2) as it sterically hinders binding to the inner branched mannose
(dashed box in Figure 1.2-5) (Feinberg et al, 2001).
Figure 1.2-5: Schematic representation of (GlcNAc)2Man3 and Man9GlcNAc2. The (GlcNAc)2Man3
and Man9GlcNAc2 glycans are represented schematically. The inner tri-mannose structure of
Man9GlcNAc2 (dashed box) is believed to be precluded from the DC-SIGNR binding site by residue
F325 while the outer branched tri-mannose (grey box) binds to the CRD.
Although the published crystal structures provide insight in to the
conformation of the DC-SIGNR CRD and the modes of glycan binding, a structure
is yet to be resolved for the CRD in complex with a disease associated ligand (such
as Man9GlcNac2 present on the HIV viral envelope glycoprotein gp120). Indeed,
DC-SIGNR has extremely low affinity for both the ligands present in the crystal
structures ((GlcNAc)2Man3 and LewisX) as neither glycan has been highlighted in
glycoarray screening (Guo et al, 2004; Yabe et al, 2010). As such, these glycans do
not accurately represent physiologically-relevant ligands. Difficulties in obtaining
crystals of DC-SIGNR CRD in complex with physiological ligands are likely due to
the inherent flexibility of highly branched oligosaccharides such as Man9 (Woods
et al, 1998). Crystal structures of branched mannose glycans (Man6, Man4 and
Man2) in complex with the CRD of the analogous protein DC-SIGN do not contain
the full ligand, suggesting that the regions of the glycan that are not in direct
contact with the CRD maintain a degree of flexibility (Feinberg et al, 2007; Guo et
(GlcNAc)2Man3
α 6
α 3
β 2
β 2
= mannose
= GlcNAc
Man9GlcNAc2
gp120
β 4 β 4
α 6
α 3
α 3
α 6
α 2α 2
α 2
α 2
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al, 2004). In addition, evidence of multiple binding modes suggests that the
mobility/dynamics of the system may preclude formation of diffraction quality
crystals.
1.2.3 Tetramer Formation.
Although individual CRDs exist as monomers and bind sugars with
relatively low affinity (the Ki of mannose is ~3.2mM and Man9GlcNAc2 ~0.19mM
(Mitchell et al, 2001)), the formation of the full length tetramer clusters the CRDs
together increasing the affinity for binding specific patterns of oligosaccharides
on the surfaces of glycoproteins (Snyder et al, 2005b). Crystal structures have
been solved for the CRD containing one repeat of the neck domain (PDB: 1XPH)
as well as a tetramer of neck repeats in the absence of the CRDs (PDB: 3JQH)
allowing a full extracellular tetramer of DC-SIGNR to be modelled (Feinberg et al,
2009). These studies have shown that the neck forms an extended α-helical 
structure, that the CRD and the neck regions behave independently, and that the
CRD is attached to the neck by a flexible linker which may allow the CRDs to re-
orient to engage with ligands. The orientations of the CRDs may impose
restraints on ligand binding, suggesting that the arrangement of the CRD cluster
and disposition relative to the neck could have an effect on higher order binding
specificity. Indeed, DC-SIGNR polymorphs with varying neck lengths (ranging from
3-9 repeats) have been identified in humans and hetero-tetramers of the
polymorphisms have proven to be stable (Guo et al, 2006). This has led to
speculation that the arrangement of CRDs with different neck lengths may affect
the affinity of binding and in turn an individual’s susceptibility to viral infection.
Chapter 1: Introduction
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There is evidence that variations in the DC-SIGNR locus can increase HIV-RNA
blood levels and sexual transmission (Xu et al, 2010), decrease viral load in
hepatitis C virus (HCV) infection (Nattermann et al, 2006) and reduce rates of
severe acute respiratory syndrome coronavirus (SARS-CoV) infection (Chan et al,
2006). However, the effect of DC-SIGNR polymorphism on infection susceptibility
is still under debate as some authors have reported no significant association
between DC-SIGNR genotype and infection (Gramberg et al, 2006; Li et al, 2008;
Zhu et al, 2010).
The clustering of CRDs in the tetramer coupled with the high glycosylation
of certain viral envelopes may explain the preference of DC-SIGNR to bind a range
of deadly viruses including HIV (Myszka et al, 2000) and HCV (Pohlmann et al,
2003) as glycosylation patterns on pathogen surfaces are distinct from those on
mammalian cells.
1.2.4 Implications in Disease.
DC-SIGNR was first investigated due to its ability to bind gp120, the
glycoprotein expressed on the HIV-1 viral envelope, and increase in trans
infection (illustrated in Figure 1.2-6) of CD4+ cells (the receptor CD4 plays an
essential role in the HIV infection pathway by binding gp120 and promoting HIV
cell entry (Dalgleish et al, 1984; Kwong et al, 1998) ) (Baribaud et al, 2001). It has
been concluded that DC-SIGNR has the potential to promote in trans infection of
HIV in vivo as it is expressed on endothelial cells adjacent to CD4+ cells in the liver
and placenta while CD4+ T-lymphocytes constantly migrate past the DC-SIGNR
expressing sinus endothelial cells present in the lymph node (Nokta et al, 2001;
Soilleux et al, 2002)
capturing properties of DC
DC-SIGNR triggers a conformational change in the viral envelope increasing
coreceptor affinity
provide a means of evading the host immune system by reducing the efficiency of
antibody binding and neut
(the primary site of HIV replication
highlights the potentially devastating role of this protein in HIV infection.
Figure 1.2-6
in trans. First
However, the virus does not infect the endo
infectious state attached to the cell surface. If a ‘target cell’ expressing the appropriate viral co
receptor (CD4 in the case of HIV infection)
cell which becomes
It is possible that DC
(transmission of HIV from mother to child) of HIV across the plac
birth. The mechanism of vertical transmission is not fully understood and despite
interventions in the form of Caesarean sections and anti
transmission before birth accounts for ~2% of HIV cases. Thus any protein
involved in HIV binding at the maternal
. However, it is not known if HIV
(Myszka et al, 2000)
: Illustration of
, DC-SIGNR binds a high
fully infected. This process can enhance host infection.
-SIGNR and its proximity to CD4+ cells, or if binding to
ralization. Expression of DC
in trans infection.
-
-
. In addition, binding to DC
in vivo) and placental endothelial cells further
DC-SIGNR enhances infection of viruses
mannose oligosaccharide on a viral envelope glycoprotein.
thelial cell expressing DC
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SIGNR is involved in the vertical transmission
-foetal boundary is certainly worthy of
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, DC-SIGNR transfers the virus to the target
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study (Soilleux & Coleman, 2003). DC-SIGNR is of particular interest as it has been
shown to bind glycoprotein on the envelopes of several other deadly viruses
including HCV (Pohlmann et al, 2003), severe acute respiratory syndrome
coronovirus (SARS-CoV) (Jeffers et al, 2004) and avian H5N1 influenza (Wang et
al, 2008). Also, the localisation of DC-SIGNR echoes the primary sites of
replication and infection of many of the diseases with which DC-SIGNR interacts.
HCV leads to chronic infection in ~70% cases and it is possible that DC-SIGNR
expression in the liver sinusoidal endothelial cells contributes to this by capturing
HCV and presenting the virus to adjacent hepatocytes. DC-SIGNR is also
expressed in human lung type II alveolar cells, suggesting it may play a role in
establishing infection at the initial sites of SARS-CoV exposure.
In addition to capturing virus and promoting in trans infection, DC-SIGNR
is utilised by viruses such as Ebola (Simmons et al, 2003) as a direct point of entry
into the host (in cis infection). Indeed, DC-SIGNR is exploited by a range of
pathogens including viruses and mycobacteria (leprosy (Barreiro et al, 2006),
tuberculosis (Tailleux et al, 2003)) in order to increase infectivity and evade the
host immune system and it has also been shown to interact with parasites
(Caparros et al, 2005) and tumour cells (Nonaka et al, 2008). As a result, DC-
SIGNR has been classed as a universal antigen receptor.
1.3 Motivation for Research.
The ability of DC-SIGNR to interact with a range of lethal diseases and
promote infection both in cis and in trans makes this a C-type lectin particularly
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worthy of study. A detailed understanding of DC-SIGNR-oligosaccharide
interactions could provide new therapies for a range of serious diseases for which
effective treatments do not currently exist. As the association of virus to cell-
surface molecules such as DC-SIGNR can be a rate limiting step in infection, these
treatments would be an attractive method of decreasing the rate of infection and
reducing viral load in cases where DC-SIGNR promotes infection in trans (HIV,
HCV).
While published crystal structures provide insight into the conformation
of the DC-SIGNR CRD and glycan binding mechanism, direct observation of
complexes with larger, physiological oligosaccharides such as Man9GlcNAc2
remains elusive. This may be due to as yet uncharacterized conformational and
dynamic factors of the CRD that prohibit crystal growth and diffraction. In
addition, little is known regarding the effect of calcium binding on the CRD and,
despite the extensive list of ligands, there are few direct measurements of
binding affinities. In addition, the dynamics of the DC-SIGNR CRD have not been
characterised. NMR has the potential to address all of these questions with the
advantage that measurements can be made in solution, under near-physiological
conditions.
High-field nuclear magnetic resonance (NMR) studies of DC-SIGNR CRD
have not been reported, although NMR studies of ligand interactions with the
homologous protein DC-SIGN have started to emerge (Angulo et al, 2008; Guzzi et
al, 2011; Mari et al, 2005; Prost et al, 2012; Reina et al, 2008; Reina et al, 2007;
Timpano et al, 2008). These largely ligand-based studies (i.e. properties of the
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ligand are measured in free and bound states with no measurements of the
changes that occur to the protein) have also been restricted to the use of small
glycans and sugar mimetics and have neither approached the conformational or
dynamics characterization of DC-SIGN in solution nor included larger physiological
glycans such as Man9GlcNAc2. Furthermore, many of these studies typically
employ molecular docking to the static crystal co-ordinates when modeling
binding interactions, perpetuating the assumption that the DC-SIGN
conformation in the crystals is the same for every CRD-ligand complex as well as
that in solution. As a result, binding of disease-associated ligands such as
Man9GlcNAc2 to molecules such as DC-SIGNR and DC-SIGN has been assumed to
be analogous to the binding of smaller glycan fragments as observed in the
crystalline state (Feinberg et al, 2007; Guo et al, 2004). As the lowest energy
structure of smaller sugar fragments can differ from the conformation when part
of a larger, branched oligosaccharide (Woods et al, 1998), the direct observation
of DC-SIGNR with large oligosaccharides would be advantageous.
The goal of this project is to increase current understanding of DC-SIGNR-
ligand interactions by investigating the binding of the DC-SIGNR CRD to a number
of oligosaccharides in solution using heteronuclear solution-state NMR
techniques that can readily deal with issues of dynamics (which may be holding
back progress in crystallography). The first backbone assignment of the DC-SIGNR
CRD is reported as well as the first structural data for binding of a disease-
associated ligand (Man9GlcNAc). These results are extended using the first
measurements of transverse and longitudinal 15N relaxation rates for the holo
and Man5-bound CRD. The data obtained suggest that the conformation and
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dynamic properties of DC-SIGNR in solution are distinct from the existing crystal
"snapshots", and that studying this protein in solution is essential for illuminating
important aspects of its intrinsic physical chemistry.
1.4 Nuclear Magnetic Resonance Spectroscopy.
To date the only techniques capable of determining high resolution
molecular structures are X-ray crystallography and NMR spectroscopy. NMR is
particularly suitable for the study of proteins as it allows the determination of
structures under close to physiological conditions in solution. In addition, NMR
can be used to investigate the thermodynamic and kinetic properties of proteins,
protein-ligand interactions, protein folding, and protein dynamics.
What follows is an introduction to the basic principles of NMR
spectroscopy. For simplicity the more intuitive, classical representation will be
used to represent the NMR phenomenon. In reality, NMR spectroscopy is based
on the intrinsic, quantum mechanical property of spin which cannot be described
(or visualised) by classical means.
1.4.1 Spin Angular Momentum.
All nuclei which do not contain an even number of protons and neutrons
possess the quantum mechanical property spin angular momentum (or spin). Spin
produces a magnetic dipole moment directly proportional to the spin angular
momentum moment and so nuclei with non-zero spin can be thought of as small
electromagnets. Equation (1.1) relates the nuclear magnetic dipole to the nuclear
spin quantum number . The value of the gyromagnetic ratio is different for
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different nuclear species resulting in differences in the strength of the magnetic
dipole moments and differences in their NMR frequencies.
(1.1)
where Planck’s constant
ଶగ
The application of an external magnetic field (B0) causes the nuclear spins
to orient in the direction of the external magnetic field (similar to a compass
aligning with north and south). In protein NMR spectroscopy, we are primarily
concerned with spin ½ ଵ
ଶ
nuclei (such as 1H, 13C, and 15N) because these split
in to only two energy levels in the magnetic field, one parallel and the other anti-
parallel to the applied magnetic field (Figure 1.4-1). The ratio of parallel to anti-
parallel spins is given by a Boltzmann distribution which shows that, at thermal
equilibrium, the two energy levels are nearly equally populated (as a result NMR
possesses inherently low sensitivity). Nevertheless, there is a slight excess of
spins parallel to the magnetic field resulting in a net macroscopic magnetization
(M0) which can be measured (Figure 1.4-1).
Figure 1.4-1
magnetic field (left) the spins are oriented isotropically. If an external magnetic field (B
(right) spin ½ nuclei orient parallel and antiparallel to the magnetic field. There is a small excess of
parallel spins resulting in a net magnetization (M
1.4.2 Larmor
If an external magnetic field is applied along the
magnetic moments will precess about this axis as shown in
of the precession is known as the Larmor frequency
that the Larm
nucleus
property of the nucleus (i.e. it is different for each isotope) and dependent on the
strength of the extern
spectrometer detects.
However, in order to observe the Larmor
moment must be perturbed away from the
application of a radio frequency (RF) pulse perpendicular to the external magnetic
: Distribution of spins in external magnetic field.
Frequency.
or frequency is dependent on the gyromagnetic ratio of a particular
as well as the external magnetic field. Therefore, it is a physical
al magnetic field. It is the Larmor precession that the NMR
0).
଴ ଴
-axis. This is achieved by the
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(1.2)
field. Applying an RF pulse at the Larmor frequency has the effect of rotati
equilibrium magnetization towards t
sufficient time, the magnetization is completely transferred from the
- plane (
magnetization is perturbed by 90°. The magnetization is now precessing in the
plane which induces an electrical current that can be
coil.
Figure 1.4-2
(B0) along the z
(M0) parallel to the magnetic field.
Figure 1.4
: A Spin precess
-axis causes the nuclear spins to precess about that axis w
-3). This pulse is called a 90° excitation pulse as the
ing about the magnetic field.
he -plane. If the RF pulse is applied for a
Application of an external magnetic field
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Figure 1.4-3
magnetization to rotate.
RF pulse along the
duration of the RF pulse is sufficient the magnetization is transferred to the
precessing in the
1.4.3 Free Induction Decay (FID).
As the precession of the magnetic moment in the
non-equilibrium state, the magnetization returns to the
equilibrium) in the absence of the RF pulse (
parameters R
relaxation rates respectively. R
magnetization as a result of the interaction of spins with the surrounding lattice
while R2 is a result of the interactions between spins. This results in the amplitude
of the detec
(FID) because it is a measure of the decay rate as a function of time (
The FID con
over time. Fourier analysis converts the time dependent FID in to a function of
frequency resulting in an NMR spectrum.
: An RF pulse perpendicular to the external magnetic field causes the equilibrium
-axis at the Larmor frequency causes the magnetization to rotate. If the
-plane which induces an electrical current which can be
1 and R
ted signal decaying over time and is known as a free induction decay
tains the evolution of many different frequencies (different nuclei)
At thermal equilibrium
2 which are known as the longitudinal and transverse
the net magnetization (M
1 represents the return to equilibrium of the
Figure 1.4
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-4).
Figure 1.4-4
equilibrium state along the
is detected by a receiver coil as a free
transforms the time domain
1.4.4 Chemical Shift.
Because each nucleus in the magnetic field acts as a small electromagnet,
each nucleus pr
For example, the magnetic field produced by the electron shell surrounding a
nucleus acts as a shield from the external magnetic field causing the nuclei to be
at a lower resonance frequenc
to the right) in the NMR spectrum. In contrast, electronegative groups are de
shielded and appear downfield (shifted to the left) in the spectrum. As a result,
the magnetic field experienced by each nucle
to precess at a different frequency resulting in separation of the signals in the
NMR spectrum (chemical shift). The chemical shift is an essential component of
NMR spectroscopy as it contains a vast amount of informati
: Free induction decay.
oduces a local magnetic field which can oppose the external field.
-axis. The precession of the nucleus creates an electric current which
in the FID in
y than expected and appear shifted upfield (shifted
Following the RF pulse, magnetization returns to the
induction decay (FID). Fourier transformation of the FID
to a frequency domain resulting in an NMR spectrum.
us is different causing each nucleus
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structure. The chemical shift allows different chemical structures (i.e. aliphatic vs
aromatic protons) to be distinguished (see
structure in proteins to be identified. In addition, the distribution of chemical
shifts in a protein (also called dispersion) allows the extent of protein folding to
be determined. A well dispersed spectrum (many different chemical sh
indicates that the nuclei are in many different environments, as would be
expected for a protein containing elements of secondary structure (α
sheet) along with a well
folded protein
all close to their random coil values resulting in a narrow dispersion (many
chemical shifts in the same region of the spectrum).
Figure 1.4-5
structures are distinct and reside in defined regions of the spectrum. The chemical shifts of the
CRD are well dispersed across the
present and the protein is well folded. Due to the size of the CRD the 1D spectrum is complex,
with many overlaying chemical shifts.
all experience similar environments and so the chemical shifts are
: 1D-1H spectrum of DC
-defined tertiary fold. In contrast, the nuclei in an un
1H dimension suggesting that secondary struc
-SIGNR CRD.
Figure 1.4-
The chemical shifts of certain molecular
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Figure 1.4-5 shows that, due to the size of the DC-SIGNR CRD (139 amino
acids), the 1D-1H spectrum contains many overlapping signals and thus is far too
complex to interpret. For this reason two-dimensional (2D) and three-
dimensional (3D) heteronuclear (15N and 13C) experiments are utilised. A 2D
experiment can separate overlapping peaks in 1D spectra (for example the peaks
in Figure 1.4-5) by the addition of a second dimension. Throughout this thesis we
are only concerned with 2D experiments which correlate two 1D spectra (through
a direct bond or through space) as shown in Figure 1.4-6. A common example of
this is the 1H-15N heteronuclear single quantum coherence (HSQC) spectrum
which only contains amide signals. The HSQC experiment and 3D experiments are
described in more detail below.
Figure 1.4-6: Simplified representation of a 2D experiment. 2D experiments can be created by
combining two 1D spectra (i.e. a 1H and 15N spectra). In this case, peaks in the 2D spectrum are
only present if there is a correlation between peaks in the 1D spectra (either through a direct
bond or through space depending on the experiment used). If a peak in the 1D spectrum does not
correlate with anything in the second 1D spectrum (red peaks) then there is no corresponding
peak in the 2D spectrum.
[ppm]
[ppm]
Two 1D spectra
combine
to form a 2D spectrum
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1.5 NMR Assignment Strategy.
In order to study conformational and dynamics changes in the CRD of DC-
SIGNR upon interaction with ligands, an assignment of the protein backbone
residues is required. Due to the size of the protein, 3D heteronuclear triple
resonance experiments will be used to assign sequentially the protein backbone.
This section gives a brief introduction to the NMR experiments used for the
amino acid assignment and the sequential assignment method.
1.5.1 The Heteronuclear Single Quantum Coherence (HSQC)
Experiment.
A good quality heteronuclear single quantum coherence experiment
(HSQC) (Davis et al, 1992) is a prerequisite for successful protein assignment. The
1H-15N HSQC spectrum of DC-SIGNR shows coupling between hydrogen and
nitrogen atoms in amide functional groups found in the protein backbone and
side-chains (Figure 1.5-1). This spectrum contains one signal for each amino acid
due to the backbone amides, and additional signals for side-chain amides. The 1H
and 15N chemical shifts of each peak are determined by the chemical
environment of the amide group, therefore the HSQC spectrum depends upon
the fold of the protein. For this reason, the HSQC spectrum is often referred to as
the protein’s ‘fingerprint’ and a well dispersed spectrum (like the spectrum of the
DC-SIGNR CRD in Figure 1.5-1) is characteristic of a well-folded protein.
Figure 1.5-1
double labelled DC
correlated by the experiment are highlighted in green. The spectrum contains one peak for each
amino acid in the protein due to the backbone amide with some extra peaks due to the side chain
amides.
The HSQC spectrum can al
changes in residues affected by ligand binding. This is an ideal method for
identifying protein residues involved in DC
because, if the chemical environment of an amino acid
ligand binding or some change in the protein conformation or dynamics as a
result of binding), the position of the peak corresponding to that amino acid will
change. In order to identify which amino acid has changed chemical enviro
upon ligand binding, each peak in the HSQC spectrum must be assigned to an
amino acid in the protein sequence. As the DC
139 amino acids in length), there are several overlapping peaks in
and it is not possible to achieve a full assignment from the HSQC data alone. For
this reason, triple resonance (3D) NMR experiments are used.
: The heteronuclear single quantum coherence (HSQC) experiment.
-SIGNR CRD at 37°C is shown as an example.
so be used as a ‘map’ to detect conformational
-SIGNR/oligosaccharide interactions
-SIGNR CRD is relatively large (at
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1.5.2 Triple
Assignment.
Triple resonance experiments are used in order to extend the two
dimensional HSQC spectrum into a third (
1.5-2). This allows overlapping peaks in the
unambiguously resolved in the
chain carbon chemical shifts give further information that can be used to identify
the amino acid
over all proteins deposited in the biological magnetic resonance data bank) for
the Cα and C
have similar carbon chemical shifts, some are easily identified and can be used to
start the assignment process. For example, serine, threonine, glycine and alanine
have characteristic C
Figure 1.5-2
only 2 peaks (green) is extended upwards into a third carbon dimension to for
analysis of the 3D data set can be simplified by
shown at a single
the HSQC peak at
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transfer pathway but not shown in the spectrum are listed in parentheses. For
example, the CBCA(CO)NH (Grzesiek & Bax, 1992) experiment shows correlations
between the backbone amide hydrogen and nitrogen atoms, the α-carbon and 
the β-carbon (Figure 1.5-4).  The magnetization is transferred via the carboxyl 
group, but a peak for this carbon is not seen in the spectrum. For each amino acid
( ), the CBCA(CO)NH spectrum correlates the backbone amide of ( ) with the two
carbon atoms (the Cα and Cβ) from the previous amino acid ( ) (as the
magnetization is being transferred ‘backwards’ via the CO). The result is a 3D
dataset with two carbon signals at the same nitrogen and hydrogen chemical
shifts as each peak in the HSQC spectrum (Figure 1.5-4).
Figure 1.5-4
of the CBCA(CO)NH and CBCANH experiments. During the CBCA(CO)NH experiment (pink) the
amide of amino acid
CBCANH experiment the amide of amino acid
Cβ( ) resulting in four peaks. The C
to be easily identified. (B) Ove
CRD. By overlaying the two spectra we can identify which signals belong to residue
to .
In order to assign sequentially the protein backbone, triple resonance
experiments are always carried out in pairs so that the carbon chemical shifts of
both the
experiment is paired with
: The CBCA(CO)NH and CBCANH experiments.
is correlated with the C
and
rlay of CBCANH and CBCA(CO)NH of double labelled, holo DC
residues can be unambigously identified. The CBCA(CO)NH
the CBCANH experiment. The CBCANH
α
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Mueller, 1993) experiment correlates the backbone amide group of residue with
the Cα and Cβ atoms in the same residue as well as with the Cα and Cβ of the
previous residue (Figure 1.5-4). This results in four carbon signals being
correlated to each backbone amide (four carbon signals for each peak in the
HSQC). However, due to loss of magnetization, the carbon signals from residue
are often weak/missing as seen in Figure 1.5-4 (B). Overlaying the
CBCA(CO)NH spectrum with the CBCANH spectrum (Figure 1.5-4 (B)) allows the
carbon signals belonging to each residue ( vs ) to be identified along with
which signals arise from the Cβ atoms, as these are opposite in phase and will
appear negative (orange peaks in Figure 1.5-4) in the CBCANH spectrum.
Taken together, data from these experiments can be used for sequential
assignment. First, a peak in the HSQC spectrum at a particular 15N and 1H
chemical shift is selected and classified as amino acid . Then, carbon chemical
shifts for Cα and Cβ atoms of amino acid are identified using the CBCANH. If
these same carbon shifts are present in the CBCA(CO)NH spectrum, the
neighbouring residue in the amino acid sequence can be found (by overlaying
with the CBCANH) and annotated on the HSQC as amino acid . Using this
method, chains of sequential amino acids are produced. Some of the amino acids
can be identified by their carbon chemical shifts and, if a unique sequence of
amino acids is found (appears only once in the protein sequence), the chain can
be assigned.
Figure 1.5-5 shows strip plots of data linking a sequential chain of amino
acids in the DC-SIGNR CRD via CBCA(CO)NH/CBCANH experiments. Using the
average chemical shifts given in
is a threonine or a serine due to the high C
residue
are no serine residues followe
1.2-2), residue
CRD in Figure
by an alanine and so an ambiguous assignment can be made.
Figure 1.5-5
overlaying the CBCANH and CBCA(CO)NH experiments, chains of sequential amino acids can be
assigned. Using unique C
low Cβ shift of strip
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In principle, a full backbone assignment can be achieved from this pair of
experiments alone. However, degeneracy (overlapping peaks) in the carbon
dimension or weak signals (due to the low sensitivity of the CBCANH and
CBCA(CO)NH experiments) can cause the chain to break, as seen in strip of
Figure 1.5-5. For these reasons, more experiments are usually required.
Figure 1.5-6 shows how the HNCA/HN(CO)CA and HNCO/HN(CA)CO
experiments (Bax & Ikura, 1991; Clubb et al, 1992; Kay et al, 1990) are used to
sequentially assign the protein. These experiments are more sensitive than the
CBCANH as the transfer of magnetization via the one bond 13Cα-15N J coupling in
the CBCANH is inefficient, particularly in proteins ~20 KDa and larger where Cα
line widths can be greater than the ~11 Hz coupling constant (Bax, 1994). In
addition the HNCA/HN(CO)CA and HNCO/HN(CA)CO experiments can be acquired
with better resolution in the 13C dimension in a reasonable time, given that the
sweep width is smaller due to less variation in chemical shift values (as compared
with the CBCANH/CBCA(CO)NH experiments) and are much more useful for
forming chains of sequential amino acids. Figure 1.5-6 shows a segment of a chain
of sequentially assigned amino acids in the DC-SIGNR CRD to illustrate the high
signal/noise ratios of these experiments.
Figure 1.5-6
transfer pathways of the HNCA/HN(CO)CA and HNCO/HN(CA)CO. For sequential assignment the
experiments are run in pairs, one shows atoms in amino acid
amino acid
(light blue) experiments. The method for assignment using the HNCO/HN(CA)CO experiments is
the same.
However, as the C
acids, it is difficult to assign the spectra with these experiments alone. The C
gives much more informat
experiments is usually required for sequential assignm
and Cβ shifts are similar for the majority of amino acids, experiments that
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future. While published crystal structures of the DC-SIGNR CRD have provided
valuable information of the CRD conformation and interactions with the
pentasaccharide (GlcNAc)2Man3, crystals of the CRD in complex with disease
associated ligands remain elusive. In addition, little is known of the effect of
calcium binding or the dynamic characteristics of the CRD in solution. This project
aims to address these questions using NMR spectroscopy. In order to study the
CRD via NMR spectroscopy isotopically labelled 15N/13C recombinant protein has
been produced in abundance. Heteronuclear experiments have been used to
complete the first assignment of the DC-SIGNR CRD. This assignment facilitates
the investigation of ligand and calcium binding along with the dynamic properties
of the CRD and in particular the first direct investigation of a disease associated
ligand (Man9GlcNAc) is reported.
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Materials & Methods
2.1 Suppliers of Reagents and Chemicals.
All reagents used in this study were of the highest grade available and
were supplied by Fisher Scientific (UK) or Sigma (UK), unless otherwise stated.
2.1.1 Carbohydrates.
All carbohydrate fragments ((GlcNAc)2Man3 (M592), Man3 (M336), Man5
(M536), GlcNAc3 (C8003)) were purchased from Dextra Labs (Dextra, Science and
Technology Centre, Earley Gate, Whiteknights Road, Reading, RG6 6BZ, UK.). The
Man9GlcNAc was prepared by digestion of recombinant gp120 with
Endoglycosidase H using gp120 glycoprotein harvested from kifunensine-treated
HEK293 cultures, followed by oligosaccharide isolation via reverse-phase
chromatography and kindly supplied by Dr. Christopher Scanlan, Oxford
Glycobiology Institute, Oxford, UK.
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2.2 Bacterial Strains.
Table 2.2-1: Escherichia coli strains used in this study.
Strain Genotype Reference
DH5α supE44, ΔlacU169(φ80lacZΔM15), hsdR17, 
redA1, endA1, gyrA96, this-1, relA1
(Hanahan, 1983)
BL21(DE3) hsdS gal (λcIts857 ind1 Sam7 nin5 lacUV5-T7 
gene 1)
(Studier &
Moffatt, 1986)
2.3 Plasmids
Table 2.3-1: Previously generated plasmids used in this study.
Plasmid Details Reference
pT5T-
CLEC4M
Pt5t, DC-SIGNR CRD insert sequence-
Q9H2X3 (CLC4M_HUMAN), Ampr
(Mitchell et al,
2001)
2.4 DNA Manipulation.
2.4.1 Preparation of Plasmid DNA.
Plasmid DNA was isolated using a QIAprep Mini-prep kit (Qiagen,
Germany). The kit was used according to the manufacturer’s instructions and
plasmid DNA was recovered in 50 µL deionized water (dH2O) and stored at -20°C.
2.4.2 Sequencing of Plasmid DNA.
Sequencing was performed by GATC biotech LTD, London, UK using T7
primers provided by GATC.
Chapter 2: Materials and Methods
38
2.5 Growth and Maintenance of E. coli.
2.5.1 Rich Media
Luria-Bertani (LB) medium (10 g/L bacto-tryptone, 5 g/L yeast extract, 10
g/L sodium chloride) was used for expression of unlabelled (i.e. not isotopically-
enriched) DC-SIGNR CRD. Ampicillin was added, when necessary, to a final
concentration of 100 µg/mL. LB medium with 16% (w/v) agar was used for
growth of E. coli on plates.
2.5.2 Maintenance.
For the long term storage of E. coli strains and constructs generated in this
study, 4 mL LB cultures were grown overnight at 30°C. The overnight cultures
were then used to prepare glycerol stocks by adding 1.2 mL 50% (v/v) glycerol
solution. These were frozen immediately on dry ice and stored at -80°C.
2.5.3 Preparation of Super Competent E. coli Cells.
Starter cultures were prepared by inoculating 5 mL LB with E. coli DH5α 
cells and incubating overnight at 37°C with shaking at 200 rpm. The following
morning, 100 mL LB was inoculated with the starter culture and cells were
incubated at 25°C with shaking at 200 rpm until the absorbance at 600 nm (OD600)
=0.3-0.4. Cells were incubated on ice for 30 min before being pelleted by
centrifugation at 1700  g, resuspended in 50 ml ice cold 50 mM CaCl2 and
incubated on ice for 1 hour. Cells were pelleted, resuspended in 3 mL ice cold 50
mM CaCl2 plus 20% (v/v) glycerol, split into 100 µL aliquots and frozen
immediately on dry ice. Aliquots were stored at -80°C until needed.
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2.5.4 Transformation of Super Competent E. coli Cells.
100 µL competent cells were mixed with 1-5 ng DNA in dH2O and
incubated on ice for 30 min. Cells were incubated at room temperature for 10
min before adding 500 µL pre-warmed LB and incubating at 37°C with shaking at
200 rpm for 1 hour. Cells were harvested by centrifugation at 1700  g, 550 µL of
supernatant was removed, the pellet was resuspended in the remaining liquid
and plated on to LB-agar plates containing ampicillin (100 ug/mL). Plates were
incubated overnight at 37°C.
2.6 Preparation of 13C/15N Uniformly Labelled Protein.
2.6.1 Minimal Media.
M9 minimal media was used for the expression of labelled (either singly
(15N) or doubly (13C/15N)) DC-SIGNR CRD. M9 media (1 L) was prepared by adding
1 g 15N-ammonium chloride and 2 g 13C-glucose to 200 mL of freshly autoclaved
M9 salts (48 mM Na2HPO4, 22 mM KH2PO4, 8.5 mM NaCl). Next, while stirring to
avoid precipitation, CaCl2 and MgSO4 were added to final concentrations of 100
µM and 2 mM respectively followed by addition of 10 mL 100 BME vitamin
solution (Sigma, UK). The pH of the media was then adjusted to 7.3 and 100
µg/mL ampicillin added. M9 plates were prepared with addition of 16% (w/v)
agar.
2.6.2 E.coli Growth in Minimal Media.
Two 100 mL starter cultures of M9 minimal media containing 100 µg/mL
ampicillin and labelled reagents were inoculated with a single colony from an
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M9/ampicillin plate and incubated at 37°C for 24 hours with shaking at 200 rpm.
A further 100 µg/mL ampicillin was added to the starter cultures following 12
hours of growth to maintain selection pressure for the pT5T-CLEC4M plasmid.
The following morning the starter cultures were used to inoculate 1 L M9 cultures
(containing 100 µg/mL ampicillin) in 2 L baffled flasks (pre-warmed to 37°C) to a
starting OD600=0.15-0.20 and incubated at 37°C with shaking at 200 rpm.
2.6.3 Plasmid Induction.
Once an OD600=0.7 was reached (typically 4 hours post-inoculation), the 1
L M9 cultures were induced with addition of isopropyl-β-D-thiogalactoside (IPTG) 
to a final concentration of 350 µM. Cells were induced for 20 hours at 25°C with
shaking at 200 rpm before cells were harvested by centrifugation at 4000  g for
15 minutes at 4°C. Cells were then washed with 20 ml of 10 mM Tris-HCl, pH 7.8,
centrifuged at 10,000  g for 10 minutes at 4°C, and the pellet frozen at -80°C
until needed.
2.6.4 Protein Extraction.
Cell pellets were defrosted and resuspended in 20 ml of 10 mM Tris-HCl,
pH 7.8 and 2 ml of Bugbuster protein extraction reagent (Merck Biosciences,
UK) and lysed by sonication (30 bursts of 30 seconds using a 7 mm probe).
Inclusion bodies containing protein were isolated by centrifugation at 10,000  g
for 15 minutes at 4°C and solubilised in 15 ml 6 M guanidine-HCl, 100 mM Tris-
HCl, pH 7.8 containing 0.01% (v/v) β-mercaptoethanol by gentle rotation at 4°C 
for 30 mins. The sample was then centrifuged at 4300  g for 30 minutes at 4°C
and the supernatant (containing protein) diluted in 60 ml loading buffer (25 mM
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HEPES, pH 7.8, 5 mM CaCl2, 150 mM NaCl) drop by drop while stirring. The
diluted mixture was then dialyzed against 2 L of loading buffer with 2 buffer
changes to remove the guanidine and β-mercaptoethanol and promote protein 
re-folding. Following dialysis, insoluble precipitate was removed by centrifugation
at 4300  g for 30 minutes.
2.6.5 Expression of Selectively Un-Labelled Protein.
Selective ‘un-labelling’ (one amino acid in the protein lacks isotopic
enrichment and so is invisible in the NMR spectra) was utilised to identify difficult
to assign amino acids. A 1 L M9 culture containing 1 g/L 15N-amonium chloride
was supplemented with 100 mg of the amino acid of interest at OD600 = 0.5. The
cells were then induced at OD600 = 0.7 as normal.
2.7 Protein Purification.
2.7.1 Mannose-Sepharose Column.
A 2 ml mannose-Sepharose column (kindly provided by Dr. Russell Wallis,
University of Leicester, UK) was equilibrated with 25 mM HEPES, 5 mM CaCl2, 150
mM NaCl pH 7.8 (loading buffer) before 20 mL of dialysed protein solution was
loaded. Next, the column was washed with one column volume of loading buffer
before eluting with 25 mM HEPES, 5 mM EDTA, 150 mM NaCl pH 7.8 in eight 1 mL
fractions. Elution fractions were analysed immediately by SDS-PAGE (§2.9.1).
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2.7.2 Fast protein liquid chromatography (FPLC)
Following purification by mannose-Sepharose, elution fractions containing
DC-SIGNR CRD (as determined by SDS-PAGE analysis) were combined and loaded
on to a Mono-Q HR 5/5 column (GE Healthcare, UK) equilibrated in 25 mM Hepes,
5 mM EDTA pH 7.8. Protein was eluted using a 500 mM NaCl gradient over 20
minutes with 1 mL fractions collected. Absorbance was monitored at 280 nm and
fractions were analyzed by SDS-PAGE (§2.9.1).
2.8 NMR Sample Preparation.
2.8.1 Buffer Exchange.
Following purification, elution fractions containing DC-SIGNR CRD were
exchanged into dH2O via extensive dialysis using snakeskin™ dialysis tubing with a
molecular weight cut-off of 7 KDa (Thermo scientific, UK). A volume of ~60 mL of
protein was dialysed against 2 L of dH2O with a total of 15 dH2O changes.
2.8.2 Lyophilisation of Purified Protein.
Following extensive buffer exchange into dH2O, purified protein was split
into multiple 20 mL fractions and frozen on dry ice to form a thin layer in a 50 mL
falcon tube. The tube was covered with parafilm containing holes created by a
syringe needle. The 50 mL falcon tubes were briefly placed in liquid nitrogen
before being attached to a vacuum. Falcon tubes were left under vacuum until all
solvent was removed and the protein was stored as a dry powder at -80°C until
required.
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2.8.3 NMR Sample.
Lyophilised protein was dissolved in NMR buffer (20 mM deuterated
Hepes (d-Hepes), 20 mM NaCl, pH 6.8 in 10% D2O / 90% H2O) to a final
concentration of ~0.7mM. The pH was re-adjusted to 6.8 if required. Precipitate
was removed by centrifugation at 1000 x g and 180 µL of sample was then
transferred to 3mm Wilmad™ NMR tubes. NMR samples were stored at 4°C.
2.8.4 Determination of Protein Concentration.
Protein concentration was determined using the BCA (bicinchonic acid)
protein assay kit (Thermo scientific, UK) as per the manufacturer’s instructions.
After incubation at 37°C for 30 min, the colour change was quantified by
measuring the absorbance at 562 nm and compared to that of known protein
standards (a standard curve was produced using bovine serum albumin (BSA)
which was diluted in the same solvent as the DC-SIGNR samples). Figure 2.8-1
represents a typical standard curve obtained from the BCA assay. Protein
concentration can be determined by calculating the gradient from the
standard curve in Figure 2.8-1 and using equation (2.1).
Figure 2.8-1
known concentrations of BSA. The line of best fit has a gradient of 0.0012 which can be used to
determine the concentration of DC
2.9 Protein Resolution.
2.9.1 SDS Poly
SDS polyacrylamide gels were cast and run on a vertical gel
electrophoresis system according to the manufacturer’s instructions, based on
the method desc
prepared with a separating gel (375 mM Tris HCl pH 8.8, 0.1% (v/v) SDS, 0.1%
(v/v) APS, 0.06% (v/v) TEMED) and a stacking gel (125mM Tris HCl pH 6.8, 0.1%
(v/v) SDS, 0.1% (v/v) APS, 0.06% (v/v)
Samples were prepared by mixing with SDS sample loading buffer (125
mM Tris-HCl pH 6.8, 20% (v/v) glycerol, 4% (v/v) SDS, 0.02% (v/v) bromophenol
: A typical BCA assay standard curve.
Protein concentration
-Acrylamide Gel Electrophoresis (SDS
ribed previously
-SIGNR CRD.
A typical standard curve obtained by measuring
Absorbance at 562nm
(Laemmli, 1970)
TEMED).
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blue, 5% (v/v) β-mercaptoethanol) or Nu-PAGE™ sample loading buffer 
(Invitrogen, UK) and boiling for 5 min. Seeblue plus 2 (Invitrogen, UK) or colorplus
prestained 7-175 KDa (New England Biolabs, UK) prestained molecular weight
markers were used for molecular weight calibration.
Whole cell fractions taken for protein yield checks were pelleted and
resuspended in 2  SDS sample loading buffer and boiled for 10 min.
A uniform running buffer (25 mM Tris, 250 mM glycine, 0.1% (v/v) SDS)
was used for electrophoresis. Gels were run at 90 mA 125 V for 15 min and for a
further 35 min at 200 V.
2.10 Protein Detection.
2.10.1 Coomassie Staining.
Following electrophoresis, gels were placed in fixer (50% (v/v) methanol,
10% (v/v) acetic acid) for 30 min, then in stain solution (10% (v/v) acetic acid,
0.025% (v/v) Coomassie G250) for at least 1 hour, followed by de-stain (20% (v/v)
methanol, 7% (v/v) acetic acid) until protein bands were visible.
2.10.2 Silver Staining.
Silver staining was used to screen for weak protein contaminants that are
not visible using Coomassie stain. Gels were placed in fixer (50% (v/v) acetone,
1.25% (v/v) TCA, 0.015% (v/v) formaldehyde) for 15 min, followed by washing in
dH2O (three washes, then a 5 min soak, followed by a further 3 washes). Next,
gels were soaked in 50% (v/v) acetone for 5 min followed by incubation in sodium
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thiosulphate solution (0.017% (w/v)) for 1 min. The gel was washed in dH2O (3 
washes) before being placed in stain solution (0.26% (w/v) silver nitrate; 0.37%
(v/v) formaldehyde) for 8 min. The gel was washed in dH2O (2  washes) and then
placed in developer (0.2 mM sodium carbonate; 0.004% (w/v) sodium
thiosulphate; 0.015% (v/v) formaldehyde) until protein bands could be visualised,
typically 20-30 sec. The reaction was quenched using a 1% (v/v) acetic acid
solution for 1-2 min before a final wash in dH2O.
2.11 Analysis of Purified Protein.
2.11.1 Mass Spectrometry.
Matrix assisted laser desorption/ionization (MALDI) mass spectrometry
was performed on a Bruker UltraFLEX TOF/TOF instrument (Bruker, UK). Pure
protein was mixed with matrix (30% (v/v) acetonitrile, 0.1% (v/v) TFA saturated
with sinapinic acid) to a final concentration of ~5 µM and the instrument
calibrated against lysozyme and BSA.
2.11.2 Circular Dichroism (CD).
Protein samples were prepared in 20 mM Hepes, 20 mM NaCl (the same
concentrations used for NMR samples). Measurements were recorded using a J-
815 spectropolarimeter (Jasco UK) using a 1 mm path-length quartz cuvette
(Starna; Optiglass Ltd., Hainhault, UK). Spectra were recorded between 180 and
300 nm with a data pitch of 0.2 nm, a bandwidth of 1 nm, a scanning speed of
100 nm/min, and a response time of 1 s. The high tension of the spectra was also
recorded.
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2.12 Nuclear Magnetic Resonance (NMR)
All NMR experiments were carried out at 37C (unless otherwise stated)
on either a 700 MHz Bruker Avance spectrometer fitted with cryoprobe (housed
at the University of Warwick) or a 5 mm triple resonance cold probe-equipped
Varian Unity Inova 800 MHz spectrometer operating at a 1H Larmor frequency of
799.766 MHz and a 15N Larmor frequency of 81.049 MHz (HWB-NMR, University
of Birmingham). Spectra recorded on Bruker instruments were referenced to
residual water while spectra recorded on Varian instruments were referenced to
an external DSS standard (Harris et al, 2001; Wishart et al, 1995). Bruker spectra
were referenced to Varian spectra using peaks known to be stationary.
2.12.1 1D Experiments.
1D proton spectra were acquired using WATERGATE (Liu et al, 1998) or
excitation sculpting (Hwang & Shaka, 1995) methods for water suppression.
Spectra were acquired using 16k complex data points and 64 co-added scans. The
data were zero-filled to 32k and processed using a squared sine window function.
2.12.2 2D Heteronuclear Experiments.
2D 1H–15N HSQC spectra (Kay et al, 1992) were acquired with 128
increments in the t1 dimension and 1k data points in the t2 dimension with 8
scans. The sweep width was 18.0 ppm in the 1H dimension and 31.8 ppm in the
15N dimension. Data were zero filled to 256 in t1 and 2k in t2 and processed using
a squared sine window function, polynomial baseline correction in t2 and linear
prediction in t1.
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2.12.3 3D Heteronuclear Experiments.
The triple resonance (1H-13C-15N) experiments (CBCA(CO)NH (Grzesiek &
Bax, 1992), CBCANH (Wittekind & Mueller, 1993), HNCA (Kay et al, 1990),
HN(CO)CA (Bax & Ikura, 1991), HNCO (Kay et al, 1990), HN(CA)CO (Clubb et al,
1992), H(CCCO)NH (Montelione et al, 1992), HCCH-TOCSY (Baldisseri et al, 1991;
Bax et al, 1990), and CCH-TOCSY (Fesik et al, 1990)) were recorded with 128
increments in t1, 40 increments in t2 and 2k increments in the t3 dimension.
Spectra were processed using squared sine window functions and linear
prediction in dimension t1 and t2.
3D 1H-15N-TOCSY-HSQC spectra (Marion et al, 1989b) were acquired with
1k, 40 and 80 increments in the t3, t2 and t1 dimensions respectively with a mixing
time of 60 ms.
2.12.4 Distance Constraints.
15N-NOESY-HSQC (Marion et al, 1989a) were acquired with 200, 80 and 2k
increments in the t1, t2 and t3 dimensions respectively. Mixing times of 50, 120,
200 and 300 ms were used to plot NOE build-up curves. The 200 ms mixing time
was used for structure calculation using the programme CYANA (Guntert, 2004).
13C-NOESY-HSQC (Marion et al, 1989a) were recorded with mixing times of 50,
100, 120 and 150 ms.
2.12.5 Data Processing and Analysis.
Spectra were processed using Topspin 2.0 (unless otherwise stated) and
analysed using CCPN Analysis software version 2.1.5 (Fogh et al, 2002; Vranken et
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al, 2005) and SPARKY 3 (Kneller & Goddard, 1993). Secondary structure
predictions based on the chemical shift index method (Wishart & Sykes, 1994;
Wishart et al, 1992) were carried out using TALOS+ (Shen et al, 2009).
2.12.6 15N N-H Backbone Relaxation Measurements.
15N longitudinal relaxation times (T1) were measured using the inversion-
recovery method as described (Farrow et al, 1994; Kay et al, 1989; Skelton et al,
1993) with relaxation delays of 0.01( 2), 0.07, 0.150( 2), 0.240, 0.340,
0.450( 2), 0.590, 0.750 seconds ( 2 indicates duplicate acquisitions).
15N transverse relaxation times (T2) were measured using the spin-echo
method as described (Farrow et al, 1994; Kay et al, 1989; Skelton et al, 1993) with
relaxation delays of 0.0077( 2), 0.0155, 0.0232( 2), 0.0386, 0.0541, 0.0696( 2),
0.0850 seconds.
All relaxation spectra were processed in NMRpipe (Delaglio et al, 1995)
and peak heights calculated and fit to a mono-exponential decay in SPARKY 3
(Kneller & Goddard, 1993).
2.12.7 Carbohydrate Titrations.
To measure binding of various carbohydrate ligands to the DC-SIGNR CRD,
titration experiments were carried out by adding increasing amounts of
carbohydrate (0.2, 0.5, 1.0, 2.0, 5.0, 10.0 and 20.0 mM Man3, 1.0, 2.0, 5.0, 10.0
mM Man5 and (GlcNAc)2Man3 and 0.1, 0.3, 0.7, 1.0, 1.5, 2.0, 5.0 and 10.0 mM
Man9GlcNAc) to 0.7 mM [U-15N,13C] - DC-SIGNR CRD at pH 6.8 and acquiring a
series of 2D 1H-15N HSQC spectra at 37°C. The pH and temperature were held
constant throughout the titration experiments. The three sugar fragments
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reached saturation by 10 mM while saturation was not reached for Man9GlcNA
due to the limited amount of material available. The total chemical shift
perturbation per residue ( total) was calculated using the following equation
total NH
ଶ
N
ଶ (2.2)
where NH and N are the chemical shift differences in the 1H and 15N
dimensions respectively. The weighting factor of 0.1 applied to the nitrogen
chemical shift corresponds to the difference in magnetogyric ratios of 15N and 1H
nuclei. The significance of chemical shift perturbation for a given residue upon
ligand addition was determined by calculating the standard deviation of the
chemical shift perturbations across all residues for each carbohydrate and using
this as a cut-off (Schumann et al, 2007). Perturbations that fell above this value
were considered significantly different from the initial (i.e. holo) state.
2.12.8 Determination of Dissociation Constants from Titration Data.
To determine the dissociation constant (KD), the chemical shift
perturbation for well-resolved residues was plotted against ligand concentration,
and the resulting curves were fitted to equation (2.3) valid for 1:1 complex
formation in fast exchange regime on the NMR chemical shift time scale.
(total,௫) max ஽ ஽ ଶ (2.3)
where and are the ligand and protein concentration respectively, (total,௫)
is the total chemical shift perturbation at ligand concentration and max the
total chemical shift perturbation upon saturation of ligand binding (Fielding,
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2007; Sudmeier et al, 1980). The fit was carried out and analysed in Origin 8.5
using the non-linear least squares method.
2.12.9 CaCl2, EDTA and pH Titrations.
The holo (calcium bound) DC-SIGNR CRD was investigated by addition of
CaCl2. Titrations of CaCl2 up to 20 mM confirmed that the CRD was saturated with
calcium by 4mM. In order to investigate calcium dissociation EDTA titrations (0.1,
0.3, 0.5, 1.0, 4.0, 10, 20, 40, 60 mM) were carried out on the holo DC-SIGNR CRD.
For all titrations the temperature (37°C) and pH (6.8) were kept constant.
The effect of pH on calcium and glycan binding was probed by addition of 0.5 mM
HCl to an NMR sample containing 4 mM CaCl2 and 10 mM glycan at pH 6.8 (pH
values of 7.2, 6.8, 6.0, 5.4, 4.2 and 3.2 were tested). All pH titrations were carried
out at 37°C.
2.13 Specialist Software
CCPN Analysis – NMR data analysis.
CYANA – solution structure calculation.
NMRpipe – NMR data processing
Origin 8.5 – calculation of dissociation constants (non-linear least squares curve
fitting)
SPARKY – NMR data analysis and assignment.
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TALOS+ - secondary structure prediction from NMR chemical shifts.
Topspin 2.0 – NMR data processing.
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Protein Preparation.
3.1 Introduction.
Although the protocol for the expression and purification of recombinant
DC-SIGNR CRD in Luria-Bertani broth (LB) media has been described (Mitchell et
al, 2001), the use of this protocol for expression in double labelled (13C/15N) M9
minimal media (see §2.6.1 for M9 media composition) produced extremely low
yields (~350 μg/L). The triple resonance NMR experiments utilized throughout 
this project require protein concentrations in the range of 0.5-1 mM, which
equates to approximately 3 mg of recombinant DC-SIGNR CRD per 180 µL NMR
sample. Due to the high cost of isotopically labelled reagents, it is not economical
nor is it practical to express multiple litres of culture for a single NMR sample.
Often optimisation of the protocol will improve protein yield in M9 minimal
media. This chapter describes the results of several expression trials in which the
point of induction, length of induction, temperature following induction and the
M9 media composition were investigated.
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3.2 Optimization of Protein Yield
3.2.1 Improving Cell Growth.
The first trials in 13C/15N-labelled (double labelled) minimal media
exhibited extremely poor growth rates, with a 1 L culture reaching an OD600nm of
only 0.3 after 24 hours. While slow growth is not unusual due to the lack of
nutrients in M9 when compared to rich media such as LB, it was hoped this rate
of growth could be improved. Slow cell growth can be a result of improper
aeration or due to the expression of protein prior to induction with IPTG,
diverting cell energy from growth (this is known as ‘leaky’ expression). Poor
aeration results in anaerobic respiration which provides 10 fold less energy than
aerobic respiration and can reduce the pH of the media (which is detrimental for
protein expression) (Berthold et al, 2010). To ensure sufficient aeration for
aerobic respiration, 2 L baffled flasks were used for 1 L culture volumes with
shaking at 200 rpm. While a 1:5 culture to flask volume ratio is recommended no
substantial difference in growth rate was observed with larger flask volumes and
so the 2 L baffled flasks with vigorous shaking were deemed to provide sufficient
aeration. ‘Leaky’ expression was eliminated as a cause of poor growth because
whole-cell samples taken before induction showed no CRD bands on SDS-PAGE
gels (Figure 3.2-2 panel (A) lane 1). As a result, the slow growth rate was
attributed to the long lag phase of BL21(DE3) cells in minimal media. Starter
cultures containing 100 ml M9 grown overnight only reached an optical density
of ~0.4 and so 1 L cultures were inoculated at a starting optical density <0.1.
BL21(DE3) cells in M9 do not exit lag phase until an optical density of 0.1-0.2
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(Berthold et al, 2010; Paliy & Gunasekera, 2007) is reached and so dilution of the
overnight starter culture caused the cells to revert into lag phase resulting in the
extremely slow growth rates. To overcome this, BL21(DE3) cells were grown on
successive rounds of M9+ampicillin plates so that cells were conditioned to grow
in minimal media. In addition, two starter cultures were grown for 24 hours at
37°C with additional ampicillin added after 12 hours to ensure selection for the
DC-SIGNR plasmid was maintained. These cultures achieved an optical density of
~1.0 and were then used to inoculate a 1 L culture to a starting OD600nm of ~0.2
ensuring that the 1 L culture began in exponential growth phase. These minor
changes allowed the 1 L M9 cultures to reach much higher optical densities and
induction at OD600nm = 0.7 was achieved in as little as 4 hours following
inoculation. Figure 3.2-1 shows the growth curve for a 1 L culture inoculated at
OD600nm = 0.15. Although these modifications substantially improved cell growth,
further optimisation of the expression protocol was explored to improve the
protein yield per cell. In order to improve yields, the length, temperature and
point of induction were investigated along with varying M9 compositions.
Figure 3.2-1
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Therefore, a more intense protein band indicates more protein is produced per
cell. Both panels (A) and (B) in Figure 3.2-2 show that increasing the length of
induction to 20 hours improves yield whether cells are induced at an optical
density of 0.7 or 0.3. Inducing at a lower optical density does not seem to
significantly affect the protein produced per cell. However, Figure 3.2-1 shows
that the rate of growth declines when cultures are induced at OD600nm = 0.3 (solid
diamond) and these cultures never reach the optical densities of the cultures
induced at OD600nm = 0.7 (solid square). In contrast, cultures induced at OD600nm =
0.7 show no decline in growth and reach the same optical density as un-induced
cultures (solid triangle). Although, there is no substantial difference between the
amount of protein produced per cell when induced at OD600nm = 0.3 (Figure
3.2-2), there are fewer cells per litre (Figure 3.2-1) indicating that inducing at
OD600nm = 0.7 will produce higher yields. It is worth noting that the DC-SIGNR CRD
migrates below the expected molecular weight of ~17 KDa. However, mass
spectrometry confirms that the CRD fragment is the correct molecular weight
and will be discussed later in §3.4.1.
Figure 3.2-2
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3.2.3 Changes in Media Composition and Temperature.
There are numerous published protocols for uniform 13C/15N labelling of
protein expressed in minimal media. The addition of metal mixtures has been
shown to improve yield, in particular the addition of iron alone can significantly
improve expression (Paliy & Gunasekera, 2007). In addition, it has been reported
that the CaCl2 is not a necessary component (Berthold et al, 2010) and, as it
precipitates due the presence of phosphate, its omission can improve yield.
Decreasing the rate of transcription so that it is coupled with the rate of
translation and post-translational events can also dramatically improve yield. This
can be achieved by using weaker promoters (such as arabinose or T5) or by using
E. coli strains containing mutations that overcome overexpression from the T7
promoter (i.e. C41(DE3) and C43(DE3)). However, the simplest method to
decrease the rate of transcription is to decrease the temperature during
expression. Indeed, protein production by BL21(DE3) cells can be improved by
decreasing the temperature following induction to 25°C (Berthold et al, 2010).
Taking the above into consideration variations in the M9 media composition
along with changes in temperature were tested for improvements in cell growth
and protein yield.
The standard M9 recipe (§2.6.1) was used as a control (M9), while the
addition of 100 μM FeCl3 (+FeCl3) and the omission of calcium chloride (–CaCl2)
were also investigated. Two 100 mL double labelled cultures were produced using
each media composition; one remained at 37°C throughout while the
temperature of the other culture was reduced to 25°C following induction. Since
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cultures induced at OD600nm = 0.3 showed decreased optical densities (Figure
3.2-1) all cultures in this trial were induced at OD600nm = 0.7. Cultures induced at
37°C were harvested after 6.5 hours (the growth curve in Figure 3.2-1 shows a
slight decline in optical density at ~7 hours) while cultures induced at 25°C were
left for 20 hours. Lane 1 of Figure 3.2-3 shows an un-induced (pre-ind), 100 mL
double labelled culture once again confirming that there is no ‘leaky’ expression.
Lane 2 of Figure 3.2-3 represents the control (this is the original protocol:
standard M9 recipe induced for 4.5 hours at 37°C).
Figure 3.2-3
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The growth curve in Figure 3.2-4 also shows that the growth of the 25°C culture
(solid triangle) surpasses that of the 37°C culture (solid circle). Figure 3.2-3 shows
that the addition of iron improves yield at low temperatures (lanes 4 & 5) and
Figure 3.2-4 shows the cultures containing iron give higher cell densities overall.
However, if induced for longer than 4.5 hours, there are no DC-SIGNR protein
bands visible (lanes 10, 11 and 15, Figure 3.2-3) indicating that the iron interferes
with protein expression. The presence of iron may promote growth of cells
without the DC-SIGNR CRD plasmid, resulting in increased growth rates of cells
not expressing protein. Alternatively, iron could cause the protein to degrade
possibly by preventing packing into inclusion bodies causing reduced protein
expression at longer induction times. It has been shown that BL21(DE3) cells
contain major defects in metal ion transport and metalloprotein biosynthesis
(Pinske et al, 2011) indicating that addition of metal mixtures may have
detrimental effects for this strain of E. coli. Removing CaCl2 from the M9 recipe
improves protein expression at 37°C when compared to the standard M9 recipe
while omission of CaCl2 at 25°C causes slower protein expression initially (lane 7,
Figure 3.2-3). However, after 6.5 and 20 hours (lanes 13 and 16, Figure 3.2-3) the
amount of protein per cell in the 25°C –CaCl2 culture has surpassed the 37°C –
CaCl2 culture. This indicates that reducing the temperature after induction,
omitting calcium and inducing for longer could greatly improve yield. However,
the growth curve in Figure 3.2-4 shows that the optical density of the 25°C –CaCl2
sample has dropped between 6.5 and 20 hours suggesting there is an optimal
OD600nm value between these two time points at which to harvest the cells.
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other proteins are eluted in the flow through and wash phases. Buffer containing
EDTA was then used to elute the DC-SIGNR CRD by chelating the Ca2+ ions and
abolishing the DC-SIGNR-mannose interaction. The yield of pure DC-SIGNR
recovered from the mannose column was then quantified by BCA assay (§2.8.4)
and is reported in Figure 3.2-5. Although the calcium-free cultures showed the
strongest protein bands on SDS-PAGE (Figure 3.2-3) and gave higher optical
densities (Figure 3.2-4), the yield of pure protein produced was lower than that of
the standard M9 recipe induced for 20 hours at 25°C (Figure 3.2-5) . This suggests
that although cell growth and protein expression are improved by omitting CaCl2
from the M9 recipe, the protein that is produced is unable to fold correctly
(during dialysis in to loading buffer as described in §2.6.4) and so cannot bind to
the mannose-Sepharose column. This is supported by Figure 3.2-6 which shows
the presence of DC-SIGNR protein bands in the flow through (FT) and wash (W) of
the culture without calcium but not in the culture containing calcium. The
presence of calcium is essential for mannose binding and is known to stabilise the
protein fold so it is reasonable to conclude that the presence of calcium during
expression of the DC-SIGNR CRD is required. The standard M9 recipe induced at
25°C for 20hrs gives the largest yield of active DC-SIGNR CRD (Figure 3.2-5 shows
that there is almost a three fold increase compared to the original protocol) and
these conditions were used in all subsequent expressions.
Figure 3.2-5
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3.2.4 Improving Protein Extraction.
Evidence of DC-SIGNR was found in the insoluble pellet (P1, Figure 3.2-7)
following cell lysis via sonication and solubilisation of inclusion bodies in 6 M
guanidine (see Materials and Methods §2.6.4 for more detail). At this stage of the
protocol, all protein should be present in the supernatant and the presence of a
significant amount of DC-SIGNR remaining in the pellet (P1) suggests that whole
cells or inclusion bodies remain intact. This indicated that sonication was not
powerful enough to lyse the cells or that the inclusion bodies were not being
completely solubilised. This was unexpected as cells grown on minimal media are
typically fragile and can easily lyse (Berthold et al, 2010). Sonicating pellet P1
once more (and purifying as normal on mannose-Sepharose) extracted a
significant amount of DC-SIGNR CRD (Figure 3.2-7 lane 1). However, following the
second round of sonication evidence of incomplete cell lysis still remained and a
strong protein band is present in pellet P2 Figure 3.2-7. This suggested that a
more aggressive means of cell lysis was necessary.
Figure 3.2-7
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With the above modifications to the protocol for expression of DC
CRD average yields of ~5 mg per L of culture were achieved.
typical mannose
purification protocol. There is a substantial increase in the amount of protein
expressed an
fraction 2, bands corresponding to dimers are apparent. However, there is no
evidence of oligomer formation under the conditions used for NMR as only one
population of peaks is present in the
and the relaxation parameters indicate a rotational correlation time consistent
with the molecular weight of the monomer (
Figure 3.2-8
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folded there is also evidence of other protein in these lanes which are not present in the elution
fractions. Numbers correspond to 1 m
the most protein eluting in fraction 2. Faint dimer bands can be seen for strongest elution
fractions suggesting some oligomerisation takes place at high concentrations.
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3.3 Summary of Improvements to Yield.
Several modifications were made to the published protocol for expression
of DC-SIGNR CRD in LB in order to optimise cell growth and expression in M9
minimal media from 350 µg to 5 mg/L culture. First, starter cultures were grown
for longer and the 1 L cultures inoculated at a higher starting optical density of
OD600nm = 0.15 in order to compensate for the extremely long lag phase of
BL21(DE3) cells in M9. This simple solution greatly improved cell growth rates
allowing optical densities of OD600nm = 1.0 to be reached.
Secondly, the optimal optical density at which the 1 L cultures were
induced was investigated. Although there was very little difference between the
amount of protein produced per cell when induced at OD600nm = 0.3, or 0.7 the
cultures induced at OD600nm = 0.7 reached a much higher optical density overall.
For this reason OD600nm = 0.7 was chosen as the point of induction. Thirdly,
variations of the M9 composition (addition of iron and omission of calcium) along
with changes to temperature following induction and the length of induction
were tested. While the addition of iron promoted higher optical densities, protein
expression suffered. The omission of calcium showed greater optical densities
and more protein expression per cell than the standard M9 recipe. However, the
calcium free cultures produced less active DC-SIGNR suggesting that the CRD
cannot correctly fold when expressed in the absence of calcium. The standard M9
recipe induced at OD600nm = 0.7 for 20 hours produced the greatest amount of
active DC-SIGNR. As a result, this protocol was used throughout this project.
Finally, the use of Bugbuster™ cell lysis reagent, a new 5 mm sonicator probe and
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increasing the amount of sonication to 15 minutes in total improved yield by
ensuring extraction of all protein from cells. These modifications result in an
average yield of ~5 mg of double labelled DC-SIGNR CRD per litre of culture. Yield
could be improved further by investigating more points of induction (here only
two were tested), the addition of more 13C-glucose or 15N-ammonium chloride
(here the minimum amounts were used in an effort to reduce cost, but it has
been shown that increasing the amount of glucose can exponentially increase
protein production (Berthold et al, 2010; Marley et al, 2001)) or by growing in rich
media prior to induction (although this can produce lower levels of label
incorporation, this method has been successfully used for NMR analysis (Chen et
al, 2006; Marley et al, 2001). However, a yield of 5 mg/L is more than sufficient
for NMR analysis and so further optimisation of the protocol was not attempted.
3.4 NMR Sample Preparation.
3.4.1 Characterisation of the DC-SIGNR CRD.
The DC-SIGNR CRD migrated faster than expected on SDS-PAGE gels, so
MALDI-TOF mass spectrometry was used to confirm that the protein was of the
correct molecular weight and that the degree of 13C/15N label incorporation was
sufficient for NMR analysis. The molecular weight of the unlabelled DC-SIGNR
CRD obtained by mass spectrometry (Figure 3.4-1) is in close agreement with the
expected molecular weight of 16194.7 Da. Figure 3.4-2 shows the results of the
mass spectrometry analysis of pure, double labelled DC-SIGNR CRD. The expected
molecular weight, assuming 100% label incorporation, is 17101.7 Da (907 Da
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greater than the unlabelled molecular weight). The major peak in Figure 3.4-2 of
17060.695 Da indicates a label incorporation of 95.8% which is sufficient for NMR
analyses. The mass spectrum confirms that the protein is of the expected
molecular weight despite migrating below 14 KDa on SDS-PAGE gels. This
discrepancy between the molecular weight apparent on the SDS-PAGE gel and
the true molecular weight is likely due to incomplete denaturation of the protein
(possibly due to the presence of disulphide bonds). The broadness of the peak
indicates that there are multiple species with varying degrees of label
incorporation; this is as expected for proteins expressed in labelled media. There
is an additional peak 204-215 Da greater than the primary peak in both spectra
which could indicate a C-terminal tryptophan modification (possibly due to a stop
codon mutation UGA to UGG). If this is the case this should pose no problems to
the NMR analysis as the C-terminal residues are not observable due to the high
degree of flexibility. In addition, the +204 Da peak is of low intensity and a single
population of peaks is present in the HSQC experiment indicating that this sample
is sufficient for NMR analysis.
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Figure 3.4-1: MALDI-TOF mass spectrometry of unlabelled DC-SIGNR CRD. The major peak of
16191.865 Da is in close agreement with the expected mass of 16194.7 Da. There is an additional,
low intensity peak +215 Da from the major peak.
Figure 3.4-2: MALDI-TOF mass spectrometry of double labelled DC-SIGNR CRD. The major peak of
17060.695 Da is in close agreement with the expected molecular weight of double labelled DC-
SIGNR CRD of 17101.7 Da. This implies an overall label incorporation of 95.5%. The broadness of
the peak is likely due to varying degrees of label incorporation. There is a secondary peak +204Da
from the major peak. However, peaks from this secondary mass do not appear in the NMR
spectra.
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CD spectra were measured of the CRD in NMR buffer (20 mM Hepes, 20
mM NaCl) in order to confirm the secondary structure of the protein. However,
the presence of almost equal amounts of α-helix, β-sheet and random coil in the
CRD produces a relatively featureless CD signal with weak intensity (Mitchell et al,
2001). As a result, NMR is much better suited to gauge the secondary structure
content of the CRD. The HSQC spectrum (§4.3, Figure 4.3-2) is used as evidence
that the protein is well folded (as dispersed chemical shifts are indicative of
secondary structure elements along with tertiary fold) and secondary structure
prediction using the chemical shift assignment and the chemical shift index (CSI)
method (discussed in detail in §5.2) are in good agreement with the crystal
structure. In addition, the protein binds to the mannose-Sepharose column
confirming that the protein is correctly folded and active.
3.4.2 Determination of Purity for NMR.
Following optimisation of the expression protocol and characterisation of
the purified protein, it was then necessary to ensure that the sample quality was
sufficient for NMR analysis. One dimensional 1H NMR spectra (Figure 3.4-3)
highlighted the presence of contaminants which appeared as sharp, resolved
peaks while protein signals are broader. These contaminants could be a result of
the purification procedure or improper buffer exchange into NMR ‘invisible’
buffers (in this case deuterated Hepes (d-Hepes)). The original protocol utilised
FPLC anion exchange chromatography as a second purification step following
mannose-Sepharose purification. However, Figure 3.4-3 (panels (A) and (B))
shows that many contaminants were present following anion exchange. The silver
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stained gel in Figure 3.4-4 (silver stain is more sensitive than Coomassie stain and
so should highlight any protein contaminants) along with the mass spectrum and
HSQC spectrum show that no protein contaminants are present following
mannose-Sepharose purification. As such there is no need for the anion exchange
purification step and so this step was omitted. Initially Vivaspin™ centrifugal
concentrators were used to buffer exchange the protein in to d-Hepes. However,
Figure 3.4-3 (A) shows that buffer exchange was not complete (residual un-
deuterated hepes peaks are present) and that glycerol was introduced using this
method. As an alternative, extensive dialysis into water was used, followed by
lyophilisation and transfer in to NMR buffer. Figure 3.4-3 (C) confirms that
mannose-Sepharose purification coupled with dialysis eliminates contaminants
and produces good quality NMR samples. Despite extensive dialysis (against as
much as 30 L of water in total) the EDTA (remaining from the mannose-Sepharose
purification procedure) was not removed completely. This is consistent with
previous reports which state that EDTA can be extremely difficult to remove
(Pereira-Mouries et al, 2002; Searcy & Greif, 1976). While the presence of EDTA
precludes the investigation of accurate calcium binding affinities, it does not
interfere with the protein assignment as it is not visible in the 15N edited HSQC. In
addition, EDTA is useful for probing the presence of calcium in the NMR samples
as the presence of two Ca2+ free EDTA peaks in Figure 3.4-3 (C) confirm that there
is no calcium present in the sample and hence that the protein is in the apo
(calcium free) form. This will be discussed further in Chapter 6.
Figure 3.4-3
exchange methods.
mannose-Sepharose was used samples were then exchanged in to NMR buffer using
centricons or
following anion exchange while centricons did not sufficiently buffer exchange as there is still
hepes and a great deal of EDTA in the sample.
extensive dialysis produced the least
: 1D 1H NMR spectra of contaminants resulting f
Initially FPLC anion exchange chromatography fol
(B) dialysis in to water followed by freeze
contaminants
(C) Omitting the anion exchange st
.
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following mannose
3.5 Conclusion.
Protein expression protocols optimised in rich media such as LB cannot
always be used f
protocol for expression of DC
many changes to the protocol were investigated. Due to the extensive lag phase
of BL21(DE3) cells in M9, cultures were inocu
(OD600nm = 0.15). While cells grown on LB can be harvested 2.5 hours following
induction, the M9 cultures were left for a total of 20 hours. Allowing the cultures
to induce for 20 hours along with dropping the temperature
to 25°C provided the greatest increase in yield of active DC
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increased yield further by ensuring that all protein is extracted from the cells. In
total the modifications described in this chapter produce, on average, 5 mg/L of
active DC-SIGNR CRD.
Following optimisation of the expression protocol the purified DC-SIGNR
CRD was characterised via mass spectrometry. This confirmed the protein was at
the expected molecular weight (despite running at a lower molecular weight on
SDS-PAGE gels) and that 95% of the 13C/15N labels had been successfully
incorporated in to the protein. Initial NMR sample preparations utilising anion
exchange showed evidence of many contaminant peaks in the 1H NMR spectrum.
As silver staining and mass spectrometry confirmed that no protein contaminants
were present following mannose-Sepharose purification the second anion
exchange purification step was abandoned. This, along with extensive dialysis
into water before lyophilisation and transfer in to NMR buffer, produced high
quality NMR samples. Despite extensive dialysis, residual EDTA from the
mannose-Sepharose purification remains. However, EDTA can be excluded from
the mannose-Sepharose purification by using a low pH elution buffer resulting in
un-contaminated NMR samples (discussed further in Chapter 6).
The modifications described in this chapter allow the production of
sufficient quantities of 13C/15N labelled DC-SIGNR CRD of sufficient quality for
NMR analysis via triple resonance experiments, as described in further chapters.
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Backbone
Assignment
4.1 Introduction.
This chapter describes difficulties in the sequential assignment of apo
(calcium free) DC-SIGNR CRD due to variable intensity of signals in the HSQC
spectrum. This variable intensity is caused by intermediate dynamics on the NMR
timescale (Lian & Roberts, 2011). Altering the rate of dynamics of the protein
backbone by the addition of calcium and increasing the temperature overcame
this problem allowing successful assignment of the holo (calcium bound) CRD.
The assignment of the calcium bound protein is a useful tool for studying changes
in conformation and dynamics of sugar binding (this will be discussed in chapter
7).
4.2 Variable Intensity of Apo DC-SIGNR CRD.
Despite the acquisition of the full complement of triple resonance
experiments (see Materials and Methods) on the apo (calcium free) CRD only
~33% of the protein backbone was able to be assigned. This is a result of
weak/absent signals in the HN(CA)CO spectrum preventing sequential
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assignment. Figure 4.2-1 (A) highlights the presence of many weak signals in the
HSQC spectrum of apo DC-SIGNR; this is a problem for sequential assignment as
3D experiments are inherently less sensitive than the HSQC. In particular, the
HN(CA)CO is the least sensitive of the triple resonance experiments (due to rapid
relaxation of the 13Cα magnetization (Cavanagh, 2007)) used for sequential
backbone assignment, and so any signals with weak intensity in the HSQC will
likely be absent in the HN(CA)CO (Figure 4.2-2). This hinders sequential
assignment substantially. The non-uniformity of the signal intensities throughout
the HSQC spectrum is characteristic of a protein with varying dynamics, as the
regions of the protein which display intermediate dynamics on the NMR time
scale give rise to broad, low intensity signals while other regions of the protein
which are in fast exchange produce stronger signal intensities. The fact that
different regions of the protein backbone are in different dynamics regimes
suggests that the DC-SIGNR CRD is extremely mobile in the absence of calcium. In
an effort to improve the signal intensity of the HSQC spectrum, we sought to
change the rate of dynamics of the protein backbone.
Figure 4.2-1
The addition of 4 mM CaCl
variable intensity seen for the apo CRD (A). However, there is still a significant amount of variable
intensity following addition of calcium indicating that the CRD remains flexible and that
assignment of the protein under these conditions will not be possible.
: Comparison of 1H-15N HSQC spectra of (A) apo and (B) holo DC
2 to the DC-SIGNR CRD (B) provides a modest improvement to the
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Figure 4.2-2
experiments recorded on
resonance experiments while the HN(CA)
that triple resonance experiments are far less sensitive than the HSQC experiment and that the
HN(CA)CO is particul
will not be present in the HN(CA)CO.
4.2.1 Addition of Calcium.
The binding of Ca
binding and
protein. Figure
improvement in variable intensity throughout the HSQC spectrum. However, the
addition of calcium alone is not sufficient to permit sequential assignment as
evidence of variable intensity remains. This suggests that the protein maintains a
high degree of flexibility following calcium binding. Interestingly,
shows significant chemical shift changes throughout the HSQC upon addition of
: A comparison of the sensitivity of 2D and 3D experiments.
arly insensitive. Therefore, it is clear that a weak intensity signal in the HSQC
could induce changes in the c
4.2-1
13C/15N DC-
2+ ions to the DC
(B) shows that the addition of 4 mM CaCl
SIGNR CRD.
CO is the least sensitive. These 1D traces clearly show
-SIGNR CRD is a requirement for glycan
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calcium confirming that conformational and/or dynamics changes are taking
place as a result of calcium binding. This will be discussed further in section 4.4.1.
4.2.2 Increasing Field Strength.
In an effort to improve the quality of the HSQC spectrum further, a higher
field spectrometer was utilised. Figure 4.2-3 compares a HSQC spectrum of the
holo CRD acquired on a Bruker 700 MHz instrument at Warwick (Figure 4.2-3 (A),
purple) and a HSQC spectrum acquired on a Varian 900 MHz instrument at the
university of Birmingham HWB-NMR national facility (Figure 4.2-3 (B), black).
Both spectra were recorded on the same sample with the same number of scans.
While, the dispersion of the spectrum acquired on the 900 MHz spectrometer is
superior (as expected) the intensity is comparatively poor. This could simply be a
result of variations in the sensitivity of cryoprobes produced by different
manufacturers. Alternatively, increasing the field strength causes faster
relaxation (as chemical shift anisotropy increases with field strength) artificially
slowing the rate of protein dynamics (Prestegard, 1998) and causing more peak
broadening. If this is the case, increasing the rate of dynamics could improve the
variable intensity by bringing the protein backbone in to fast exchange on the
NMR timescale.
Figure 4.2-3
and (B) 900 MHz
far more sensitivity than the HSQC acquired on
HSQC spectra
CaCl2, 20mM d
: Comparison of
at 25°C.
were collected
-Hepes, 20mM NaCl, pH
1H-15N HSQC spectra of holo DC
The HSQC acquired on
on the same sample (~
the Bruker
the Varian 900
6.8) with the same number of scans.
Chapter 4: Backbone Assignment
-SIGNR CRD acquired at
700 MHz spectrometer (
0.7 mM
MHz spectrometer (bla
[U-13C-15N]-DC
(A) 700 MHz
purple) shows
ck). Both
-SIGNR CRD, 4mM
83
Chapter 4: Backbone Assignment
84
4.2.3 Increasing Temperature.
An attempt to accelerate the rate of dynamics was made by acquiring
HSQC spectra at increasing temperatures. A range of temperatures from 25°C to
37°C were tested and the most significant improvement in signal intensity was
observed at 37°C. Figure 4.2-4 shows that increasing the temperature from 25°C
to 37°C led to HSQC peaks which were more uniform in intensity. This, in turn, led
to a significant improvement in the triple resonance experiments. Table 4.2-1
compares the number of peaks present in the most sensitive 3D experiment, the
HNCO, and the least sensitive experiment, the HN(CA)CO, at 25°C and 37°C. There
is a small improvement in the number of peaks present in the HNCO at 37°C
(although even in this experiment some peaks are absent) while there is a much
more significant improvement in the HN(CA)CO at 37°C.
Table 4.2-1: Percentage of peaks present in HNCO and HN(CA)CO spectra at 25°C and 37°C. The
HNCO experiment is the most sensitive of the triple resonance experiments used for sequential
assignment of the protein backbone while the HN(CA)CO is the least sensitive. At 37°C 79% of the
expected signals are present in the HN(CA)CO spectrum indicating that sequential assignment will
be possible under these condition.
Visible peaks
Experiment 25°C 37°C
HNCO 115 (86%) 121 (90%)
HN(CA)CO 65 (49%) 106 (79%)
Figure 4.2-4
(B) 37°C at 700 MHz.
improvement in variable intensity occurring at 37°C (B,
of the signals is more uniform.
: Comparison of
A range of temperatures were investigated with the most noticeable
1H-15N HSQC spectra of holo DC
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blue). It is clear that at 37°C the intensity
(A) 25°C and
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As the greatest improvement in variable intensity was achieved with
addition of calcium at 37°C on the 700 MHz spectrometer (and because calcium
binding is a requirement for the formation of DC-SIGNR-oligosaccharide
complexes, the study of which is a major aim of this project) these conditions
were used to acquire a full suite of triple resonance experiments.
4.3 Assignment of Holo DC-SIGNR CRD.
4.3.1 An Example of the Sequential Assignment Approach.
The modifications described above produced 3D experiments of sufficient
quality to allow successful assignment of the holo CRD. Figure 4.3-1 shows a chain
of five sequentially assigned amino acids to highlight the quality of the 3D
experiments. The HNCA/HN(CO)CA and HNCO/HN(CA)CO experiments have high
resolution and are useful for making the links required to identify chains of
sequential amino acids. Despite the lack of a HN(CA)CO signal in lane 1 of Figure
4.3-1 (B) the HNCA/HN(CO)CA (Figure 4.3-1 (A)) and CBCANH/CBCA(CO)NH
(Figure 4.3-1 (C)) spectra confirm that this residue is part of the chain. As there is
little variation in Cα and CO chemical shifts for the 20 naturally occurring amino
acids, the amino acid type could not be identified by the HNCA/HN(CO)CA and
HNCO/HN(CA)CO alone. As a result, the CBCANH spectrum is invaluable since the
Cβ chemical shift can be used to determine amino acid type (see §1.5 for more
detail). We can see from the CBCANH spectrum (purple Cα and orange Cβ signals)
in Figure 4.3-1 (C) that strips 1 and 3 have high Cβ chemical shift values which are
characteristic of serine and threonine residues while strip 4 has an extremely low
Cβ chemical shift value indicating that it i
1.5-3 for average C
an alanine in the CRD sequence this chain must be
is only one possible solution: S
experiments in this way, the majority of the
assigned.
Figure 4.3-1
HNCA (dark blue), HN(CO)CA (light blue), (B) HNCO (green), HN(CA)CO
positive contours and orange negative contours), and CBCA(CO)NH (pink) spectra are combined to
sequentially assign chains of amino acids. The sensitivity of the HNCA and HNCO experiments
make them useful for sequential assignment
experiment provides valuable information on amino acid type.
4.3.2 Backbone Assignment of Holo DC
The assigned
is shown in
β chemical shi
: An example of the sequential backbone assignment of holo DC
Figure 4.3
1H-15N HSQC spectrum of the calcium
-2 and the full list of assignments is given in Appendix A,
s an alanine residue (see
fts). As there are no serine residues followed by
292V293T294
while the C
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at the N terminus
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‘tail’ regions sample multiple environments)
in the HSQC
Figure 4.3-2
temperature to 37°C improved the quality of the HSQC and the triple resonance
sufficiently to facilitate assignment of the protein backbone. In total, 96% of the backbone
residues present in the HSQC are assigned. The boxed region is enlarged to avoid overlap of
labels.
The
the calcium bound state
changes in chemical environment for a given nucleus, either through a
binding event
Of the 139
spectrum due their lack of a backbone amide
and
(this is common in HSQCs of protein fragments as the flexible
, 96% have been unambiguously as
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, conformational
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spectrum is a powerful tool for probing ligand binding and allows rapid
investigation of a range of ligands (this will be discussed in detail in Chapter 7).
4.3.3 Improving Assignment Using ‘Sparse Unlabelling’.
Even at the increased temperature of 37°C, some residues remain un-
assigned due to spectral overlap or weak intensity. In particular, residues N361 and
N362 in the primary calcium binding loop (which form part of the conserved EPN
motif discussed previously) cannot be assigned using the sequential assignment
procedure. This indicates that the primary calcium binding site is highly dynamic
even in the presence of calcium (the dynamics of the calcium binding loops is
discussed further in §7.5). As these residues are of particular interest due to their
location in the calcium binding loop, a sparse unlabelling approach was used to
facilitate their assignment (as described in Materials and Methods §2.6.5).
The unlabelling approach aims to identify all signals in the HSQC spectrum
which arise from a specific amino acid type by eliminating their signals. This is
achieved by the addition of the unlabelled amino acid of interest to 15N labelled
M9 media prior to induction. If the amino acid is incorporated in to the protein
successfully, all signals arising from that amino acid will be absent from the HSQC
spectrum. Comparison with a HSQC spectrum of uniformly labelled protein allows
fast identification of the signals corresponding to the amino acid type of interest.
However, metabolic scrambling can result in unlabelled atoms being propagated
throughout the protein (Hiroaki et al, 2011) making the technique unreliable. To
address this, an amino acid with no ambiguous assignments (threonine) was
used. Figure 4.3-3 confirms that the amino acid of interest was successfully
‘unlabelled’ since the only signals absent from the spectrum (
orange) correspond to the, already assigned, threoni
there is no metabolic scrambling in this system and that the unlabelling strategy
can be utilised to identify un
confirms that the assignments of all threonine residues made using the
sequential assignment technique are correct. However, it is worth noting that the
absence of residue T
not useful in cases of significant signal overlap.
Figure 4.3-3
threonine residues (orange) contains less peaks than the uniformly labelled spectra (blue). All
residues that are missing in the unlabelled spectrum correspond to the Thr residues confirming
that this is a viable tech
T388 is not clearly absent showing that this technique is not useful when there is significant
overlap.
The T
unlabelling technique, therefore an N
effort to identify the missing assignments in the primary Ca
388
: Overlay of [U
nique for identification of difficult to assign amino acids. However, residue
-unlabelled sample in
-
is not clear in
-15N]-CRD and T
assigned amino acids. In addition,
Figure
-unlabelled CRD.
Figure
-unlabelled sample was prepared in an
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4.3-4 shows an overlay of the HSQC spectra recorded on the unlabelled sample
(green) and the uniformly labelled sample (blue). All of the assigned Asn residues
were absent from the unlabelled spectrum (confirming that these assignments
are correct), and several additional peaks were also missing. The signals circled in
Figure 4.3-4 are due to the asparagine side-chain amides, while the two missing
signals at ~117 ppm (inset panel in Figure 4.3-4) are due to the backbone amides
of the missing assignments N361 and N362. It is worth noting that residues K270 and
G337 are extremely weak in the unlabelled HSQC (Figure 4.3-4 arrows). However,
these residues often give low intensity signals at low protein concentrations and
at higher field and so this is likely due to the lower concentration of the
asparagine unlabelled protein and not metabolic scrambling. Although the
unlabelled strategy allows us to identify where the signals corresponding to
residues N361 and N362 appear in the HSQC spectrum, we cannot distinguish
between the residues because they are absent in the 3D spectra. This is almost
certainly due to extremely fast 15N relaxation (see §7.5 for dynamics data).
Nevertheless, this ambiguous assignment allows us to record chemical shift
perturbation and dynamics data of this region of the primary calcium binding
loop.
Figure 4.3-4
absent in the spectra of N unlabelled DC
missing residues at low
signals at ~117 ppm circled in the inset panel are due to the missing assignments (residues 103
and 104).
4.4 Assignment of Apo DC
Although the complete assignment of apo DC
resonance
spectrum, the assignment of the holo CRD can be used to infer information on
calcium binding. Calcium binding to the DC
detail and so any information
and apo HSQC spectra is of interest.
Despite the large differences between the spectra, the assignment of the
holo DC-SIGNR spectrum can be superimposed on to the apo spectrum allowing a
tentative assignment
perturbed by addition of calcium and isolated peaks (no other chemical shifts
nearby) where there was no ambiguity as to the corresponding peak in the holo
: Overlay of [U
experiments was not possible due to the variable intensity of the HSQC
-15N]-CRD and N
1H ppm (circled) are d
that can be gained from a comparison of the holo
of the un
-unlabelled CRD.
-SIGNR (green) along with some additional residues. The
ue to asparagine side
-SIGNR CRD.
-perturbed residues. Peaks that were not
Chapter 4: Backbone Assignment
All assigned asparagine residues are
-SIGNR CRD has not been studied in
-chains while the missing
-SIGNR using triple
92
HSQC spectrum were assigned in the apo HSQC. This
combined with information from the triple resonance experiments (chains of
sequential amino acids and partial assignments) to improve the assignment of the
apo CRD (
residues in the apo DC
~33% assigned using triple resonance experiments alone). This tentative
assignment facilitated
Figure 4.4-1
assignments from the holo HSQC on to the apo
resonance experiments resulted in assignment of ~6
4.4.1 Calcium Binding Induces Significant Conformational and
Dynamics Changes Throughout the CRD.
Figure
throughout the HSQC upon calcium binding. Almost every peak in the spectrum is
perturbed indicating that significant chang
Several amino acids distal to the calcium binding loops are significantly perturbed
Figure 4.4
: Partial assignment of apo DC
4.4-2 highlights that significant chemical shift perturbations occur
-1). Using the holo assignment as a guide, ~63% of the
-SIGNR CRD were assigned (an improvement from the
a preliminary investigation of calcium binding.
-SIGNR CRD.
combined with sequential assignment using triple
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(for example F
which are not implicated in calcium binding) further
addition causes global changes to the CRD. These conformational and/or
dynamics changes could explain the increased stability of the holo CRD and could
result in formation of the ligand binding site. Indeed, residues F
form part of the binding site in the crystal structure (the ‘shelf’ formed by
2) are perturbed substantially.
Figure 4.4-2
HSQC spectra of apo DC
good as the holo HSQC (blue). By overlaying the two spectra
chemical shift perturbations as a resu
conformational and/or dynamics change occurs
that undergo significant changes as a result of calcium binding, are highlighted.
In the HSQC spectrum of
primary calcium binding site cannot be assigned either due to absence of the
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holo-form. Residues N
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P360 (in the conserved EPN motif of calcium binding loop 1) in the absence of
calcium (this has been shown for other C-type lectins) (Ho et al, 2010; Ng et al,
1998; Nielbo et al, 2004; Pavlicek et al, 2003; Poget et al, 2001). In addition,
residue N334 in the secondary calcium loop is not visible in the apo HSQC, and
residues N356, at the beginning of the primary loop, and E336, which is implicated
in direct Ca2+ binding in the secondary loop, are significantly perturbed and have
extremely weak intensity in the apo spectrum. This indicates that the dynamics of
the calcium binding loops is altered substantially in the presence of calcium.
4.5 Conclusion.
Analysis of HSQC spectra of both the apo and holo DC-SIGNR CRD
highlights the dynamic nature of this C-type lectin. The variable intensity at room
temperature indicates that the CRD is mobile while the significant chemical shift
perturbations and line width changes in the holo HSQC are characteristic of
binding induced conformational and dynamics changes. The perturbations occur
throughout the HSQC suggesting a global change in the CRD on calcium binding
which could result in formation of the ligand binding site. In addition, residues
which reside in the calcium binding loops substantially increase in intensity in the
holo HSQC which is indicative of a dynamics change in these regions. The mobility
of the protein may play a functional role by increasing affinity for glycans which
are also inherently flexible and structural/dynamics changes as a result of calcium
may explain the lack of glycan binding in the absence of calcium. Although
addition of calcium improves the intensity of several HSQC signals there is still a
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degree of variable intensity at 25°C suggesting that the protein maintains a level
of mobility in the calcium bound state. However, this was improved by increasing
the temperature to 37°C allowing a nearly complete assignment of the holo CRD
backbone residues. This is the first reported solution state NMR assignment of
the DC-SIGNR CRD. The assigned HSQC is a powerful tool for the study of ligand
interactions which will be described in Chapter 7.
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Side-chain
Assignment and Work
Towards a Solution
Structure.
5.1 Introduction.
Solution structure calculations require measurement of nuclear
Overhauser effects (NOEs). This transfer occurs through-space and is a powerful
tool for determining distance restraints which allow the full 3D tertiary structure
of proteins to be calculated. In order to determine which nuclei are experiencing
NOE transfer, a full side-chain assignment (assignment of all carbons and protons
in the DC-SIGNR CRD) is required. This assignment is used to identify the NOE
peaks and then calculate distance constraints (based on the intensity of the NOE
signals) and perform a structure calculation (these steps are usually carried out
iteratively using a programme such as CYANA). In addition to the side-chain
assignment and NOE peak intensities, the structure calculation also requires
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information on phi and psi torsion angles. The torsion angles are calculated from
prediction of the protein secondary structure using the chemical shift index
method.
This chapter reports the results of predicting the secondary structure of
the DC-SIGNR CRD using the backbone assignments described in §4.3.2 along with
the Hα assignments obtained from experiments described below. In addition, the
experiments required for the full side-chain assignment of the CRD are described
and the full table of chemical shifts is reported in Appendix A. The full side-chain
assignment of the CRD paves the way for solution structure elucidation via
15N/13C-NOESY-HSQC experiments. Appropriate mixing times for these
experiments have been determined and full data sets acquired. Unfortunately,
structure calculations using the full assignment, torsion angle constraints and
NOE intensities from the 15N-NOESY-HSQC spectrum did not converge. As a result,
13C-NOESY-HSQC spectra have been acquired because this experiment contains
more information on side-chain distance restraints. Work to solve the structure
with addition of the 13C-NOESY-HSQC restraints is on-going.
5.2 Secondary Structure Prediction is in Good Agreement
with the Crystal Structure.
The assignment of the backbone residues (Cα, Cβ, CO) described in §4.3.2
(along with the Hα assignments obtained from the side-chain experiments
described below in §5.3) allows a prediction of the secondary structure elements
present in the CRD to be made using the chemical shift index method (Wishart &
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Sykes, 1994; Wishart et al, 1992). This method is based on the observation that
the chemical shifts of residues in defined secondary structure elements are
shifted from the average (random coil) values. For example, Hα, Cα and CO are
shifted to higher chemical shift values (deshielded) when in α-helices while the Cβ
is shifted to lower chemical shift values (shielded). In this case the amino acid is
assigned the value -1. The opposite is true for β-sheet regions (amino acids with 
these chemical shifts are assigned the value +1). If four or more consecutive
amino acids are assigned the value -1, then that region is classified as an α-helix, 
while three or more consecutive amino acids with the value +1 are required to
define a β-sheet region. Using this method, the secondary structure of the 
protein can be estimated. In addition, the programme TALOS+ can be used to
predict the dihedral angles which in turn are used to predict secondary structure
elements. The phi and psi torsion angles predicted by TALOS+ can be used as
input in solution structure calculation programmes such as CYANA (Guntert,
2004).
Figure 5.2-1 shows the secondary structure prediction per residue for the
DC-SIGNR CRD using the programme TALOS+ (Shen et al, 2009) compared to the
secondary structure in the 1K9J crystal structure. There is good agreement with
the crystal structure for the N-terminal section of the CRD. However, TALOS+
makes no predictions in the C-terminal end of the CRD likely due to missing
assignments in this region.
Figure 5.2-1
predict the dihedral angles and, in turn, the secondary structure elements of the CRD in solution
using the programme TALOS+. There is good agreement with the secondary structure in the
crystal for the N
C-terminal region likely due to the presence of un
5.3 Side
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(illustrated in Figure 5.3-1) was used. This experiment provides the same
information as the HSQC-TOCSY, but the backbone amide is correlated with the
side-chain of the previous residue and the magnetization is transferred via the
side-chain carbons (Figure 5.3-1). Unlike the TOCSY experiment which uses
isotropic mixing to transfer magnetization between spins (during which the
magnetization is lost due to relaxation), the H(CCO)NH does not use this
approach and thus can overcome the problems experienced with the HSQC-
TOCSY and provide more side-chain information. Figure 5.3-1 shows that while
there is signal present in the H(CCO)NH, there are a significant number of missing
side-chain correlations. However, the Hα correlation was present for almost all
amino acids allowing these to be quickly assigned, when using the assigned 1H-
15N-HSQC as a guide. The Hα assignment, along with the previously assigned Cα
and Cβ residues, provide enough information for the use of experiments which
lack the backbone amide correlation and hence are not based on the 1H-15N HSQC
spectrum.
Figure 5.3-1
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represents the directly attached carbon (the carbon bound to a proton with
chemical shift ppm). All other carbon atoms in the side-chain appear
horizontally to this diagonal peak (marked with a diagonal line in Figure 5.3-2). In
contrast, the HCCH-TOCSY spectrum contains two 1H dimensions and a single 13C
dimension. A 1H-13C plane shows all protons in an amino acid aligned horizontally
at the 13C chemical shift of the directly attached carbon. For example, if the 3rd
dimension (direct-1H) is set to the chemical shift of the Hα nucleus in residue 20,
signals for all protons in the side-chain of residue 20 will be aligned horizontally at
the chemical shift of the Cα nucleus. If the 3rd dimension is then moved to the
chemical shift of the Hβ nucleus the same pattern of side-chain protons will now
be aligned horizontally at the carbon chemical shift of the Cβ nucleus. In this way
the chemical shifts of all side-chain protons for each amino acid can be identified
using the HCCH-TOCSY. By moving to these proton chemical shifts in the CCH-
TOCSY, all side-chain carbons can be identified and the carbon directly attached
to the proton is known because it falls on the diagonal.
Figure 5.3-2
assign all aliphatic side
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the diagonal representing the carbon directly bound to the side
The HCCH
magnetization transfer via the backbone amide, so the HSQC spectrum cannot be
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for the Cβ chemical shift. Residue K307 is used as an example in Figure 5.3-2. The
chemical shifts of the already assigned Cα and Hα nuclei along with the pattern of
side-chain carbon chemical shifts (see Figure 5.3-3) confirm that this is in fact
residue K307, so the carbon peaks in the CCH-TOCSY can be assigned. As the Cβ
signal is on the diagonal, the corresponding proton chemical shift (in the 3rd
dimension of the HCCH-TOCSY) must represent the Hβ atom. Moving to this 1H
chemical shift in the HCCH-TOCSY allows the identification of the side-chain
protons of residue K307 (these are aligned horizontally along the chemical shift of
the Cβ nucleus in the 13C dimension). The side-chain protons are assigned by
identifying the directly attached carbon in the CCH-TOCSY spectrum. For example,
at the Hα chemical shift position in the CCH-TOCSY the same pattern of K307 peaks
are found with the Cα peak on the diagonal. This confirms the Hα assignment.
Using the CCH-TOCSY and HCCH-TOCSY, ~75% of the expected side-chain peaks
have been assigned (see Appendix A for a full chemical shift assignment table).
Figure 5.3-3
commonly occurring amino acids. Most amino acids can be identified by their distinctive side
chain carbon chemical shift patterns.
5.4 Distance Constraints.
A complete residue assignment is a prerequi
effect (NOE) based structural elucidation. The NOE refers to the transfer of
polarization between spins as a result of dipole
due to the magnetic fields produced by neighbouring nuclei) known as c
relaxation. As a result the NOE is dependent on the distance between nuclei as
well as their mobility
: All average carbon chemical
(Williamson, 2009)
shifts. Average carbon chemical shifts for each of the 20
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proportional to ଵ
௥ల
where is the distance between nuclei (Williamson, 2009). This
allows intermolecular distances to be calculated, thus providing information on
the molecular geometry which is indispensable to the calculation of 3D protein
structures. Figure 5.4-1 (A) illustrates that by increasing the amount of time that
the NOE is allowed to evolve (the mixing time) then larger distances can be
reported.
The ଵ
௥ల
dependence assumes that the protein is rigid and tumbles
isotropically in solution. Internal motions decrease the rate of cross-relaxation, in
turn decreasing the intensity of the NOE peak. However, this does not pose a
significant problem as NOE distances are usually pooled into categories
designated as weak, intermediate and strong as opposed to assigning an exact
distance. This means that if a NOE peak has a low intensity due to protein
mobility (the nuclei are close together but due to the mobility of the protein the
observed NOE is weaker than expected) then it is assigned as a ‘weak’ restraint
rather than a ‘strong’ restraint (very close in space). Assigning a NOE peak as a
‘weaker’ restraint than it should be, does not severely hinder the structure
calculation procedure. However, the mobility of the protein can result in
disappearance of peaks and fewer distance restraints, which may be more
problematic. The largest problem in analysing NOE distance restraints arises from
spin-diffusion – the transfer of NOEs along molecular bonds. As an NOE can be
more efficiently transferred along bonds than through space, spin-diffusion can
result in an intense NOE signal between nuclei that are distant in space but linked
through one or more bonds. The result is that peaks that are distant in space are
assigned a short distance constraint (‘strong’), wit
signals representing nuclei that are close in space appear weak in comparison and
so are assigned a longer (‘weak’) distance constraint. This can be overcome by
simply relaxing the distance constraints or by measuring NOEs at
times where the effect of spin
Figure 5.4-1
experiment.
through-space allowing longer distances to be observed. At a short mixing time NOEs are
observed between amino acid A and B. If the mixing time is increased then larger distances ar
reported and a NOE is observed between amino acid A and C. (B) The
the HSQC spectrum into a 3rd
through space and so a diagonal peak for the amide proton (green) is
the amide in space are correlated vertically with the intensity of the signal decreasing with
increasing distance from the amide.
5.4.1 15N NOE Distance Constraints.
The
This experiment combines a
: (A) Illustration of NOE transfer with increasing mixing time and (B)
(A) As the mixing time is increased, the NOESY magnetization is transferred further
15N-NOESY
-diffusion is minimized
1H dimension. During this experiment magnetization is transferred
-HSQC is essential for determination of distance restraints.
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effect spectroscopy) sequence resulting in a 3D experiment containing two 1H
dimensions and a single 15N dimension (Marion et al, 1989a). The data are
comprised of a series of 1H-1H planes, each at a specific 15N chemical shift, with
the HN signal along the diagonal and NOESY cross peaks to nearby protons in a
vertical strip (Figure 5.4-1 (B)). This allows distance constraints between the
backbone amide and all nearby protons to be determined: using the side-chain
assignment the NOE cross peaks are assigned distance constraints based on their
relative intensities.
Multiple 15N-NOESY-HSQC experiments were acquired with varying mixing
times in order to determine the optimal mixing time for distance constraint
determination (Figure 5.4-2). At short mixing times, the NOE can only report over
a short distance and hence a small number of peaks are observed. As the mixing
time increases, the NOE reports over longer distances, giving rise to more peaks.
However, as the mixing time increases so do the contributions from spin-
diffusion, severely hindering the determination of accurate distance constraints.
Figure 5.4-2 shows that at the shortest mixing times tested (50-120 ms), there are
a small number of NOE peaks. This is unexpected as large molecules experience
fast NOE build-up (because long rotational correlation times promote cross-
relaxation) and suggests that internal mobility is causing NOE signals to be lost.
This further highlights the flexibility of the CRD and supports the variable
intensity seen in the HSQC spectra at room temperature and the lack of signal in
the HSQC-TOCSY experiments due to 15N relaxation. The greatest number of
peaks occurs with 300 ms mixing time. However, at this prolonged mixing time
there is likely a significant contribution from spin-diffusion and so this mixing time
should be avoided. As a result,
for determination of distance restraints for structure calculation (although spin
diffusion cannot be ruled out and so restraints may need to be relaxed during
initial structure calculations).
Figure 5.4-2
increases the amount of cross
nuclei that are further away can
from spin-diffusion are increased and so accurate distance restraints are difficult to obtain.
5.4.2 Structure Calculation Using
Converge.
A structure calculation was att
distance restraints obtained from the
obtained from the secondary structure prediction using TALOS+ and the full
(backbone and side
: 15N-NOESY
a mixing time of 200 ms was deemed most useful
-HSQC spectra at different mixing times.
-relaxation that occurs and hence as the mixing time increases
be seen. However, as the mixing time is increased the effects
-chain) assignments. The automated, combined NO
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assignment and structure calculation method was used (
the potential for a significant number of restraints from this data alone as a total
of 665 NOE peaks were present in the
did not converge because the guidelines for successful runs were not met: the
number of unassigned NOEs and the number of discarded long
both greater than 20%, and
(Guntert, 2004)
calculation protocol to produce a satisfactory structure is possibly due to the lack
of 13C NOE constraints.
Figure 5.4-3
the automated structure calculation used by the programme CYANA is shown. The programme
utilises an iterative procedure t
. The failure of the combined NOE assignment and structure
: Automatic NOESY assignment and structure calculation using CYANA.
the RMSD value of cycle 1 was greater than
o assign the NOE peaks and calculate the protein structure.
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5.4.3 13C NOE Distance Constraints.
The
above, with the exception that the
The 1H-13C
bound to a carbon and so is more crowded than the
13C-NOESY
result is a NOESY ‘strip’ for each
distance restraints between any carbon
spectrum provides a great deal more structural information than the
HSQC as distance constraints between side chain nuclei a
Figure 5.4-4
proton bound to a carbon in the protein. For this reason it is more crowded than the
spectrum. Negative peaks are shown in green, this is due to peaks that are outside of the spectral
window being aliased.
13C-NOESY
-HSQC (Figure
-HSQC extends the
: 1H-13C-HSQC spectrum of DC
-HSQC is analogous to the
5.4-4) spectrum contains a single peak for each proton
1H
15N dimension is replaced by a
-13C-HSQC in to a third
1H-13C-HSQC peak allowing the determination of
-bound proton and all other protons. This
-SIGNR CRD.
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in order to determine the correct mixing time for the
5.4-5 shows
single plane) of the
substantial increase in the number of NOE signals was observed with a mixing
time of 150 ms, and so this was used to acquire a full 3D dataset. Mixing times
greater than 150 ms were not investigated in o
spin-diffusion. The number of peaks present in
that a sufficient number of additional
from the 13
on-going to fully analyse the
including these distance restraints. If the additional d
converged structure further structural refinement will be required.
Figure 5.4-5
HSQC are shown (
shown simultaneously). Very few NOE peaks are present at 70 and 100 ms mixing times. A mixing
time of 150 ms results in the greatest number of peaks and so this will be used for
calculations in the future.
1H-1H planes (all signals in the 3D experiment are collapsed on to a
C-NOESY-HSQC which could improve the structure calculation. Work is
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5.5 Conclusion.
The backbone assignment along with the Hα assignments obtained from
the H(CCO)NH spectrum were used to predict the secondary structure of the DC-
SIGNR CRD using the programme TALOS+ which is based on the chemical shift
index method. The secondary structure prediction is in good agreement with the
crystal structure (1K9J) with the exception of the C-terminal region which lacks
predictions due to the presence of un-assigned residues. The size of the CRD
prevented assignment of the full side-chain (using the TOCSY-HSQC experiment)
due to fast 15N backbone relaxation causing loss of signal during the TOCSY mixing
time. Instead, HCCH-TOCSY and CCH-TOCSY experiments were acquired enabling
the first reported side-chain assignment of the DC-SIGNR CRD (Appendix A). The
assignment paves the way for a full solution structure determination of the CRD.
While the 15N-NOESY-HSQC spectrum (with a 200 ms mixing time)
provides over 600 NOE cross peaks which could produce valid distance restraints,
simultaneous structure calculation and NOE assignment using the programme
CYANA did not converge using these NOE peaks alone. As a result, the quality of
the 13C-NOESY-HSQC spectrum was investigated because the 13C-1H NOE
correlations provide more structural information. A mixing time of 150 ms
produces many NOE cross peaks with sufficient signal/noise in the 13C-NOESY-
HSQC spectrum. Work is on-going to determine if the addition of these restraints
could help the solution structure to converge.
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Calcium Binding and
pH Dependence.
6.1 Introduction.
This chapter investigates the calcium binding characteristics of the DC-
SIGNR CRD, incorporating the presence of EDTA (a calcium chelating agent) and
low pH conditions in an effort to understand further the DC-SIGNR-calcium
interactions which, as yet, have not been investigated in detail.
EDTA can be used to probe the presence of calcium in solution via NMR as
the 1D 1H spectra of free and calcium-bound EDTA can be easily distinguished
(Han & Ba, 2004; Han, 2007). EDTA binds strongly to calcium and should compete
with the DC-SIGNR CRD for calcium ions. As a result, addition of EDTA to the DC-
SIGNR CRD samples was used to confirm that the CRD was in the apo state
because the presence of free EDTA NMR signals confirmed the absence of
calcium. If EDTA has a higher affinity for calcium than the CRD, the addition of
excess EDTA to the holo CRD (calcium-bound) should result in chelation of all
calcium ions leaving the CRD in the apo form (which can be confirmed by
comparing the HSQC spectrum with that of a known apo sample).
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In addition, the effect of pH on both calcium and glycan binding to the
CRD was investigated. This is of interest as it has been suggested that DC-SIGNR
acts as an endocytic receptor by internalising pathogens and releasing them in
the low pH environment of cytosolic compartments (Gramberg et al, 2008; Guo
et al, 2004; Snyder et al, 2005b). It has been confirmed that many other C-type
lectins have this function, including DC-SIGN (Engering et al, 2002). However, the
fact that DC-SIGNR lacks a Y L motif present in DC-SIGN, which is known to act
as an internalisation signal, brings this into debate. In addition, it has been
reported that DC-SIGNR does not internalise ligand and has no pH dependence
when transfected into rat fibroblasts (Guo et al, 2004). Any knowledge of the pH
dependence (and by extension the endocytic activity) of the CRD will provide
valuable insight in to the potential biological function of DC-SIGNR. The pH
dependence of the DC-SIGNR CRD was investigated by acquiring HSQC spectra of
the holo and glycan-bound CRD at pH 6.8 and pH 4.2. Any changes to the CRD as a
result of decreasing pH, either conformational changes or release of
calcium/glycan, should be apparent in the HSQC spectra as these changes will
result in chemical shift perturbations. We have already seen in §4.4.1 that there
are substantial differences between the HSQC spectra of the apo and holo CRD
and so it is reasonable to expect that decreasing the pH will result in significant
changes in the HSQC spectrum if calcium is released.
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6.2 EDTA as a Probe for Calcium Binding.
The 1H chemical shifts of EDTA in the free and calcium bound state have
been reported previously (Han & Ba, 2004; Han, 2007). The free and calcium-
bound EDTA chemical shifts are easily distinguishable: free EDTA results in two
sharp singlet peaks due to the acetate-methylene (labelled 1 in Figure 6.2-1) and
amine-methylene protons (labelled 2 in Figure 6.2-1). Calcium binding causes
splitting of the acetate-methylene proton peak while a singlet remains for the
amine-methylene protons. In the calcium bound form, both peaks are shifted up-
field with respect to the free EDTA chemical shifts. Consequently, the addition of
EDTA can be used to screen for the presence of calcium in a solution (EDTA has
been used to determine the quantity of calcium, as well as other metal ions in
hard water (Yappert & DuPre, 1997)). EDTA is expected to compete with the DC-
SIGNR CRD for calcium and so the differences in the 1H spectrum of free and
calcium bound EDTA can be used to determine whether the CRD is in the apo
(calcium free) or holo (calcium bound) state. If the addition of EDTA to the CRD
results in two singlet peaks (free EDTA peaks) then we can conclude that the CRD
is in the apo form because no calcium is present. If EDTA has a higher affinity for
calcium than the CRD then addition of EDTA to a holo CRD sample should result in
complete removal of calcium, leaving the CRD in the apo form.
Figure 6.2-1 (A) shows the aliphatic region of the 1H spectrum of apo DC-
SIGNR containing EDTA. Only signals arising from free-EDTA are present
confirming the complete absence of calcium and hence the CRD must be in the
apo state. This confirms that the HSQC spectrum in §4.4, Figure 4.4-1 is indeed of
the apo CRD. Spectrum (B) in
SIGNR CRD sample (containing 4 mM CaCl
Only signals from calcium bound EDTA are present. The protein concentration is
0.7 mM so the addition of 4 mM CaCl
CRD is in the holo
to the EDTA producing the peaks in
(60 mM) to the holo CRD results in chelation of all free calcium and the presence
of free EDTA in solution resulting in the spectrum in
Figure 6.2-1
EDTA added to holo DC
the presence of calcium as the 1D spectrum of free and calcium
Assignments are mapped on to the EDTA structure and the pH of all spectra was kept constant.
(A) The addition of EDTA to apo DC
there is no calcium present and that the protein is indeed in the apo state. In contrast, addition of
EDTA to holo DC
with EDTA. Adding excess EDTA to the holo sample (C) results in the appearance of additional free
EDTA peaks.
form. As a result, free calcium is present in solution and binds
: 1D-1H spectra of EDTA added to (A) apo DC
-SIGNR.
-SIGNR (B) produces only calcium
Figure
All spectra were recorded at pH 6.8. EDTA can be used to probe
-SIGNR CRD produces only free EDTA peaks confirming that
6.2-1
2 ensures that calcium is in excess and the
Figure
-bound EDTA peaks
shows the
2) following addition of 1 mM EDTA.
6.2-1 (B). The addition of excess EDTA
Figure
-SIGNR, (B) holo DC
-
Chapter 6: Calcium Binding
1H spectrum of a holo DC
6.2-1 (C).
-SIGNR and (C) excess
bound EDTA are easily identified.
as the free calcium interacts
118
-
Chapter 6: Calcium Binding
119
Interestingly, there is evidence of calcium exchange between free and
calcium bound EDTA. Figure 6.2-2 shows the effect on the 1H spectrum of holo
DC-SIGNR as the EDTA concentration is increased. Initially, the calcium bound
EDTA peaks increase in intensity until all of the free calcium has been chelated
and free EDTA peaks begin to emerge. However, while the free EDTA peaks
increase in intensity, the bound EDTA peaks begin to decrease and broaden
suggesting exchange between the free and bound EDTA (calcium is transferring
between EDTA molecules). This is possibly due to sub-optimal chelation by EDTA
at pH 6.8 (EDTA chelates metal ions most efficiently at pH ≥ 10 where the fully 
deprotonated form is dominant) (Skoog et al, 1994). However, the quality of NMR
spectra suffers at higher pH values (due to the increased rate of proton exchange
causing line broadening) and the study of DC-SIGNR at close to physiological
conditions is desirable, therefore EDTA titrations at higher pH values were not
acquired.
Figure 6.2-2
holo DC-SIGNR is increased the calcium
calcium binding to the EDTA. When all of the
appear. Interestingly, the calcium
exchange between the free and calcium
the titration.
The fact
mM) EDTA is not the same as the spectrum of apo DC
suggests that exchange betw
presence of free EDTA peaks in the
containing 60 mM EDTA implies that all of the calcium is sequestered (if we
assume that EDTA binds calcium with higher affinity than th
should be no calcium remaining which is capable of binding to the CRD.
Therefore, the differences between the HSQC spectra suggest that there is
exchange between the calcium bound to DC
the chemical
apo, holo (three calcium ions bound), and possibly 1 and/or 2 calcium ion
forms. In fact, the chemical shifts of the excess EDTA sample are not a weighted
: 1H stack plots of EDTA titrations of
that the HSQC spectrum of holo DC
shifts in the HSQC spectrum appearing at a position between the
-bound EDTA peaks also decrease at this point suggesting
een EDTA and calcium may be taking place. The
holo DC
-bound EDTA peaks increase in intensity due to free
free calcium is bound to EDTA, free
-bound EDTA. The pH was kept constant at 6.8 throughout
1H spectrum of the holo DC
-SIGNR.
-SIGNR containing excess (60
-SIGNR and free EDTA. This results in
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average between the apo and holo forms implying that there are other species
present (most likely the 1 and/or 2 calcium ion-bound forms). The variable
intensity of the spectrum could be further evidence of exchange between these
multiple species. Thus, the HSQC spectrum of the CRD containing 4 mM CaCl2 and
60 mM EDTA (Figure 6.2-3, green) represents a calcium depleted form of the CRD.
This means that regions of the DC-SIGNR CRD can bind calcium with very high
affinity, potentially on the same order as the affinity of EDTA for calcium
(determined previously as ~0.055 mM (Brinley et al, 1975; Christensen et al,
2003)). However, this is significantly stronger than dissociation constants
published for other C-type lectins such as the asialoglycoprotein receptor, which
exhibits an apparent Kd of ~330 µM for calcium at calcium-binding sites 1 and 2
and ~19 mM for calcium-binding site 3 at pH 6.9 (Onizuka et al, 2012).
Unfortunately, this exchange coupled with difficulties associated with the
removal of calcium (due to the apparent high affinity of the CRD for calcium)
means that the apo form cannot be retrieved from the holo CRD. However, the
HSQC spectra of holo DC-SIGNR both in the absence and presence of EDTA, but
with addition of excess calcium, are the same (Figure 6.2-4 (B)).
Figure 6.2-3
(green) both at pH 6.8
HSQC does not resemble the apo HSQC as expected. This suggests that at this pH the chelat
ability of EDTA is not sufficient to remove all calcium from the CRD. This highlights that the
calcium affinity of DC
Figure
in the presence of a fixed amount of EDTA. Initially, free EDTA is present in
solution as seen by the free EDTA peaks present in the 1D spectrum (
(A)). As the calcium concentration increases all of the free EDTA becomes bound
resulting in loss of the free EDTA peaks and increased intensity of the calcium
bound peaks. Under these conditions (60 mM EDTA, 70 mM CaCl
spectrum overlays almost exactly with the spectrum of holo DC
6.2-4 (B)) suggesting that calcium exchange between protein and bound EDTA is
negligible at these concentrations. This means that EDTA has no effect on the
holo HSQC spectrum but detailed information on DC
cannot be obtained in the presence of EDTA due to calcium exchange.
: Overlay of HSQC spectra of apo DC
. Despite the addition of 60 mM EDTA to the holo DC
-SIGNR is high.
6.2-4 shows the effec
-SIGNR (red)
t of increasing calcium on holo DC
and
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Figure 6.2-4
(B) overlay of HSQC spectra of holo DC
excess EDTA and calcium (black)
excess EDTA causes the free EDTA peaks to disappear and the calcium
intensity. The pH was kept constant at 6.8 throughout the titration. (B) The HSQC spectra of holo
DC-SIGNR in
(black) are extremely similar. This suggests that there is sufficient calcium to saturate both the
EDTA and the CRD.
: (A) 1H stack plots of calcium titrations on holo DC
absence of EDTA (blue) and following addition of 60 mM EDTA and 70 mM CaCl
at pH 6.8
-SIGNR in absence of EDTA (blue) and presence of both
. (A) Titration of calcium into the holo CRD containing
-SIGNR
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6.3 The pH Dependence of DC-SIGNR Glycan Release.
While the complete physiological role of DC-SIGNR is not known with
confidence it is known to have roles in cell-adhesion (Yabe et al, 2010), cell
signalling (Johnson et al, 2012) and may be involved in initiating primary immune
response through binding to ICAM-3 (Bashirova et al, 2001). There is also
speculation that DC-SIGNR could act as an endocytic receptor by internalising
pathogens. Other C-type lectins have endocytic functionality (Engering et al,
2002; Valladeau et al, 2000; Wragg & Drickamer, 1999) and there are reports that
DC-SIGNR can internalise glycoprotein ligands (Gramberg et al, 2008). Endocytic
C-type lectins are believed to release glycoproteins/pathogens in the endosome
as a result of calcium release in the low pH environment (Mellman et al, 1986).
However, there is a report which shows that DC-SIGNR-ligand binding is not pH
dependent and that DC-SIGNR does not internalise glycoproteins (Guo et al,
2004). In addition, DC-SIGNR lacks an internalisation signal (a Y L motif in the
cytoplasmic domain) that is present in the unequivocally endocytic receptor DC-
SIGN (Soilleux et al, 2000). As a result, some authors argue that DC-SIGNR has
evolved to perform different (as yet uncharacterised) biological functions than
DC-SIGN that do not necessarily involve ligand internalisation. This hypothesis
was investigated utilising NMR spectroscopy. A comparison of HSQC spectra at
varying pH values could provide information on the conformational state of the
CRD and shed light on the pH dependence of DC-SIGNR ligand binding.
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6.3.1 Decreasing the pH Causes Significant Changes in the HSQC
Spectrum of Holo DC-SIGNR CRD.
Figure 6.3-1 compares HSQC spectra of holo DC-SIGNR CRD at pH 6.8 (dark
blue) and 4.2 (light blue). It is clear that large conformational/dynamics changes
occur throughout the CRD as a result of decreased pH as many chemical shifts are
perturbed. The most likely explanation for this is the release of calcium. However,
the holo HSQC spectrum at pH 4.2 does not overlay exactly with the HSQC
spectrum of apo CRD at pH 6.8 (Figure 6.3-2) indicating that decreasing the pH
contributes to an additional conformational or dynamics change or that there is
exchange between multiple species (apo, holo and calcium depleted) of the CRD.
These pH induced changes to the holo-CRD HSQC spectrum are reversible since
increasing the pH back to 6.8 returns the spectrum to the holo form, indicating
that the CRD regains the ability to bind ligand when it returns to the higher pH
extracellular environment.
Although the spectra of the holo CRD at low pH (light blue) and apo CRD
(red) (Figure 6.3-2) do not overlay exactly, there are patterns of peaks that
appear at low pH that are only present in the apo spectrum. Most notably the
peaks circled in Figure 6.3-2 appear as the pH is decreased, these peaks are only
ever present in the apo spectrum. Unfortunately, these peaks are not assigned
(as they are not present in the holo HSQC spectrum) but they are possibly aliased
arginine side-chain peaks. The significant changes in the HSQC spectrum (Figure
6.3-1) along with the appearance of the peaks highlighted in Figure 6.3-2 lead us
to speculate that calcium is released at low pH.
Figure 6.3-1
the pH of the holo DC
intensity throughout the HSQC indicating that significant conformation/dynamics changes occur.
The most likely explanation is that calcium is released at low pH. However, the spectrum of the
holo CRD at pH 4.2
affect the protein conformation.
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is not the same as the apo CRD at pH 6.8 indicating that the pH may reversibly
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Figure 6.3-2
(red). Although the HSQC spectra of holo DC
which could mean that calcium is released at low pH, there are some chemical shift differences
indicating that the low pH contributes to an
peaks that are only present in the apo and low pH spectra are circled.
6.3.2 Evidence of Glycan Release at Low pH.
The large number of chemical shift perturbations in the HSQC spectra of
holo DC-SIGNR at low pH c
release coupled with a pH induced conformational/dynamics change in the DC
SIGNR CRD could be responsible for ligand release in the cell cytosol. The effect of
pH on ligand binding was tested by decre
presence of 10 mM GlcNAc
residues are found at the reducing end of high
has been implicated in interactions between DC
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ompared to pH 6.8 suggests the possibility that calcium
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et al, 2006). Binding of GlcNAc3 to DC-SIGNR was confirmed via chemical shift
perturbations observed for a number of HSQC signals (Figure 6.3-3). Decreasing
the pH of the GlcNAc3-bound DC-SIGNR CRD to 4.2 causes significant chemical
shift perturbations (more perturbations than induced by glycan binding)
suggesting a drastic, and global change in the CRD as a result of decreasing the
pH. Figure 6.3-4 compares the HSQC spectra of holo DC-SIGNR (no glycan present,
light blue) and GlcNAc3-bound DC-SIGNR (purple) both at pH 4.2. The similarity
between the two spectracould be a direct result of ligand (and calcium) release.
The peaks circled in Figure 6.3-2 and Figure 6.3-3 are due to aliased arginine side-
chain amides. These peaks are visible in the low pH spectra of both holo and
glycan-bound DC-SIGNR CRD but at pH 6.8 are not visible due to broadening /
chemical shift changes. More work is required to determine the cause of these
changes. Interestingly these peaks are also visible in the apo spectrum of DC-
SIGNR CRD at pH 6.8 (Figure 6.3-2, red). There are differences between the two
spectra in Figure 6.3-2 which could indicate that reducing the pH does not
completely abolish ligand/calcium binding resulting in chemical shifts
intermediate between bound and un-bound states. This could also explain the
discrepancies between the HSQC spectra of holo CRD at pH 4.2 and apo at pH 6.8
(Figure 6.3-2).
Figure 6.3-3
confirm that there is an interaction between the DC
Figure 6.3-4
(purple). Dropping the pH of the DC
similar effect on the HSQC spectrum. However, there are a number of significant chemical shift
perturbations which may indic
which appear at low pH that are only present in the apo HSQC spectrum are circled.
: HSQC spectra
: HSQC spectra of DC
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complex. This is expected as there are potentially multiple un
(calcium and glycan) along with conformational and dy
with the change in pH. There is evidence of line broadening (circled in
6.3-5) which is indicative of intermediate ex
could indicate that ligand/calcium binding has not been completely abolished. In
addition, linear shifts represent fast exchange on the chemical shift timescale and
could be a direct result of ligand or calcium release (fast
chemical shift perturbations are discussed in more detail in
some chemical shifts follow a curved perturbation path which
than one molecule is involved, suggesting that both ligand and calcium are
released at low pH.
Figure 6.3-5
varying pH on glycan bound DC
chemical shift perturbation (compared to pH 6.8) while decreasing the pH causes significant
perturbations throughout the protein. Some peaks are perturbed l
curved path which is indicative of multiple molecules binding/unbinding. In addition, some peaks
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In order to confirm that DC-SIGNR releases ligand at low pH protein was
bound to a 2 mL mannose-Sepharose column (as described in the Materials and
Methods §2.7.1) and eluted using an EDTA-free buffer at pH 4.2. Figure 6.3-6
confirms that DC-SIGNR dissociates from the mannosylated resin, and elutes from
the column when the pH is decreased which supports the NMR data above. The
protein is predominantly found in the third 1 mL elution fraction at low pH, which
is in contrast to the EDTA elution method wherein the majority of protein is
consistently eluted in the second 1 mL fraction. In addition, using the low pH
method results in a small amount of protein present in the fourth 1 mL elution
fraction while the EDTA method results in all protein eluting by the third 1 mL
fraction. This indicates that lowering the pH does not completely abolish ligand
binding. This supports the NMR data suggesting that the differences between the
HSQC spectra of holo CRD and glycan bound CRD at pH 4.2 are due to exchange
between bound and un-bound states as a result of decreased, but not abolished,
ligand binding. Carbohydrates are weak acids with pKa values ranging from 12-14
(Lange & Speight, 2005) and so a pH drop from 6.8 to 4.2 will not have any
substantial effect on the glycan protonation state, confirming that the changes in
the HSQC are due to the pH dependence of the CRD.
Figure 6.3-6
column was eluted using 20 mM hepes, 150 mM NaCl pH 4.2. The majority of protein elutes in
fraction 3 confirming the DC
EDTA elution method, there appears to be a small amount of protein in fraction 4 suggesting that
lowering pH does not abolish binding as efficiently as EDTA addition.
6.4 Conclusion.
This chapter describes changes in the HSQC spec
CRD in the presence and absence of calcium, upon addition of EDTA, addition of
glycan, and at low pH. Several HSQC spectra were acquired which represent the
CRD in different forms: apo, holo, calcium
These are summarised schematically in
insight in to the calcium binding characteristics of the CRD, which has not been
studied in detail previously. The data suggest that the CRD binds calcium with
high affinity (once added in excess, Ca
CRD using EDTA alone) and that calcium and ligand are released at low pH
supporting the argument that DC
(Gramberg et al, 2008; Snyder et al, 2005b)
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Sepharose column with low pH.
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Figure 6.4-1: Schematic representation of the data described in this chapter and the CRD species
that have been observed. Each shape represents the HSQC of the CRD in different conditions.
Under different conditions the chemical shifts in the HSQC spectra change. However, the HSQC of
the holo CRD and the glycan-bound CRD at low pH are extremely similar. This, coupled with the
low pH mannose-Sepharose elutions suggests that the CRD releases glycan at low pH.
EDTA provided an effective means of determining the presence of excess
free calcium in protein samples. The acquisition of 1H spectra of the apo CRD
following addition of EDTA confirms that no calcium is present in the sample and
thus the protein is in the apo state. Equally, addition of EDTA to the holo CRD
samples confirms the presence of excess calcium. Attempts to acquire a HSQC
spectrum of apo DC-SIGNR in the presence of calcium by addition of excess EDTA
were unsuccessful. This is due to calcium exchange between the CRD and free
EDTA resulting in chemical shifts at positions intermediate between the apo and
holo spectra producing a HSQC spectrum of the calcium-depleted CRD. This
indicates that DC-SIGNR binds calcium with high affinity and that the calcium
binding sites have different affinities. This problem might be resolvable by
increasing the pH to >9.0 and thus increasing the affinity of EDTA for calcium.
Apo
pH 6.8
Holo
pH 6.8
Glycan-bound
pH 6.8
Holo
pH 4.2
Calcium-
depleted
low pH
+ 4mM
CaCl2
+ 10mM
glycan
+ 60mM
EDTA
Calcium exchange
between EDTA and
CRD means cannot
remove Ca2+ with
EDTA.
HSQC and mannose-
Sepharose elution
fractions suggest partial
glycan release at low pH.
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However, this would have a detrimental effect on the spectral signal/noise and so
was not explored. The use of chelating agents with stronger calcium affinity, such
as EGTA, could be used as an alternative.
The effect of pH on calcium and ligand binding was investigated as there
are conflicting reports in the literature and because any insight in to mechanisms
of ligand release could help in understanding the biological role of DC-SIGNR.
Decreasing the pH of the holo CRD causes substantial changes to the HSQC
chemical shifts which indicate structural rearrangement that could be a result of
calcium release. However, the HSQC spectrum of holo CRD at low pH is not the
same as that of the apo CRD indicating that additional conformational/dynamics
changes occur as a result of lowering the pH or that not all Ca2+ is released at low
pH. Similarly, the HSQC spectra of DC-SIGNR CRD bound to GlcNAc3 undergoes
extensive chemical shift perturbations at low pH. A pH titration highlights the
chemical shift perturbations and confirms the complexity of the effect of pH on
the CRD. This could be a result of ligand and calcium release causing curved
perturbations as well as line broadening. This line broadening, along with the fact
that the low pH HSQC spectra do not overlay with the apo HSQC spectrum,
indicates that decreasing the pH does not completely abolish ligand binding.
Protein was successfully eluted from the mannose-Sepharose column using pH
4.2 buffer confirming that DC-SIGNR-glycan interactions are pH dependent.
However, protein was observed in elution fraction 4 (this is not observed when
using the EDTA elution method) suggesting that some degree of mannose binding
is maintained at low pH. This supports previous work which shows that, while DC-
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SIGNR releases ligand at low pH, the effect of pH on DC-SIGNR is not as
substantial as the effect on DC-SIGN (Gramberg et al, 2008).
While these results illuminate some interesting effects of pH on the glycan
binding ability of the DC-SIGNR CRD, they are not conclusive and further work is
required to achieve a deeper insight in to the mechanism of ligand release at low
pH. On-going work includes investigation of the apo CRD at low pH (the
difficulties in obtaining calcium free protein prevented analysis of this within the
timescale of this project), investigation of the effect of pH on mannose-containing
ligands (particularly branched, disease-associated ligands), and the determination
of protein-ligand dissociation constants at low pH.
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Glycan Binding.
7.1 Introduction.
The backbone assignment of the holo DC-SIGNR CRD (described in §4.3)
provides a ‘map’ of the protein and allows the effects of ligand binding on the DC-
SIGNR CRD to be investigated directly. The backbone chemical shifts are sensitive
to changes in the chemical environment of a given nucleus, and so direct
interaction with a ligand along with ligand induced conformational or dynamics
changes will result in the perturbation of chemical shifts in the HSQC spectrum.
This allows for the easy identification of residues/regions of the CRD that are
affected by ligand binding. This method of probing protein-ligand interactions
allows rapid investigation of a range of ligands in solution eliminating the
problems which arise from difficult-to-crystallise ligands. Due to their inherent
flexibility (Woods et al, 1998), branched oligosaccharides can be a challenge to
crystallise and crystal structures of the DC-SIGNR CRD in complex with large,
disease-associated ligands remain elusive. In particular, utilising solution state
NMR has allowed the investigation of Man9GlcNAc derived from the HIV envelope
glycoprotein gp120. This chapter describes the interaction of a number of glycan
fragments ((GlcNAc)2Man3, Man3, Man5, and GlcNAc3 shown schematically in
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Figure 7.1-1) along with the first investigation of the DC-SIGNR CRD with a
disease-associated ligand (Man9GlcNAc).
Figure 7.1-1: Glycans investigated in this study. The glycans used in this study are represented
schematically. (GlcNAc)2Man3 allows comparison with the crystal structure 1K9J while
Man9GlcNAc differs from the HIV associated Man9GlcNAc2 by a single, terminal GlcNAc residue.
7.1.1 Chemical Shift Perturbations in Fast and Slow Exchange.
By titrating increasing amounts of glycan into a sample of 15N-labelled DC-
SIGNR CRD and recording a HSQC spectrum at each titration point the chemical
shift perturbations in the HSQC spectrum can be tracked. This is because the
chemical shifts of a molecule in fast exchange between two states are a weighted
average between those two states. In this case, exchange refers to the inter-
conversion between the bound and un-bound states of the CRD. Thus, a ligand
with weak affinity for the CRD will be in fast exchange. If this is the case, then
increasing the concentration of ligand forces the equilibrium towards the bound
state (the CRD is in the bound state more often) until eventually the chemical
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α 6
α 2α 2
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shift is that of the CRD in the bound state. This is called saturation. The titration
points before saturation produce chemical shift values which are a weighted
average between the un-bound and bound chemical shifts resulting in a linear
pattern of peaks which can be easily tracked (Figure 7.1-2).
Figure 7.1-2: Illustration of chemical shift perturbations in fast and slow exchange. Ligand binding
causes a change to the chemical environment of the chemical shift and so the bound chemical
shift is at a different position than the un-bound. If the protein has weak affinity for the ligand
then the conversion between the bound and un-bound state will be in fast exchange. In this case,
as the concentration of ligand is increased chemical shifts at positions between the bound and un-
bound peaks are observed. If the ligand binds more strongly, then the conversion between bound
and un-bound states is slower and the protein-ligand complex enters slow exchange. As the ligand
concentration is increased the un-bound chemical shift signal broadens and decreases in intensity
until it disappears, then the bound chemical shift appears and increases in intensity.
The chemical shift perturbations are more complex if the CRD has a high
affinity for the ligand. The protein-ligand complex enters the slow exchange
regime due to the stronger binding causing slower exchange between the bound
and un-bound states. In this case, the un-bound chemical shift signal broadens
and decreases in intensity as the ligand concentration is increased until the signal
is no longer visible. Next, the bound chemical shift signal appears and increases in
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intensity with increasing ligand concentration. The chemical shifts are deemed to
be saturated when the intensity of the bound chemical shift no longer increases
(Figure 7.1-2). As a result, the chemical shift perturbations provide information
on the lifetime of a protein-ligand complex and can be used to determine the
binding affinity.
7.1.2 15N T1 and T2 Relaxation Parameters.
In addition to the chemical shift perturbation analyses described above
measurements of transverse (T2) and longitudinal (T1) 15N relaxation times for the
holo and Man5-bound CRD were also acquired. Relaxation is the mechanism by
which the nuclear spins return to the equilibrium state. T1 relaxation is caused by
fluctuations in the magnetic field orthogonal to the -direction, restoring thermal
equilibrium, while T2 relaxation is caused by magnetic field fluctuations in the -
direction, which results in de-phasing of the transverse magnetization. These
magnetic field fluctuations are a result of the overall motion (tumbling) of the
protein as well as internal motions because different orientations of the protein
molecule result in changes to the electron shielding of the nuclei (due to the
chemical shift anisotropy) and the strength of the dipolar coupling interactions.
Therefore, the T1 and T2 relaxation parameters provide valuable information on
the dynamics of the protein. In particular, the 15N relaxation measurements
provide information on the dynamics of the protein backbone (i.e. which residues
are mobile and which are more rigid). These dynamics measurements are of
interest due to the variable intensity of signals in the HSQC spectrum of the apo
CRD (§4.2) which indicated that DC-SIGNR is very mobile. In addition, the ability
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of DC-SIGNR to bind a wide range of inherently flexible glycans suggests that the
dynamics of the CRD may play a vital role in glycan recognition.
7.2 Binding of Glycan Fragments with DC-SIGNR CRD.
A series of HSQC spectra were acquired upon titration of the glycan
fragments GlcNAc3, Man3, Man5, or (GlcNAc)2Man3 (shown schematically in
Figure 7.1-1) into a solution of the DC-SIGNR CRD (0.7 mM) at 37˚C. All glycans 
induced chemical shift perturbations throughout the HSQC spectrum confirming
that interaction with the CRD was taking place (HSQC spectra of fragments
containing mannose are shown in Figure 7.2-1 while the HSQC spectra of the
GlcNAc3 titration was shown previously in §6.3, Figure 6.3-3). (GlcNAc)2Man3 (the
sugar present in the 1K9J crystal structure, Figure 7.2-4) allowed the direct
comparison of results in solution to published crystal data. The extent of the
perturbations induced by each mannose-containing glycan ((GlcNAc)2Man3, Man3,
Man5 and Man9GlcNAc) are illustrated in Figure 7.2-2 and by GlcNAc3 in Figure
7.2-3. It is clear that significant chemical shift perturbations are observed in
several regions along the sequence of the CRD upon binding of all sugars. The
standard deviation of the chemical shift perturbation across all residues
(indicated by a dashed line in Figure 7.2-2 and Figure 7.2-3) was used (Schumann
et al, 2007) to determine residues most affected by binding. Perturbations above
this threshold were considered significant. For each sugar investigated, the most
perturbed residues were mapped onto the DC-SIGNR CRD crystal structure
obtained in complex with (GlcNAc)2Man3 (1K9J) in Figure 7.2-5.
Figure 7.2-1
spectra of titrations of (A) (GlcNAc)
cause several linear chemical shift perturbations. Inset panels highlight some linear chemical shift
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Figure 7.2-2
chemical shift perturbation upon addition of 5 mM of each glycan is plotted per residue. Dashed
lines represent the standard deviation across
considered to be significant.
: Chemical shift perturbations per residue for
all residues, perturbations above this line are
mannose
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Figure 7.2-3
chemical shift perturbation upon
represent the standard deviation across all residues, perturbations above this line are considered
to be significant.
Figure
of some regions in the protein near the principal glycan binding site as suggested
by the 1K9J crystal structure. Specifically, residues in the loop region that make
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7.2.1 Evidence of Different Binding Modes for the Glycan Fragments.
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shown to form a direct contact with (GlcNAc)2Man3 in the crystal, was not
perturbed significantly in solution. Fewer perturbations in α-helix 2 were 
observed upon binding of Man3, Man5, and GlcNAc3 and no glycan induced any
perturbation of the F325 peak. However, Man3, Man5, and GlcNAc3 significantly
perturb the residue S326 adjacent to F325 while (GlcNAc)2Man3 does not.
The chemical shift perturbations in solution also highlighted changes in
regions distal to the proposed glycan binding site. Man3 binding induced
perturbation of residues 270 & 271 at the N-terminus of the CRD (solid box in
Figure 7.2-5(B-C)) while GlcNAc3 and Man5 only perturbed residue 270.
(GlcNAc)2Man3-binding exhibited unique perturbations in the loop region
consisting of residues 382-385 (Figure 7.2-5(A), dashed box) suggesting that
perturbations in this region may be due to the GlcNAc moieties. This is unusual as
these residues are not involved in glycan binding seen in the crystal structure
(1K9J), suggesting that the perturbations are a result of a conformational or
dynamics change in this region. Interestingly, this loop region is not perturbed by
GlcNAc3, indicating that the size of the (GlcNAc)2Man3 molecule, in conjunction
with the GlcNAc moieties, could be responsible for this unique
conformational/dynamics change.
Figure 7.2-5
addition of 5
Residues with total chemical shift perturbations greater than the standard deviation cut
highlighted in red for each glycan investigated. (GlcNAc)
perturbed residues, particularly in
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ligand binding in solution. This is in contrast to results obtained from
crystallography, which yield virtually identical average structures for the free and
ligand-bound states
for an overlay
Figure 7.2-6
structures solved of the DC
of the CRD in complex with (GlcNAc)
(black, 1XPH) as an example.
of two
: Overlay of glycan
-Induced Conformational/Dynamics Changes.
these
anges in conformation and/or dynamics occur upon
(Feinberg et al, 2001; Snyder
representative
-bound (white) and holo (black) CRD crystal structures.
-SIGNR CRD adopt nearly identical conformations. The crystal structure
results are compared to the existing structura
structures
2Man3 (white, 1K9J) is shown with the CRD in holo form
et al, 2005a)
for these opposing states
Chapter 7: Glycan Binding
titration
(see
in all cases is
Table 7.2
Figure
).
All crystal
147
l
-1).
7.2-6
Chapter 7: Glycan Binding
148
Table 7.2-1: Residues significantly perturbed by ligand binding. Residues which form contacts with
the (GlcNAc)2Man3 ligand in the 1K9J crystal structure are listed along with residues which are
perturbed significantly upon addition of 5 mM (GlcNAc)2Man3, Man3, Man5, Man9GlcNAc, and
GlcNAc3 in the NMR analyses.
crystal
structure
(GlcNAc)2Man3
(5 mM) Man3 (5 mM) Man5 (5 mM)
Man9GlcNAc
(5 mM)
GlcNAc3
(5 mM)
270 270 270 270 270
271 271 271
272
288 288
290
314
316
317 317 317
319
320 320
321 321 321 321
322 322 322
323 323 323
324 324
325
326 326 326 326
327 327
328 328 328 328
330 330
331
332 332 332 332
333 333
334 334
336
337 337 337
338
339 339 339
341
350 350
355
356 356 356 356 356
357 357 357 357 357
359 359 359 359 359 359
361
363 363
364 364 364 364 364
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365 365
366 366 366 366 366
367 367 367 367
368 368 368
369 369 369
370 370 370 370 370
371 371 371
372 372 372 372 372 372
373 373 373 373
375 375
377 377 377 377 377 377
378 378 378 378 378 378
379 379 379 379 379
380 380 380 380 380
381 381
383 383 383
384
385
386
7.3 Binding of Man9GlcNAc to the DC-SIGNR CRD.
To extend current knowledge of the DC-SIGNR CRD to binding of more
complex, physiologically important and/or disease-associated ligands, and
provide a better understanding of DC-SIGNR-HIV interactions, titration
experiments were carried out using Man9GlcNAc derived from the gp120 protein
of HIV. Man9GlcNAc is very closely related to Man9GlcNAc2 on HIV gp120,
differing by a single GlcNAc unit at the reducing terminus which would be
anchored to the polypeptide backbone and hence less likely to play a crucial role
in DC-SIGNR binding. As shown in Figure 7.2-2(D) (spectra are shown in Figure
7.3-1), binding of Man9GlcNAc also resulted in significant chemical shift
perturbations in several regions of the CRD, and those greater than the standard
deviation are mapped onto the DC
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helix 2 (Figure 7.2-5), which is significantly perturbed by binding of (GlcNAc)2Man3
(and to a lesser extent by Man5, Man3 and GlcNAc3), shows no perturbation upon
binding of Man9GlcNAc. In addition, residue F325 (Figure 7.2-4) shows no
significant chemical shift perturbation upon addition of Man9GlcNAc. This is
interesting because the crystal structure of DC-SIGNR in complex with
(GlcNAc)2Man3, along with all glycan-bound structures of the homologous protein
DC-SIGN, highlight the same extended binding site, part of which is formed by α-
helix 2 and F325 is consistently stated as an important solvent-exposed side-chain.
The NMR data presented here show that, in solution, α-helix 2 is involved in 
binding to the small fragments (particularly (GlcNAc)2Man3) but not to
Man9GlcNAc. In addition, residues S320, N323 (in α-helix 2), N361, S363, and G373 are
all involved in direct sugar contacts in the (GlcNAc)2Man3 crystal structure but are
not significantly perturbed on addition of Man9GlcNAc. This suggests that
Man9GlcNAc has a different mode of binding to the CRD than does
(GlcNAc)2Man3, and highlights that inferring the mechanism of binding of larger,
branched glycans from structural data of smaller, less physiologically-relevant
glycans should be treated with caution. On-going work to determine a high-
resolution solution structure of DC-SIGNR CRD bound to ligands will shed further
light upon this.
7.4 Ligand Binding Affinities in Solution.
In addition to highlighting potential binding sites for various ligands, NMR
titration data can also provide detailed affinity information. Figure 7.2-1 shows
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the HSQC spectra acquired as increasing concentrations of (GlcNAc)2Man3, Man3
or Man5, respectively, were titrated into the DC-SIGNR CRD. The three sugar
fragments behaved similarly upon titration, displaying linear chemical shift
perturbations and no line broadening as ligand concentration was increased. This
behaviour is characteristic of fast exchange between free and bound protein on
the NMR chemical shift timescale, and suggests that the interaction between the
CRD and sugar fragments is weak. This supports previous evidence that DC-SIGNR
preferentially binds highly branched oligosaccharides (Feinberg et al, 2001; Guo
et al, 2004; Snyder et al, 2005a). Fitting the chemical shift perturbations to a 1:1
binding model (see Materials and Methods §2.12.8) produced the best fits to the
data and provided estimates of the dissociation constants for each sugar (Figure
7.4-1 shows examples of the curve fit for some residues near α-helix 2). All 
significantly perturbed residues in the CRD could be fitted to the same 1:1 binding
model and yielded similar KD values suggesting the presence of a single glycan
binding site. Table 7.4-1 shows that GlcNAc3, (GlcNAc)2Man3, Man3 and Man5 all
bind with similar, weak affinities, yielding KD values between 1.57-3.58 mM. This
value is considerably weaker than binding of similar simple sugars to other lectin
CRD domains such as galectin-1 (where KD values for binding of lactose have been
reported ranging from approximately 40 M (Nesmelova et al, 2010) to 520 M
(Miller et al, 2009)), galectin-3 (lactose bound with a KD = 231 M (Diehl et al,
2010)), BclA (methyl--D-mannoside bound with a KD = 2.75 M (Lameignere et
al, 2008)), and the asialoglycoprotein receptor (where binding constants of 66-
539 M were reported for a variety of simple sugars (Onizuka et al, 2012)).
However, these KD values are in line with the affinity of the analogous protein DC-
SIGN for other small glycans such as fucose (6 mM) and mannose (13 mM)
(Timpano et al, 2008)
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7.4.1 The DC-SIGNR CRD has Higher Affinity for Man9GlcNAc than the
Glycan Fragments.
In contrast to the glycan fragments described above, we can see from
Figure 7.3-1 that binding of Man9GlcNAc causes significant broadening and
disappearance of a number of CRD resonances. This is consistent with
intermediate exchange on the NMR time scale (Keeler, 2005; Lian & Roberts,
2011). This implies that Man9GlcNAc binds with higher affinity than
(GlcNAc)2Man3, Man3, GlcNAc3 or Man5, since we move from fast exchange to
intermediate exchange on the NMR chemical shift timescale as the lifetime of a
complex is increased. This was expected and is consistent with previous
competition assay data obtained for DC-SIGNR binding to Man9GlcNAc2 which
yielded a Ki value of 200 M (Mitchell 2001), as well as other lectins (such as
galectin-1) that show increased affinity for larger, more complex glycans (Miller
et al, 2009). Due to the severe line broadening at the highest Man9GlcNAc
concentrations (5 mM, a concentration estimated to saturate binding at 25 the
reported Ki) resulting from intermediate-timescale exchange, an accurate
dissociation constant could not be estimated for Man9GlcNAc binding. However,
it is generally accepted that intermediate exchange corresponds to dissociation
constants in the range of 10-3-10-7 M (Lian & Roberts, 2011).
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7.5 NMR Dynamics Reveal a High Degree of Flexibility for
the Ca2+-Bound (Holo) DC-SIGNR-CRD.
Because a larger number of chemical shift perturbations were observed
than expected based on the size of the canonical binding site present in the CRD
crystal structure, residue by residue changes in 15N relaxation times upon glycan
binding were also investigated. The high degree of dynamics in the DCSIGNR CRD
was first suspected because of the variable signal intensities in the HSQC
spectrum of the apo CRD (§4.2). These variable signal intensities suggest that, in
its Ca2+-free form, the protein can exchange between an ensemble of
conformational states with a rate corresponding to the intermediate exchange
regime on the NMR 1H and 15N chemical shift timescale at 700 and 800 MHz.
To explore the dynamics of the CRD further, T1 and T2 relaxation times
were measured for the CRD in the absence (holo) and presence of 10 mM Man5
(Figure 7.5-1 (A) and (B), and Table 7.5-1). Man5 was selected for this study
because binding of Man9GlcNAc produced severely exchange-broadened spectra,
preventing accurate measurement of relaxation parameters. The T1 data are very
similar for the two states, showing a similar trend across the protein, with
average values of 788.26  22.4 ms for the holo and 806.22  40.35 ms for the
Man5-bound forms. However, more significant differences are observed in the
transverse relaxation time constants (T2). For the holo CRD, though most of the T2
values fall near the average (76.27  2.27 ms), residues in both Ca2+ binding loops,
-helix 1, -sheets 6 and 7, and at the N-terminus (see shaded regions in Figure
7.5-1) display shorter relaxation times suggesting either more structured
Chapter 7: Glycan Binding
156
conformations in these regions or chemical exchange processes (or both)
(Csizmok et al, 2008). A similar trend is seen in the T2 data for the Man5-bound
CRD, but with an overall lower average T2 relaxation time (66.54  8.23 ms) and
further reductions in the T2 transverse relaxation times observed in all regions
listed above.
7.5.1 Man5 Binding Hinders the Motion of the Primary Calcium Loop.
Asterisks in Figure 7.5-1 indicate residues in the Ca2+ binding loops whose
signals are so severely broadened as to be unobservable in these experiments,
supporting the rapid relaxation of these regions. Specifically, these residues
included E359, N361 and N362 in the primary Ca2+ binding loop, which make up the
EPN motif conserved among all mannose-binding C-type lectins (Drickamer,
1992). Binding at the primary Ca2+ site is well characterised (it is a distinguishing
feature of C-type lectin binding) and it has been confirmed that the EPN sequence
is responsible for mannose specificity (Drickamer, 1992). In addition to the EPN
motif, residues across the entire primary Ca2+ binding loop display enhanced
transverse relaxation in both the holo and ligand bound forms. For the holo
form, motions on the s-ms timescale near the primary Ca2+ site may be due to
conformational exchange as the Ca2+ ions come on and off the CRD. There is
previous evidence for several other C-type lectins that, in the absence of bound
calcium, undergo cis-trans isomerisation about the peptide bond of the
conserved proline (P360) in the EPN motif (Ho et al, 2010; Ng et al, 1998; Nielbo et
al, 2004; Pavlicek et al, 2003; Poget et al, 2001). In most cases, binding of Ca2+
has resulted in stabilization of one conformer; however no data for DC-SIGNR
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have been reported thus far in this regard. The data described in this study
suggest that considerable local dynamics persist in the Ca2+ bound form. The
further reduction in T2 values upon addition of Man5 suggests a further reduction
in the rate of dynamic motion (i.e. motion is more hindered) in the primary
calcium binding loop upon sugar binding, thus supporting previous reports that
that this is the site of key CRD-mannose interactions.
Table 7.5-1: Average relaxation parameters of holo and Man5-bound CRD. Average T1, T2 and the
ratio of T1/T2 were calculated across all residues. The rotational correlation time (τc) was
estimated from the T1/T2 ratio excluding residues with ratios greater/less than one standard
deviation above/below the mean.
Holo CRD Man5 bound CRD
Average T1 (ms) 788.26 ± 22.4 806.22 ± 40.35
Average T2 (ms) 76.27 ± 2.27 66.54 ± 8.23
Average T1/T2 10.67 ± 0.43 13.19 ± 1.75
Rotational correlation time (τc) (ns) 10.4 ± 0.4 12.5 ± 1.36
Figure 7.5-1
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A decrease in T2 upon addition of Man5 is also observed for residues
throughout -sheets 6 and 7 which, as discussed earlier, form part of the sugar
binding site proposed in the literature. Specifically, it is thought that the loop
joining these two strands directly interacts with the glycan, thus sugar binding to
the loop region may hinder the motions of the individual strands. This hindered
motion would lead to enhanced transverse relaxation as the rate of the dynamics
(both global and local) changes in this region.
7.5.2 Dynamics Changes Distal to the Ligand Binding Site.
The relaxation data presented here also highlighted regions in the CRD
that have not yet been implicated in binding to sugars, namely the secondary
calcium binding loop and -helix 1. Residues all along the length of -helix 1
show a subtle but significant reduction in T2 in the holo CRD, and a further
reduction upon binding of Man5.  α-helix 1 is positioned towards the N-terminus 
of the CRD, where increased transverse relaxation rates are also observed for
residues 269-272.  The N-terminus of the CRD connects to the α-helical neck in 
the full length protein, and others have proposed that this region forms a flexible
‘hinge’ (Leckband et al, 2011; Snyder et al, 2005a; Yu et al, 2009) allowing the
CRD to sample multiple orientations with respect to the neck. Taking this
previous work into account, one tentative explanation for the enhanced
relaxation in -helix 1 and the N-terminus is that binding of Man5
restricts/hinders motions at the flexible ‘hinge’, locking the CRD into a more
restricted set of interconverting conformations with respect to the neck domain.
Given the size of the Man5 ligand, the linear chemical shift perturbations
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obtained, and the fit to a 1:1 binding model, it is unlikely that Man5 is binding to
multiple sites in the CRD, but it is likely that the binding of the glycan has a
marked effect on the dynamics of regions distal to the binding site.
The secondary calcium binding site also responds to glycan binding,
despite the fact that this region has not previously been shown to play a role in
direct glycan contact within any crystal structure. In the holo protein, the
reduced T2 values in this region (T337 was broadened beyond detection) were
attributed to slower internal motions of the loop (on the millisecond to
microsecond timescale) due to binding of Ca2+. This fits with the interpretation of
the relaxation data for the primary Ca2+-binding loop described above. The
further enhancement in transverse relaxation rates upon Man5 binding is less
obvious, since this region of the CRD has not been previously shown to form part
of the extended glycan binding site. The secondary calcium loop lies in close
proximity to the proposed binding site, and given the structural plasticity
proposed for C-type lectins which allows them to accommodate a wide range of
diverse ligands, it is possible that Man5 has a different mode of binding to the
DCSIGNR CRD than was shown for (GlcNAc)2Man3 which includes the secondary
Ca2+ binding loop.
7.5.3 Rotational Correlation Time (τc)
The average T2 value decreased from 76.27 to 66.54 ms upon ligand
binding. This is attributed to slower tumbling of the ligand-bound protein
compared to the holo protein in solution. This was confirmed by using the T1/T2
ratio (Figure 7.5-1(C)) as an estimate of the overall rotational correlation time (τc)
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by first excluding residues with T1/T2 values more than one standard deviation
from the average (and thus experience a significant contribution from either
chemical exchange or internal motion (Clore et al, 1990)). A value for the
relaxation-derived τc of 10.4  0.4 ns was obtained for the holo CRD, which is only
slightly longer than the expected value of 8.55 ns obtained using the general rule
of 0.5 ns τc per 1 kDa molecular weight (Clore et al, 1990; Copie et al, 1996; Kay et
al, 1989). This deviation from the ideal value is not large enough to infer
oligomerization of the CRD, but may reflect a non-spherical shape of the
monomeric protein. There is a modest (~17%) increase in the rotational
correlation time from 10.4 to 12.5 ns upon binding of Man5 to the CRD (Table
7.5-1). The addition of a single Man5 molecule is unlikely to cause any appreciable
increase in the rotational correlation time, and binding induced aggregation
would result in a much larger increase in τc, suggesting that the CRD adopts a
more ‘open’ conformation as a result of Man5 binding. This could be due to the
carbohydrate binding site ‘opening’ to accommodate Man5 (however, this is not
seen in the crystal data for other sugars). A more ‘open’ structure for the ligand
bound state has also been observed for the CRD of galectin-1 (Nesmelova et al,
2010).
In broad terms, comparison of the relaxation and chemical shift
perturbation data demonstrate that while several regions in the CRD undergo
marked changes in dynamics upon glycan binding, many more residues display
chemical shift perturbations. As a result all of the chemical shift perturbations
throughout the CRD cannot be explained by dynamics changes alone. Therefore
ligand-induced conformational changes must also play a role. The extent of these
Chapter 7: Glycan Binding
162
conformational changes warrants further investigation, as no conformational
changes have been observed in any published crystal structures for DC-SIGNR
CRD upon ligand binding. Future work will involve solving the solution structures
of holo- and ligand-bound states in an effort to characterise these conformational
changes.
7.6 Conclusions.
This chapter describes the first solution state NMR studies of glycan
binding to the DC-SIGNR CRD along with the first structural information on
binding to a large, disease-associated ligand: Man9GlcNAc. Chemical shift
perturbation studies allowed investigation of a range of glycans in solution and
provided several interesting observations. The glycan fragments (GlcNAc3,
(GlcNAc)2Man3, Man3, and Man5) investigated all displayed significant chemical
shifts in the primary calcium binding loop, along with residues in β-sheets 6 and 7, 
supporting previous research which shows that this region (and particularly the
EPN motif in the primary calcium binding loop) is responsible for mannose-
specific binding of C-type lectins. However, the perturbation data also shows that
the three glycan fragments have different, extended binding modes. Most
interestingly, α-helix 2 was perturbed most by (GlcNAc)2Man3 (supporting the
1K9J crystal structure which shows that α-helix 2 forms a ‘shelf’ complementary
to the glycan structure) but to a lesser extent by GlcNAc3, Man3 and Man5. In
addition, the loop region formed by residues 382-385 was only perturbed by
(GlcNAc)2Man3 suggesting that this glycan may have a significantly different
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binding mode than Man3 and Man5, possibly due to the GlcNAc moieties.
However, the lack of perturbation in this region by GlcNAc3 suggests that the size
of the (GlcNAc)2Man3 and, possibly, the position of the GlcNAc moieties may also
play a role in the conformational change of this loop region. The unique
perturbations in this loop region are likely due to conformational/dynamics
changes because there are no direct contacts with (GlcNAc)2Man3 in the crystal
structure. In addition, (GlcNAc)2Man3 causes chemical shift perturbations
throughout the CRD, many more than was expected based on the size of the
ligand and the canonical binding site in the crystal. This could be because
(GlcNAc)2Man3 is not a ‘natural’ ligand of DC-SIGNR (it has not been highlighted in
any glycan-array screenings suggesting that DC-SIGNR has very weak affinity for
(GlcNAc)2Man3 (Guo et al, 2004; Yabe et al, 2010)) therefore the CRD must
undergo more extensive conformation/dynamics changes in order to
accommodate it. This is in contrast to Man9GlcNAc binding, which caused fewer
chemical shift perturbations (and in different regions of the CRD) despite it being
larger.
7.6.1 Man9GlcNAc has a Different Binding Mode than the Glycan
Fragments.
Man9GlcNAc displayed significantly different chemical shift perturbations
than the glycan fragments investigated. Most notably, no significant chemical
shift perturbations occur in α-helix 2 despite this helix forming the extended
binding site in the 1K9J crystal structure, and all glycan-bound structures (of small
glycan fragments) of the analogous protein DC-SIGN. This suggests that
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Man9GlcNAc has a significantly different binding mode than the glycan fragments
and that the use of small glycans as models for binding of larger, physiological
ligands should be treated with caution. In addition, this study of the DC-SIGNR
CRD-Man9GlcNAc complex demonstrates that solution state NMR is potentially
more accommodating, informative and essential for the design of drug molecules
that could inhibit binding of large, disease associated carbohydrates and
glycoproteins.
The NMR data presented here also allowed the first estimates of the
binding affinities of the glycan fragments for the DCSIGNR CRD. All three glycan
fragments bound with similar, weak affinities (KD = 1.57-3.5 mM). The affinity of
Man9GlcNAc for the CRD was significantly higher, as indicated by severe signal
broadening unique to this ligand and characteristic of intermediate exchange on
the NMR timescale (which corresponds to KD values in the range 10-3-10-7 M).
This higher affinity could explain why Man9GlcNAc (the largest of the ligands
tested) yielded the smallest number of chemical shift perturbations: the binding
site in the DCSIGNR CRD is “tuned” for this ligand and does not need to rearrange
significantly in order to accommodate it.
7.6.2 The DC-SIGNR CRD is Very Dynamic Even Following Ca2+ and
Man5 Binding.
The chemical shift perturbation data was extended by the first
investigation of the DC-SIGNR CRD dynamics in both the holo and Man5-bound
form. The amount of variable intensity in the HSQC spectrum was reduced upon
addition of calcium. Residues in the primary calcium binding loop were
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particularly affected by calcium addition suggesting that binding of calcium alters
the conformational dynamics of the protein. It is possible that the CRD converts
between multiple conformations in the apo form (causing the line broadening
seen in the apo HSQC spectrum) and that calcium binding hinders the conversion
between these conformations. This is supported by the dynamics data which
shows that the holo CRD displays hindered dynamics in the calcium-binding loops
as well as -helix 1 and residues at the N-terminus. This indicates that (a) there
may be some stabilization of structure in these regions as a result of calcium
binding, (b) the holo CRD is sampling fewer conformations than the apo CRD,
and/or (c) the rate of interconversion between the conformations is slower (more
hindered). However, despite the stabilizing effect of calcium binding, the holo
CRD maintains a level of mobility.
Interestingly, binding of Man5 to the DC-SIGNR CRD did not completely
diminish the dynamics, and interconversion (albeit on a slower timescale) still
prevailed. However, the average T2 value was reduced upon Man5 binding
denoting slower overall global rotational diffusion (larger c) and reflecting
slightly slower internal motions. This would suggest that sugar-binding further
hinders the local internal motions (and the global tumbling), thus further
reducing the overall flexibility of the protein. This is most pronounced in both
calcium-binding loops, -sheets 6 and 7, -helix 1 and the N-terminus. These
results support previous reports which show that the primary calcium binding
loop and -sheets 6 and 7 are sites of key CRD-mannose interactions, while
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highlighting the secondary calcium-binding loop, -helix 1 and the N-terminus as
potentially important new sites.
Binding of Man9GlcNAc was again unique in that these spectra displayed
severe line-broadening, which could be interpreted as further hindered dynamics
in the CRD (compared with Man5–associated CRD). It follows that the larger,
higher-affinity Man9GlcNAc could restrict/slow the motions of the CRD more than
the smaller, low affinity Man5, and that the CRD would interconvert between a
smaller number of possible conformations when this ligand was bound.
7.6.3 Ligand Binding Induces Dynamics/Conformational Changes
Distal to the Glycan Binding Site.
Analysis of the backbone relaxation (and chemical shift perturbation) data
showed that Man5 binding not only had an effect on the dynamics of regions in
the CRD near the proposed glycan binding site (primary calcium-binding loop, -
sheets 6 and 7), but also had a pronounced effect on distal regions of the CRD. On
addition of Man5, the N-terminal half of α-helix 1 along with residues at the N-
terminus (most pronounced for D271) show evidence of hindered dynamics. This
region of the CRD forms the link between the CRD and the helical neck region in
full length DC-SIGNR, and decreased mobility in this region suggests that ligand
induced signals could be propagated through the CRD, along the neck, to the
cytoplasmic region of the full-length protein. Alternatively, ligand binding could
alter the orientation of the CRD with respect to the neck promoting multi-valent
binding by adjacent CRDs.
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It is clear from the chemical shift perturbation data that more residues are
affected by ligand binding than can be explained by direct interaction of the
protein with the oligosaccharides. This implies that the DCSIGNR CRD is a highly
flexible, dynamic domain that can interconvert between multiple conformations.
Further work is needed to confirm the extent of these ligand-induced effects, for
which solution NMR is ideally suited. On-going determination of the solution
structure of both the holo- and ligand-bound CRD along with saturation transfer
difference experiments and further backbone relaxation measurements could
further characterise the conformational and dynamics effects of glycan binding.
In addition, the acquisition of heteronuclear NOE experiments would provide a
more detailed analysis of the protein dynamics using the model-free formalism
described by Lipari-Szabo (Lipari & Szabo, 1982a; Lipari & Szabo, 1982b). In the
future, this work can easily and quickly be extended to investigate more ligands
including disease-associated glycoproteins and potential drug molecules.
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Conclusions & Future
Work.
Complex carbohydrate binding events that occur within the human
immune system are absolutely vital to healthy immune function and to proper
host responses to a wide variety of pathogens and parasites. Greater
understanding of this essential glycoimmunology field promises to provide
important insights into major world health risks such as HIV, tuberculosis and
Gram-negative multiresistance - diseases that remain incurable and possess
salient structural carbohydrates that are central to their infectious cycles. C-type
lectins in serum and on leucocytes and endothelial cells represent some of the
most important receptors for complex carbohydrates and their roles in
contributing to sophisticated pathogen recognition and cellular response
mechanisms are only just beginning to emerge. Structural studies have provided
insights into the mechanisms via which C-type lectins assemble and bind to their
targets with specificity, displaying a range of strategies including oligomerization,
monosaccharide selectivity and, in some cases, extended binding sites
incorporating multiple protein-glycan contacts across broader surfaces of both
lectin domain and oligosaccharide. However, characterisation of the interaction
of larger, disease-associated glycans with C-type lectins (such as HIV-derived
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Man9GlcNAc with the human C-type lectin DC-SIGNR) has not been reported thus
far.
The C-type lectin DC-SIGNR is particularly worthy of study due to its ability
to bind a wide range of disease-associated oligosaccharides via its carbohydrate
recognition domain (CRD) and promote both incis and intrans infection. Several
crystal structures have been solved of the DC-SIGNR CRD which provide valuable
insight in to the protein conformation and extended binding sites responsible for
interactions with small glycan fragments such as (GlcNAc)2Man3 (namely the
‘shelf’ region formed by α-helix 2 and the solvent exposed F325 residue). However,
structures of the DC-SIGNR CRD in complex with larger, disease-associated
glycans remain elusive. As a result, the interactions of the DC-SIGNR CRD with
oligosaccharides such as Man9GlcNAc2, present on the HIV envelope glycoprotein
gp120, are assumed to be analogous to that of the (GlcNAc)2Man3 glycan present
in the 1K9J crystal structure. In addition, the calcium binding properties and
dynamic nature of the CRD have not been investigated.
Here the first solution state NMR study of the DC-SIGNR CRD has been
described. A protocol for the production of uniformly double labelled (15N/13C)
DC-SIGNR CRD in abundance has been successfully developed and the backbone
and side-chain assignment of the CRD in the holo form has been reported. The
assigned HSQC has provided a ‘map’ of the protein backbone and allowed the
characterisation of the binding properties of calcium ions and a variety of glycan
ligands (including Man9GlcNAc) with the DC-SIGNR CRD in solution. The pH
dependence of calcium and glycan binding has also been investigated. In addition,
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solution NMR methods have been used to initiate characterisation of the
molecular dynamics of the CRD in its free and ligand-bound states. These data
have revealed several interesting properties of the DC-SIGNR CRD which are
summarized below.
8.1.1 Calcium Binding Induces Significant Conformational/Dynamics
Changes in the DC-SIGNR CRD.
The data presented here suggest that the DC-SIGNR CRD is highly dynamic
and may convert between multiple conformations in the apo state. The addition
of calcium causes a large number of chemical shift perturbations throughout the
HSQC spectrum suggesting a global conformation/dynamics change in the CRD.
These changes are most pronounced in the primary calcium binding loop, where
signals for residues N361 and N362 are absent in the apo HSQC spectrum. The
calcium induced conformational and dynamics changes could be responsible for
the glycan binding ability of the CRD, possibly by formation of a glycan binding
site or by hindering the inter-conversion between conformational states so that
conformations capable of binding ligands are favoured. However, further work is
needed in order to characterise these calcium induced changes.
EDTA titration experiments revealed that the DC-SIGNR CRD has very high
affinity for calcium. The fact that a calcium-depleted HSQC spectrum is acquired
in the presence of excess EDTA (as opposed to a spectrum identical to the apo
HSQC spectrum) suggests that the calcium binding sites in the CRD may have
different affinities. This supports previous work which has shown that other C-
type lectins, such as the asialoglycoprotein receptor, possess both high and low
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affinity calcium binding sites (Onizuka et al, 2012). The use of techniques such as
isothermal titration calorimetry could help in determining the CRD calcium
affinity in the future.
8.1.2 The DC-SIGNR CRD Releases Ligand at Low pH.
Comparison of HSQC spectra of both holo and glycan-bound DC-SIGNR
CRD at pH 6.8 and 4.2 suggest that the DC-SIGNR CRD releases ligand (and
calcium) at low pH. This supports previous suggestions that the DC-SIGNR CRD
can act as an endocytic receptor in certain cells, internalising ligands and
releasing them in a low pH endosome environment. While the HSQC spectra of
holo and glycan bound CRD at low pH are extremely similar, there are subtle
differences suggesting glycan binding is not completely abolished at low pH
values. Eluting protein bound to a mannose-Sepharose column using pH 4.0
buffer confirmed that the CRD releases glycan at low pH and that the glycan
binding affinity is not completely abolished (as protein eluted across more
fractions than when using the EDTA elution method). Future work is required to
confirm the extent of this pH dependence. In particular, investigation of the apo
CRD at low pH and the effect of pH on mannose-containing ligands (particularly
disease-associated glycans) is required.
8.1.3 Different Binding Modes for Small Glycans Versus Man9GlcNAc.
Interestingly, members of the C-type lectin family contain nonregular
secondary structure in the CRD and, typically, the ligand binding sites are located
in these nonregular regions. Another key feature of the C-type lectin family is its
enormous potential for ligand binding diversity, despite the majority of C-type
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lectin proteins containing the same CRD scaffold. This ligand binding diversity is
due to variety in the non-regular loop regions across C-type lectin family
members (Drickamer & Taylor, 2005). It is very likely that the C-type lectin family
has evolved into a range of homologous proteins (with the same scaffold) with a
very broad spectrum of ligand specificities, including targets of both exogenous
and endogenous origin.
The different binding modes for the glycans studied here, as indicated by
the unique patterns of chemical shift perturbations, support the structural
plasticity proposed for C-type lectins, which allows them to accommodate a wide
range of diverse ligands. All glycans investigated in this study caused
perturbation of protein regions near the principal glycan binding site as suggested
by the 1K9J crystal structure, namely the primary Ca2+-binding loop and β-sheets 
6 and 7. However, each glycan had a unique set of additional perturbations in α-
helices 1 and 2, the N-terminus of the CRD, and the loop region consisting of
residues 382-385. For example, the majority of residues in α-helix 2 were 
preferentially engaged during binding of (GlcNAc)2Man3, which supported its role
as a critical region (along with residue F325) in forming a ‘shelf’ complementary to
the (GlcNAc)2Man3 structure in the extended glycan binding site. However, fewer
residues were affected in α-helix 2 upon binding of GlcNAc3, Man3 and Man5, and
none were affected by Man9GlcNAc binding. This suggests that, while the primary
binding mode (including the primary Ca2+ loop and β-sheets 6 and 7) is similar for 
each glycan, the extended binding sites/modes differ. In addition, the
(GlcNAc)2Man3 glycan causes the largest number of chemical shift perturbations
overall, far more than expected based on the size of the canonical binding site
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present in the 1K9J crystal structure. This could be a result of (GlcNAc)2Man3 not
being a ‘natural’ ligand of DC-SIGNR (as compared to branched oligomannose
structures) therefore the CRD must undergo more extensive
conformation/dynamics changes in order to accommodate it. This is in contrast to
Man9GlcNAc binding, which caused fewer chemical shift perturbations (and in
different regions of the CRD) despite it being larger.
The NMR data presented here also provided the first quantitative
estimates of the direct binding affinities of the small glycan fragments
investigated for the DCSIGNR CRD. All three glycan fragments bound with similar,
weak (KD = 1.57-2.2 mM) affinities. The affinity of Man9GlcNAc for the CRD was
significantly higher, as indicated by severe signal broadening unique to this ligand
and characteristic of intermediate exchange on the NMR timescale (which
corresponds to KD values in the range 10-3-10-7 M). This higher affinity helps
explain the fact that Man9GlcNAc (the largest of the ligands tested) yielded the
smallest number of chemical shift perturbations, i.e. the binding site in the
DCSIGNR CRD is “tuned” for this ligand and does not need to rearrange
significantly in order to accommodate it.
Overall, the data suggest that use of small glycans as models for
illustrating the binding of larger, physiological ligands by lectins such as DC-SIGNR
should be treated with caution. This strongly supports the notion that direct and
empirical investigations of the interactions of large, disease-associated ligands
with the DC-SIGNR CRD are required to provide future understanding of the basic
function of these molecules and also drive the identification and development of
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effective drug molecules that could inhibit these interactions. NMR is ideally
suited for this task as it allows the investigation of large, disease-associated
ligands in solution.
8.1.4 The DC-SIGNR CRD is Very Dynamic.
Whilst several structural analyses of mammalian C-type lectins have
revealed substantial spatial information on glycan ligand binding, the level of
dynamics data relating to these carbohydrate-binding proteins is surprisingly
limited. The fact that members of the C-type lectin family typically possess the
same CRD scaffold, and yet display a wide range of ligand binding specificities and
affinities could mean that the dynamics of these molecules, especially in their
nonregular regions, play important roles. Previous studies on the tunicate C-type
lectin TC14 have shown that the nonregular sequences in the CTLD are rigid
(Poget et al, 2001). However, just as primary sequences and ligand specificity for
the C-type lectin family are many and varied, so too could the dynamic properties
of the assorted domain family members. Indeed, other C-type lectins have been
reported to exhibit flexibility in the nonregular calcium binding loops (Sallum et
al, 2007; Wurzburg et al, 2006).
The data presented here indicate that, contrary to C-type lectins such as
TC14, DC-SIGNR shows considerable flexibility within its nonregular sequences
and this may contribute to its ability to interact with large, flexible glycans and
transduce intracellular signals. In its Ca2+-free form, the apo CRD appeared to be
very dynamic, probably exchanging between an ensemble of conformations. The
holo DC-SIGNR CRD displays hindered dynamics in the calcium-binding loops as
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well as -helix 1 and residues at the N-terminus, indicating that there may be
some stabilization of structure in these regions, the holo CRD is sampling fewer
conformations than the apo CRD, and/or the rate of interconversion between the
conformations is slower (more hindered). However, the CRD maintains a degree
of mobility in the presence of calcium suggesting that the holo CRD still samples
multiple conformations. An explanation for this mobility may be the exchange of
Ca2+ ions on and off the protein (but more work is required to confirm this).
Interestingly, the dynamics are not diminished completely on Man5-
binding, and interconversion (albeit on a slower timescale) still prevailed.
However, the average T2 value was reduced upon Man5 binding denoting slower
overall global rotational diffusion (larger c) and reflecting slightly slower internal
motions. This would suggest that sugar-binding further hinders the local internal
motions (and the global tumbling), thus further reducing the overall flexibility of
the protein. This is most pronounced in both calcium-binding loops, -sheets 6
and 7, -helix 1 and the N-terminus. These results support previous reports that
the primary calcium binding loop and -sheets 6 and 7 are sites of key CRD-
mannose interactions, while highlighting the secondary calcium-binding loop, -
helix 1 and the N-terminus as potentially important new sites for critical lectin-
glycan interactions/conformational rearrangements.
Binding of Man9GlcNAc was again unique in that these spectra displayed
severe line-broadening, which could be interpreted as further hindered dynamics
in the CRD (compared with Man5–associated CRD). It follows that the larger,
higher-affinity Man9GlcNAc could restrict/slow the motions of the CRD more than
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the smaller, low affinity Man5, and that the CRD would interconvert between a
smaller number of possible conformations when this ligand was bound.
8.1.5 Ligand Binding Induces Dynamics/Conformational Changes
Throughout the CRD.
Analysis of the backbone relaxation and chemical shift perturbation data
shows pronounced effects in regions of the CRD distal to the proposed glycan
binding site, particularly at the N-terminus. This region forms the link between
the CRD and the helical neck in full length DC-SIGNR, and suggests that ligand
induced signals could be propagated through the CRD, along the neck, to the
cytoplasmic region of the full-length protein. Alternatively, ligand binding could
alter the orientation of the CRD with respect to the neck promoting multi-valent
binding by adjacent CRDs. Structural analyses of the human C-type lectin CLEC5A
allude to similar possibilities that dynamic changes in the CRD, attributable to
distal glycan binding, could contribute to the transmission of conformational
information and signalling beyond the target binding site to the intracellular
regions of the native polypeptide (Watson et al, 2011). In the case of DC-SIGNR, a
receptor previously believed to be involved primarily in adhesion, evidence of
signalling activity has been demonstrated in the context of respiratory syncitial
virus glycoprotein binding (Johnson et al, 2012).
Changes in the CRD distal to ligand binding site along with the extent of
the chemical shift perturbations mean that more residues are affected by ligand
binding than can be explained by direct interaction of the protein with the
oligosaccharides. This suggests that the DC-SIGNR CRD could undergo a
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conformational change as a result of ligand binding and further highlights that the
CRD is a highly flexible, dynamic domain that can interconvert between a number
of conformations. However, the crystal structures for free and ligand-bound DC-
SIGNR CRD are very similar, and do not suggest conformational rearrangement
upon ligand binding. An alternative interpretation is that glycans bind to multiple
binding sites or experience multivalent binding. For the homologous protein DC-
SIGN, crystallography has revealed multiple binding modes for the glycans Man2
and Man6 (Angulo et al, 2008; Feinberg et al, 2007). However, only a single
binding mode was observed in crystals of (GlcNAc)2Man3 with DC-SIGNR (Feinberg
et al, 2001), and no non-linear chemical shift perturbations or broadening (which
would result from multiple binding sites and/or modes) was observed after
addition of the glycan fragments. The linear chemical shift perturbations also fit
very well to a one-site binding model. Man9GlcNAc binding did result in
broadening of signals, therefore multiple binding modes cannot be ruled out for
this ligand, but taken together with the rest of the data leads to the conclusion
that significant changes (both dynamic and conformational) are taking place in
the CRD as a result of ligand binding in solution that cannot be sampled in the
crystal structures. This inherent flexibility gives the CRD its ability to
accommodate a variety of ligands and potentially transmit information
throughout the protein.
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8.1.6 Future Work.
Further work is needed to confirm the extent of the ligand-induced effects
described above, for which solution NMR is ideally suited. On-going
determination of the solution structure of both holo- and ligand-bound CRD along
with saturation transfer difference experiments and further backbone relaxation
measurements (particularly heteronuclear NOE experiments which will allow a
more detailed analysis of the CRD dynamics through model-free analysis) will
further characterise the conformational and dynamics effects of glycan binding.
In addition, more work is required to confirm the apparent pH dependence of DC-
SIGNR CRD-glycan binding (investigation of mannose-containing ligands is
required). Complementing the NMR data with other techniques such as
isothermal titration calorimetry and surface plasmon resonance could provide
further information on calcium and glycan binding affinities in solution. In future,
the work described here can easily and quickly be extended to investigate more
ligands including disease-associated glycoproteins and potential drug molecules.
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Appendix A: Full Chemical Shift Assignment.
Table A2: Chemical shift assignments of the holo DC-SIGNR CRD. All chemical shifts are listed in ppm and referenced to external DSS. Atoms which are not present in an
amino acid are marked with an ‘x’ and missing assignments with a ‘-‘.
# aminoacid H NH Cα Cβ Cγ Cγ2 Cδ Cδ2 Cε Hα Hβ Hβ2 Hγ Hγ2 Hδ Hδ2 Hε 
261 A - - - - x x x x x - - x x x x x x
262 E - - 62.05 - - x x x x - - - - - x x x
263 R 8.467 122.5 58.88 32.56 - x - x x - - - - x - x x
264 L 6.632 117.8 59.56 42.51 - x - - x - - x - x - - x
265 C 9.101 121.2 51.6 40.6 x x x x x - - - x x x x x
266 R 9.296 123.3 54.98 38.47 - x - x x 5.744 2.681 1.67 1.897 x - x x
267 H 9.139 126 54.42 34.68 x x x x x - - - x x x x x
268 C - - - - x x x x x - - - x x x x x
269 P - - - - - x - x x - - - - x - - x
270 K 9.484 124.5 - - - x - x - - - - - x - x -
271 D 11.53 127.3 - - x x x x x - - - x x x x x
272 W 8.533 120.7 57.42 29.86 x x x x x 5.313 3.661 3.268 x x x x x
273 T 9.744 118.9 62.85 71.85 x x x x x - - x x x x x x
274 F 9.061 128.9 58.15 41.13 x x x x x 5.56 3.37 3.144 x x x x x
275 F 8.752 126.6 59.31 40.95 x x x x x 3.992 2.284 2.221 x x x x x
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276 Q 8.669 127.1 56.79 - - x x x x - - - - x x x x
277 G - - 45.61 x x x x x x x x x x x x x
278 N 7.604 118.1 52.25 44.09 x x x x x 5.397 2.765 2.016 x x x x x
279 C 9.478 117 53.52 43.14 x x x x x 5.878 3.16 2.851 x x x x x
280 Y 9.947 121.2 57.3 41.6 x x x x x 5.86 2.979 2.826 x x x x x
281 F 8.578 125.3 55.42 40.16 x x x x x 4.275 1.242 - x x x x x
282 M 7.732 127 53.97 31.89 33.32 x x x x 4.494 1.631 1.744 2.385 x x x x
283 S 7.768 119.2 59.23 62.5 x x x x x - - x x x x x x
284 N - - 52.54 39.81 x x x x x 5.118 2.844 2.993 x x x x x
285 S 7.255 113.4 56.87 65.33 x x x x x - - x x x x x x
286 Q 8.342 116.7 54.91 32.65 - x x x x - - - - x x x x
287 R 9.616 122.4 55.69 37.34 29.29 x 43.63 x x 4.987 1.726 - 1.899 x 2.662 x x
288 N 9.33 120.5 49.82 37.5 x x x x x - - - x x x x x
289 W 8.243 121 64.11 31.39 x x x x x - - - x x x x x
290 H 7.54 115.7 60.42 30.19 x x x x x 3.916 3.269 3.14 x x x x x
291 D 8.932 118.3 56.16 39.42 x x x x x 4.496 2.532 - x x x x x
292 S 7.917 123.6 63.14 61.97 x x x x x 3.148 3.231 x x x x x x
293 V 7.436 122.9 67.15 31.39 20.96 22.77 x x x 3.276 2.079 x 0.7926
-
0.1229 x x x
294 T 7.412 114.8 65.99 82.33 x x x x x - - x x x x x x
295 A 7.866 124.6 55.32 17.88 x x x x x 4.073 1.185 x x x x x x
296 C 7.722 112.4 55.44 36.43 x x x x x 4.879 2.809 2.696 x x x x x
297 Q 7.882 122.8 59.9 28.17 34.38 x x x x 4.391 2.475 2.257 2.73 2.593 x x x
298 E 8.317 120 59.35 29.97 37.63 x x x x 4.185 2.352 2.245 2.695 2.555 x x x
299 V 7.153 109.7 60.05 30.05 19.38 21.74 x x x 4.773 2.733 x 1.308 1.051 x x x
300 R 7.927 115.7 57.02 26.48 27.8 x 43.54 x x 4.021 2.003 2.044 1.674 x 3.294 x x
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301 A 8.176 120.5 50 24.77 x x x x x 4.996 1.65 x x x x x x
302 Q 8.124 117 54.15 33.78 34.97 x x x x 5.124 2.008 2.201 2.697 2.406 x x x
303 L 9.109 132.9 57.83 43.02 25.6 28.31 x - - 5.025 1.676 x 0.2836 1.221 - - x
304 V 7.967 122.7 65.34 33.62 19.7 22.8 x x x 3.862 2.203 x 1.589 1.198 x x x
305 V 7.1 127.9 60.55 32.92 20.33 22.94 x x x 4.371 1.938 x 1.253 1.409 x x x
306 I - - 61.4 37.74 - - - x x - - x - - - x x
307 K 9.212 123.3 55.26 35.14 24.84 x 29 x 42.25 4.49 1.995 - 1.244 x 1.522 x 2.743
308 T 7.578 107 59.42 73.81 x x x x x 5.293 4.953 x x x x x x
309 A 9.22 125.2 55.08 18.28 x x x x x 4.152 1.568 x x x x x x
310 E 8.974 117.7 60.71 29.12 - x x x x - - - - - x x x
311 E 8.182 123.4 59.68 30.56 - x x x x - - - - - x x x
312 Q 7.757 121.3 58.92 26.16 32.03 x x x x 4.327 - - - x x x x
313 N 8.18 117.1 56.59 38.39 x x x x x - - - x x x x x
314 F 7.701 120.5 60.58 39.25 x x x x x 4.058 2.35 2.392 x x x x x
315 L 7.992 120 57.38 42.3 - x - - x - - x - x - - x
316 Q 8.833 122.3 59.07 28.92 33.95 x x x x 3.667 2.502 - 2.361 x x x x
317 L 7.641 119.8 58 41.65 27.12 x 24.38 - x 4.054 1.583 1.73 - x 0.8994 - x
318 Q 7.559 116.4 58.41 27.88 - x x x x - - - - x x x x
319 T 7.768 111.6 65.32 68.64 x x x x x 3.748 3.657 x x x x x x
320 S 8.111 118.7 61.64 63.16 x x x x x 4.326 4.137 x x x x x x
321 R 8.022 121.3 58.75 30.07 - x - x x - - - - x - x x
322 S 8.649 116 58.46 64.32 x x x x x 5.669 3.978 x x x x x x
323 N 7.873 118.6 54.33 37.55 x x x x x 4.319 3.074 2.709 x x x x x
324 R 7.474 116.5 55.18 32.28 26.37 x 43.24 x x 4.439 1.302 1.244 0.9352 x 2.318 1.868 x
325 F 8.679 125.1 56.84 38.52 x x x x x 5.153 3.123 3.047 x x x x x
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326 S 7.432 113.8 56.5 67.53 x x x x x 5.363 3.662 x x x x x x
327 W 9.895 124.9 57.63 34.33 x x x x x 5.356 3.626 - x x x x x
328 M 8.389 113.9 53.42 37.98 - x x x x - - - - - x x x
329 G 9.889 112.2 48.94 x x x x x x 3.753 x x x x x x x
330 L 8.354 128.3 55.07 46.58 - x - - x - - x - x - - x
331 S 8.55 120.6 58.99 68.18 x x x x x - - x x x x x x
332 D 7.966 123.8 51.9 37.7 x x x x x 4.596 2.155 - x x x x x
333 L 6.662 119.4 57.49 44.5 26.8 x 25.15 - x 3.709 1.487 1.346 0.7396 x 1.038 - x
334 N 7.845 115.6 56.3 38.63 x x x x x 4.438 2.722 2.667 x x x x x
335 Q 7.754 120.7 55.25 30.55 33.88 x x x x 8.493 1.914 1.86 2.2 x x x x
336 E 8.075 128.2 57.16 28.49 34.32 x x x x 3.934 1.677 2.281 2.485 1.896 x x x
337 G 10.91 120.7 45.18 x x x x x x 3.77 x x x x x x x
338 T 8.5 120.9 61.88 69.57 x x x x x 4.614 4.179 x x x x x x
339 W 8.8 128.8 57.95 29.6 x x x x x 4.261 3.23 3.006 x x x x x
340 Q 9.115 123.3 54.73 34.12 34.24 x x x x 5.001 2.137 1.978 2.522 2.251 x x x
341 W 9.566 128.6 57.03 32.11 x x x x x 5.929 3.972 3.59 x x x x x
342 V 9.023 115.1 64.65 32.08 - - x x x - - x - - x x x
343 D 7.382 117.9 53.58 40.64 x x x x x - 3.379 2.684 x x x x x
344 G 8.567 109 45.15 x x x x x x 4.17 x x x x x x x
345 S 8.375 119.2 57.27 63.49 x x x x x - - x x x x x x
346 P - - 62.84 32.84 27.29 x 50.46 x x 4.971 2.399 2.114 2.229 2.286 3.799 - x
347 L 7.936 121.6 55.44 42.86 27.16 x 25.25 23.8 x 3.977 1.683 x 1.721 x 0.9681 - x
348 S 8.991 127.1 56.9 63.94 x x x x x 5.178 3.141 3.032 x x x x x
349 P - - - - - x - x x - - - - x - - x
350 S 7.736 119.9 60.81 63.09 x x x x x 4.39 4.039 x x x x x x
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351 F 8.249 120.5 57.42 39.12 x x x x x 4.589 3.524 3.85 x x x x x
352 Q 7.47 117.6 58.29 27.8 36.93 x x x x 4.232 2.316 2.236 2.613 2.411 x x x
353 R 6.988 113.5 56.52 29.17 27.24 x 31.04 x x 4.166 - - - x - x x
354 Y 6.756 118.3 58.44 34.87 x x x x x - - - x x x x x
355 W 6.444 117.9 57.86 30.69 x x x x x 4.493 3.262 2.895 x x x x x
356 N 9.92 123 53.18 39.15 x x x x x - 3.117 - x x x x x
357 S 114.3 8.515 60.57 63.15 x x x x x - - x x x x x x
358 G - - 45.72 x x x x x x x x x x x x x x
359 E 8.258 118.9 52.81 29.62 - x x x x - - - - - x x x
360 P - - - - - x - x x - - - - x - - x
361 N - - - - x x x x x - - - x x x x x
362 N - - 54.69 - x x x x x - - - x x x x x
363 S 7.606 114 59.55 62.3 x x x x x 4.129 - x x x x x x
364 G 8.588 118.1 46.91 x x x x x x 3.971 x x x x x x x
365 N 7.636 114.5 55.44 36.77 x x x x x 4.241 - - x x x x x
366 E 7.621 123.3 56.14 31.89 26.39 x x x x 4.086 1.999 - - - - x x
367 D 7.999 125.1 51.46 41.59 x x x x x 5.498 2.787 2.656 x x x x x
368 C 8.125 116.5 59.41 49.15 x x x x x - - - x x x x x
369 A 8.102 126.5 52.07 21.38 x x x x x 5.54 1.167 x x x x x x
370 E 9.16 117 52.4 33.39 35.2 x x x x 5.67 1.706 - 2.451 2.061 x x x
371 F 9.382 121.1 59 41.11 x x x x x 4.046 2.282 2.231 x x x x x
372 S 8.719 117 56.42 64.66 x x x x x - - x x x x x x
373 G 8.59 114.9 47.29 x x x x x x - x x x x x x x
374 S - - 58.73 64.32 x x x x x - - x x x x x x
375 G 7.575 113.6 46.61 x x x x x x - x x x x x x -
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376 W 8.369 122.4 53.02 32.59 x x x x x 6.007 2.706 2.552 x x x x x
377 N 9.26 118 51.99 42.48 x x x x x 5.571 - - x x x x x
378 D 9.207 120.7 52.53 42.4 x x x x x 5.374 2.757 2.012 x x x x x
379 N 9.982 125 49.34 42.07 x x x x x 5.477 2.99 - x x x x x
380 R 9.541 122.7 56.84 30.97 - x - x x - - - - x - x x
381 C 8.57 119.9 58.64 46.17 x x x x x - - - x x x x x
382 D 8.555 114.2 54.37 40.44 x x x x x 4.231 3.065 2.837 x x x x x
383 V 7.72 121.2 63.1 32.95 21.65 22.27 x x x 4.207 2.497 x 0.9576 1.203 x x x
384 D 7.808 121.2 54.06 41.37 x x x x x - 2.47 2.991 x x x x x
385 N 8.528 123.2 50.53 41.85 x x x x x 5.237 1.05 2.674 x x x x x
386 Y 7.188 116.4 60.3 37.98 x x x x x - - - x x x x x
387 W - - - - x x x x x - - - x x x x x
388 I - - - - - - - x x - - x - - - - x
389 C - - - - x x x x x - - - x x x x x
390 K - - - - - x - x - - - - - x - x -
391 K - - - - - x - x - - - - - x - x -
392 P - - 63.43 32.56 - x - x x - - - - x - - x
393 A 7.769 123.2 52.81 18.99 x x x x x - - x x x x x x
394 A 8.757 123.5 51.16 21.05 x x x x x - - x x x x x x
395 C - - - - x x x x x - - - x x x x x
396 F - - - - x x x x x - - - x x x x x
397 R - - 56.2 31.27 - x - x x - - - - x - x x
398 D 8.302 122.5 54.59 41.34 x x x x x 5.259 2.781 2.632 x x x x x
399 E 125.8 58.07 31.52 36.69 x x x x 4.214 2.121 1.972 2.253 - x x x -
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Abbreviations.
+FeCl3 M9 media with addition of 100 µL iron.
-CaCl2 M9 media with calcium omitted.
[U-15N-13C] Uniformly 15N and 13C labelled.
γ Gyromagnetic ratio.
1D One-dimensional.
2D Two-dimensional.
3D Three-dimensional.
B0 Applied magnetic field.
BC Protein sample before column purification.
BSA Bovine serum albumin.
CRD Carbohydrate recognition domain.
CSI Chemical shift index.
C-type Calcium binding lectin.
DC-SIGN Dendritic cell specific ICAM-3 grabbing non-integrin
DC-SIGNR Dendritic cell specific ICAM-3 grabbing non-integrin related.
dH2O Deionized water.
d-Hepes Deuterated hepes.
EDTA Ethylenediaminetetraacetic acid.
FT Flow through.
ħ Planck’s constant/2π
HCV Hepatitis C virus
HIV Human immunodeficiency virus.
HSQC Heteronuclear single quantum coherence.
Spin state
ICAM-3 Intracellular adhesion molecule 3.
LB Luria-Bertani broth.
M0 Net macroscopic magnetization.
M9 M9 minimal media.
NMR Nuclear magnetic resonance.
NOE Nuclear Overhauser effect.
NOESY Nuclear Overhauser effect spectroscopy.
OD Optical density.
P1 Pellet 1.
P2 Pellet 2.
pre-ind Pre-induction.
R1 Longitudinal relaxation rate.
R2 Transverse relaxation rate.
RF Radio frequency.
SARS-CoV Severe acute respiratory system coronavirus.
Abbreviations
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T1 Longitudinal relaxation time.
T2 Transverse relaxation time.
TOCSY Total correlation spectroscopy.
W Wash fraction.
ω0 Larmor frequency.
§ Section.
